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 Osteoarthritis, a degenerative joint disease that affects nearly 30 million Americans, is 
characterized by lesions of articular cartilage that often lead to severe pain and loss of joint function. The 
current economic burden of osteoarthritis is estimated to be approximately $190 billion, and with the 
prevalence of arthritis expected to rise due to the aging population, the associated costs are forecasted to 
increase. Debilitating osteoarthritis is managed clinically by the surgical implantation of a cartilage graft or 
cartilage cells to replace the damaged tissue; however, current repair methods often result in poor long-
term outcomes due to inadequate integration of the graft with host cartilage and bone. Thus, there is a 
significant clinical need for approaches that enable functional connection of grafting devices to the host 
tissue. To address this challenge, the strategy described in this thesis is a versatile, cup-shaped fibrous 
scaffold system designed to promote the simultaneous integration of the cartilage graft with both the host 
cartilage and subchondral bone. This thesis is guided by the hypotheses that 1) graft integration with 
native cartilage can be strengthened by inducing chondrocyte migration to the graft-cartilage junction 
through chemotactic factor release from the walls of the cup, and 2) graft integration with host bone and 
the formation of calcified cartilage can be facilitated by pre-incorporation of calcium phosphate 
nanoparticles in the base of the cup.  
To test these hypotheses, a microfiber-based integration cup was designed with degradable, 
polymer-based walls that release insulin-like growth factor-1, which is well-established for inducing 
chondrocyte migration, and a base consisting of polymer with calcium deficient apatite nanoparticles. In 
the first aim of this thesis, the dose of insulin-like growth factor-1 in the cup walls was optimized to 
enhance the migration of cells from surrounding cartilage into the scaffold, and this design was tested in 
vitro to ensure that the scaffold supports chondrocyte viability, growth, and biosynthesis of a cartilage-like 
matrix. In the second aim of this thesis, the composition and dose of calcium phosphate in the base of the 
cup was optimized to support chondrocyte growth and the production of calcified cartilage-like tissue. 
Subsequently, in the third aim, the independently developed walls and base were joined into a scaffold 
 
that was tested in vitro and in vivo, using a simulated full thickness defect model, to examine its potential 
for clinical translation. Results from these studies demonstrate that the cup system can be implemented 
with autologous tissue and cell-based grafting strategies as well as with tissue engineered hydrogel grafts 
to promote integration with host tissue. Moreover, these investigations have yielded new insights into both 
chemical and structural parameters that direct chondrocyte migration and calcified cartilage formation. 
In summary, this thesis describes the design and optimization of a novel, multi-functional device 
for improving integration of cartilage grafts with host tissues. The impact of the studies in this thesis 
extends beyond cartilage integration, as the interface scaffold design criteria elucidated here are readily 
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CHAPTER 1: INTRODUCTION  
2 
1.1 Specific Aims 
Osteoarthritis, a degenerative joint disease, is a leading cause of disability among Americans [1]. This 
condition is characterized by lesions of articular cartilage that often lead to severe pain and loss of joint 
function. Since cartilage has a limited capacity for self-repair [2], surgical intervention is often required for 
treatment. Current repair methods are associated with poor long-term outcomes due to unwanted 
fibrocartilage formation and inadequate repair tissue integration with both host cartilage and subchondral 
bone [3-6]. A variety of hydrogel-based cartilage grafts have been investigated for cartilage repair with 
promising results [7-12]; however, the integration of cartilage grafts with host cartilage remains a 
translational barrier. In addition to structural contiguity between neo and host cartilage, the presence of a 
structural barrier between the healing cartilage and bone is also critical to limit osseous invasion and 
maintain the integrity of the repaired cartilage [13].  
To address the challenge of graft integration, the goal of this thesis is to develop and optimize a 
bioactive integration scaffold to enable the biological fixation of the cartilage graft with both the host 
cartilage and subchondral bone. For cartilage-cartilage integration, the ideal scaffold should promote cell 
migration into the region between the graft and native cartilage and encourage neo-cartilage formation. 
For cartilage-bone integration, the scaffold should serve as a temporary barrier during healing while 
integrating the graft to the bone by promoting the formation of calcified cartilage tissue that is rich in 
collagen II and proteoglycans.  
The research strategy described in this thesis 
centers on the design of a cup-shaped scaffolding 
system in which the walls of the cup are designed for 
cartilage-cartilage integration, and the base of the 
cup is designed to promote cartilage-bone integration 
via osteochondral interface regeneration (Fig. 1.1). 
Poor graft integration with native cartilage results 
from reduced cell density at the wound edges caused 
by cell death associated with surgical intervention. Stimulating cell migration to the graft-cartilage 



















Figure 1.1 Schematic 
of the integrative 
scaffold with 
optimized phases for 
integration with the 
surrounding bone 
and cartilage  
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the walls of the cup will be designed to promote cartilage integration by releasing insulin-like growth 
factor-1 (IGF-1), which will be optimized in Aim 1. For cartilage-bone integration, hydrogel scaffolds 
promote the formation of calcified cartilage-like matrix [11;15], fibrous ceramic scaffolds have been shown 
to enhance scaffold-bone integration [16], and the combination of hydrogel and fibrous scaffolds has been 
shown to result in organized calcified cartilage formation [17]. Therefore, in Aim 2, both hydrogel- and 
fiber-based ceramic composites will be investigated as components for the base of the cup. Ceramic 
properties and dosage will be optimized to promote calcified cartilage formation. In Aim 3, the walls will be 
joined to the base to form a cup, and the system will be evaluated in vitro and in vivo using a full 
thickness defect model. The working hypothesis of this thesis is that a scaffold with IGF-1-releasing 
walls and a mineral-containing base can enhance graft integration, thereby improving long-term success 
of cartilage repair. Accordingly, the three research aims and related hypotheses are:  
 
Aim 1:  
 
Hypothesis: 
Design, characterize, and optimize a polymer fiber-based scaffold for cartilage-
cartilage integration 
IGF-1 release can be optimized to produce a scaffold that homes cells and supports 





Design, characterize, and optimize a polymer-ceramic composite scaffold for 
cartilage-bone integration 
Ceramic composition and dose can be optimized to enhance chondrocyte viability, 
growth, and matrix production in agarose and microfiber scaffolds 
 
Aim 3:  
Hypothesis: 
Fabricate and evaluate the cup scaffold system in an explant model 
The phases optimized in Aims 1 and 2 can be combined to support the integration of a 
cartilage graft with the surrounding tissue without impairing viability or matrix 
maintenance of native cartilage and bone  
 
Specifically, Aim 1 will center on the fabrication and optimization of a bioactive polymeric scaffold to 
promote cartilage-cartilage integration. An IGF-1-releasing, degradable scaffold will be fabricated to 
bridge the gap between the cartilage graft and native tissue, supporting localized matrix elaboration over 
time. Insulin-like growth factor-1 promotes chondrocyte and stem cell migration [14;18] and will therefore 
be incorporated into the scaffold to attract cells. Electrospinning will be used to generate fibrous scaffolds 
because it allows tuning of material properties [19;20] and incorporation of growth factors [21-23]. The 
dose of incorporated IGF-1 will be optimized to maximize cellular infiltration (chapter 2), and the response 
of chondrocytes, which will likely be responsible for neo cartilage formation in the cup walls will be 
4 
determined (chapter 3). Overall, the anticipated benefit of the cup walls is that IGF-1 release will induce 
cell migration to the native tissue-graft junction, resulting in matrix deposition that integrates the host and 
graft cartilage.  
Aim 2 will focus on the optimization of a scaffold that promotes cartilage-bone integration through the 
regeneration of calcified cartilage. Recent preliminary results from a rabbit in vivo study revealed that the 
combination of agarose-hydroxyapatite (HA) and poly(lactide-co-glycolide) (PLGA)-HA scaffolds resulted 
in more organized interface formation than a hydrogel or fibrous scaffold alone. This result suggests that 
a polymer-hydrogel-ceramic hybrid scaffold may be optimal for calcified cartilage regeneration [17]. 
Furthermore, it is hypothesized that matrix elaboration can be further enhanced with the incorporation of a 
bioactive ceramic. To this end, the ceramic phase of the scaffold will be optimized in terms of composition 
(chapter 4) by evaluating deep zone chondrocyte (DZC) proliferation and matrix production over time in 
an agarose hydrogel scaffold. The dose of the bioactive ceramic will be optimized in both agarose 
(chapter 5) and microfiber (chapter 6) scaffolds for the base of the cup. It is anticipated that a polymer-
hydrogel-ceramic scaffold with an optimal bioactive ceramic dose will support the generation of a dense, 
mineralized matrix that is rich in both proteoglycans and collagen, similar to the calcified cartilage.  
After the completion of Aims 1 and 2, the translational potential of the integrative scaffold system will 
be evaluated in Aim 3. Specifically, the cartilage-cartilage integration scaffold will be attached to the 
cartilage-bone integration scaffold to build a cup, and the optimized agarose-ceramic scaffold will be 
added to the base. A full thickness defect model will be developed, characterized, and used to test the 
efficacy of the scaffold system in terms of integration with both cartilage and bone in vitro (chapter 7) and 
in vivo (chapter 8). Matrix formation will be evaluated using histology, with a focus on cellularity as well as 
proteoglycan and collagen deposition at the graft-native tissue junctions.  
In order to promote integrative cartilage repair, the studies outlined in this proposal consist of (1) 
complex scaffold design and optimization, as well as (2) development and implementation of a full 
thickness cartilage defect model. The proposed approach is unique because it aims to address both the 
integration of a cartilage graft with the native cartilage and with bone through osteochondral interface 
regeneration. It is anticipated that the optimized scaffold system will improve integration of cartilage grafts 
and long-term clinical success. Moreover, these studies have significance in fields beyond cartilage 
5 
repair, as they will likely establish key parameters for modulating cell-ceramic response, establish scaffold 
design criteria that can be applied at other graft-tissue junctions, and develop organ culture parameters 
that can be extended to new explant culture systems.  
 
1.2 Background and Significance 
1.2.1 The Structure and Function of Healthy Articular Cartilage and the Osteochondral Interface  
Healthy cartilage tissue is composed of liquid and solid phases that together facilitate load bearing 
and joint articulation [24]. The extracellular matrix is actively maintained by resident chondrocytes and is 
rich in proteoglycans [25;26] as well as collagen II, with smaller amounts of collagen III, VI, IX, X, and XI 
present [27-30]. The charged proteoglycans attract water that swells the tissue, allowing it to support 
compressive loads, while the tensile properties of the collagen network contribute swelling resistance and 
shear strength [24;31-35]. In addition, interstitial fluid pressurization, combined with molecules released 
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Cartilage is organized into four structurally contiguous zones defined by variations in matrix 
composition, structural organization, and chondrocyte phenotype [37-39]. The surface zone, located at 
the articulating edge of the cartilage, accounts for approximately 10% of the height of the total tissue. This 
zone consists of thin, elliptical chondrocytes combined with progenitor cells that are surrounded by a 
matrix with high water content (~78%), low proteoglycan content relative to the other zones, and collagen 
fibrils (4-12 nm) that are oriented parallel to the surface [40-50]. The cells in this zone produce superficial 
zone protein that contributes to the lubrication of the joint [51;52]. Below the surface, the next 40-60% of 
the cartilage depth consists of the middle zone, within which spherical chondrocytes reside in a matrix 
rich in proteoglycans and randomly aligned collagen fibrils (9-60 nm) [44;46-49]. The deep zone, located 
below the middle zone, comprises approximately 30% of the cartilage depth and is marked by spherical 
chondrocytes oriented in stacks that are perpendicular to the articular surface. These cells, while sparsely 
distributed, maintain a matrix of relatively high glycosaminoglycan (GAG) content, relatively low water 
content (~68%), and radially oriented collagen fibrils (60-140 nm) [41;45;47-50]. Although the collagen 
fibrils generally increase in diameter from the surface to the deep zone, fine fibrils have been noted 
throughout the depth of the cartilage in human specimens [45-47]. 
Between the deep zone and the subchondral bone is the osteochondral interface which is comprised 
of hypertrophic chondrocytes embedded in a mineralized matrix rich in collagen II and proteoglycans. In 
humans, the calcified cartilage is reported to range from 20 to 243 µm in thickness, with this wide range of 
reported values accounted for by variability in age and total cartilage thickness [39;53;54]. In a study that 
histologically evaluated decalcified healthy human cartilage after exposure to a variety of enzymatic 
digestions, Fawns et al. first coined the term “tidemark” to reference the line that marks the limit of 
calcification [55]. Using scanning and transmission electron microscopy (SEM and TEM, respectively), 
Bullough et al. directly imaged the calcification front of adult canine cartilage harvested from the tibia 
plateau after removing the organic matrix either chemically or via exposure to high temperatures. 
Although the calcified cartilage is tightly interlocked with the underlying subchondral bone, a distinct 
border between the two tissues was observed that is actively regulated by living chondrocytes [56]. While 
the subchondral bone is highly vascularized, SEM imaging of mature human, lapine, and canine cartilage-
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bone junctions revealed that most blood vessels terminate at the interface in healthy tissue and are 
separated from the calcified cartilage by a layer of bone [57].  
The calcified cartilage matrix is composed primarily of proteoglycans, mineral, and collagen II, IX, and 
X [27;58-60]. Highly aligned collagen II fibers run continuously from the deep zone into the calcified 
cartilage layer [61-63]. The alignment of the collagen bundles at the transition and the interdigitated 
nature of the calcified cartilage-bone junction together serve to anchor the non-calcified cartilage to the 
bone [62;64]. In a study by Redler et al., 30 human osteochondral specimens were examined using SEM, 
and the authors proposed that the undulating junction provides an ideal geometric configuration to resist 
the shearing action of articulation [64]. In addition, the network of branching collagen fibrils at the 
interface also contributes to the load bearing capabilities of the joint by diffusing and distributing load 
during force transmission from the cartilage to bone, reducing stress concentrations at the interface 
[62;64].  
In addition to anchoring the cartilage to the bone, the collagen fibers also serve as a template for 
mineralization [55;56]. In a study that characterized the mineral in human bone and calcified cartilage, 
Zizak et al. noted a striking change in the mineral particle orientation from perpendicular to the interface in 
the calcified cartilage to parallel to the interface in the bone, reflecting the underlying alignment of the 
collagen fibers [65]. While the collagen fibers run continuously from the calcified cartilage to the deep 
zone, the mineral is localized to the calcified cartilage and bone regions, with an exponential increase in 
mineral content between non-calcified and calcified regions that persists with age [66]. This calcified 
collagen and proteoglycan network imparts strength to the calcified cartilage which has been 
characterized via a three-point bending test and nanoindentation. Using a three-point bending test, bovine 
calcified cartilage stiffness has been measured to be approximately 0.32 ± 0.25 GPa, which is 
intermediate between uncalcified cartilage and bone [67]. A modulus ranging from 10-30 GPa [68;69] has 
been reported for nanoindentation measurements of human femoral calcified cartilage. Interestingly, a 
direct positive correlation between mineralization and mechanical properties was demonstrated in adult 
human femoral calcified cartilage [69]. 
The calcified cartilage mineral is poorly crystalline carbonated hydroxyapatite that is similar to bone 
mineral in terms of both chemistry and size (2-4.2 nm) [59;61;65;70]. It is reported that calcified cartilage 
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has a higher calcium content than bone, although values reported for the calcium content of the interface 
range from 1-28 wt% [65;68]. The dense, mineralized matrix acts as a barrier that limits diffusion and 
prevents osseous invasion from the subchondral bone [13]. In the calcified cartilage of mature murine [71] 
and equine [72] specimens, the diffusion coefficient of small molecules (~400 Da) was 0.26 and 0.9 
µm
2
/s, respectively. In the equine model, the diffusion coefficient in the calcified cartilage was five-fold 
lower than in the uncalcified region, highlighting the barrier effect of the calcified cartilage layer. However, 
using fluorescence loss induced photobleaching (FLIP), patches of nonmineralized regions were found 
that may serve as transport pathways for small molecules, accounting for 22% of the volume of calcified 
cartilage in the murine model. This finding suggests that the calcified cartilage may have a complex, 
multifaceted role in the transport of molecules between the bone and articular cartilage [71].  
1.2.2 Age- and Disease-Related Changes 
Structural and functional changes in cartilage with age are well established and have recently been 
reviewed in detail [73]; however, a brief summary is provided here. Hallmarks of the normal aging process 
in human cartilage include decreased thickness and cellularity [74] as well as an accumulation of 
advanced glycation end-products that alter collagen crosslinking, disrupting matrix integrity [75]. The 
earliest changes are observed in the superficial zone, with a 50% decrease in chondrocyte density 
reported between 20 and 90 years of age. As cell density declines, it is likely that intrinsic repair is further 
diminished, leading to an increased risk of fibrillation and osteoarthritis [74].  
Changes are also observed in the calcified cartilage with age. The thickness of human calcified 
cartilage decreases with age [53] and becomes less permeable as it transitions to serve as a barrier to 
solute diffusion from the bone in adult years [76]. A steady decline in the number of blood vessels is 
observed with age in human femoral and humoral heads. This decline continues into the seventh decade 
of life, at which point the trend reverses to increased vascularization [77]. Parallel trends in remodeling 
have been reported, suggesting that blood vessel presence may be correlated to an active remodeling 
state [77].  
Accumulation of these age-related changes can lead to osteoarthritis. This disease is a result of the 
disruption between the inherent homeostasis of anabolic and catabolic processes and leads to fibrillation 
of the articulating surface, osteophyte formation, and subchondral bone thickening [49;78-80]. This 
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process may be initiated gradually by wear that occurs during aging or rapidly due to trauma, such as a 
ligamental or meniscal injury [81]. While the specific factors that initiate joint degeneration are unknown, 
Bullough noted that age-related degeneration first occurs in areas of unloaded cartilage. From this 
observation, he proposed that, as the joint remodels with age, areas of cartilage which were previously 
unloaded and had thus degenerated are exposed to new levels of load, leading to overtaxing. This 
process results in further degeneration that may lead to osteoarthritis [82;83]. Conversely, osteoarthritis 
may begin with changes in the subchondral bone, such as cracking, that result from overloading and 
occur beneath the intact hyaline cartilage, leading to subchondral bone collapse and eventual lesion 
formation in the articular cartilage [84]. 
Although catabolic processes overtake anabolic activities, the disease state is accompanied by an 
increase in overall chondrocyte activity [85]. The net loss of proteoglycans and the disruption of the 
collagen network have been attributed to increased matrix metalloproteinase (MMP) and aggrecanase 
activity as well as changes in chondrocyte phenotype, such as collagen III production [86;87]. Shifts in the 
underlying matrix architecture consequently result in lower compressive and tensile mechanical 
properties [32;88-90], ultimately compromising joint function. 
1.2.3 Challenges in Cartilage Repair  
Inherently, cartilage has a limited capacity for self-repair due to its avascular and aneural nature [2]. 
Consequently, spontaneous healing does not occur in partial thickness defects. In full thickness defects, 
spontaneous repair tissue can be generated, as bleeding from the bone carries both cells and growth 
factors into the cartilage lesion. In such cases, the regenerated tissue is fibrocartilaginous in nature, 
mechanically inferior to native tissue, and usually does not persist over time [2;91;92].  
Surgical intervention is often implemented to encourage a healing response in partial thickness 
defects and improve healing in full thickness lesions. Clinical treatments that provide access to the 
osseous vascular supply include subchondral drilling and microfracture [93-95]. Larger defects are often 
treated with osteochondral transplantation, in which plugs from cadavers or non-load bearing regions of 
the patient’s own joint are transplanted into the damaged area [96;97]. Cell-based approaches [98] and 
tissue engineered constructs have also emerged as a promising alternative to existing treatment options. 
Despite their promise, current grafts have focused primarily on cartilage and bone regeneration, and as a 
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result, two challenges are integration of cartilage grafts with 1) native articular cartilage and 2) 
subchondral bone. Cartilage-cartilage integration is critical for stable repair because, in the absence of 
continuity between host and neo cartilage, micromotion between the graft and adjacent tissue can fuel 
further cartilage degeneration [99]. Regeneration of the osteochondral interface is also necessary for 
stable repair because this calcified cartilage layer contributes to graft-bone integration, mechanical 
functionality, and long-term stability. The importance of a structural barrier separating the bone and 
healing cartilage was demonstrated by Hunziker et al. using a full-thickness cartilage defect model. It was 
observed that a structural barrier, in this case a Gore-Tex® membrane (0.2 µm pore diameter), placed 
between the cartilage and bone compartments was necessary to maintain the integrity of the newly 
formed cartilage, largely by limiting vascular ingrowth from the subchondral bed and preventing ectopic 
mineralization [13].  
1.2.4 Current Efforts in Cartilage-Cartilage Integration 
Cartilage-cartilage integration is necessary for incorporation of graft systems into the defect over time. 
Surgical preparation for cartilage graft placement involves the removal of the damaged cartilage directly 
surrounding the lesion to ensure that the graft is well shouldered by healthy tissue. This process can 
result in chondrocyte apoptosis and necrosis [100], leaving a hypocellular region surrounding the defect 
[101]. As a result, the integration of the new cartilage graft with surrounding native tissue is a significant 
hurdle [102;103]. Approaches to overcome this challenge have largely focused on increasing cellularity in 
the boundary region via chemotactic agents that draw viable cells into the gap between the graft and 
native tissue or digestion rinses that break down the dense matrix at the border of autografts/allografts to 
facilitate cell migration [104-107]. The use of digestion reagents, such as hyaluronidase [104-106], 
collagenase [104-106], and chondroitinase ABC [104;107;108], have been investigated. Lee et al. 
demonstrated the utility of digestive rinses for improving cartilage integration by showing that treatment of 
cartilage explants with chondroitinase ABC (1 U/mL for 5 minutes or 0.5 U/mL or 1 U/mL for 15 minutes) 
led to enhanced chondrocyte adhesion, as measured by a micropipette micromanipulation system [109]. 
Similarly, treatment with collagenase at 10 U/mL [106] and 30 U/mL [105] increased cellularity in the 
edges of bovine full thickness explants in vitro. Combined treatment with hyaluronidase (0.1%, 24 hours) 
followed by collagenase (10 U/mL or 30 U/mL, 24 hours) resulted in cellular concentrations in the wound 
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edge that exceeded that of healthy tissue [106]. By adjusting the doses and treating with the two enzymes 
simultaneously (300 U/mL collagenase with 3% hyaluronidase for 1 hour), improved cartilage-cartilage 
integration was demonstrated histologically between bovine explants that were cultured subcutaneously 
in an athymic rat for 35 days [106]. The safety of these treatments has been investigated by Quinn & 
Hunziker with regard to changes in cell density, structure, and cell-mediated matrix deposition that result 
from choindroitinase ABC treatment (1 U/mL for 5 minutes). While chondroitinase ABC treatment did 
appear to further decrease cell densities within 100 µm of the defect surfaces, the decrease was small 
compared to the effect of the defect itself and was contained to the area immediately adjacent to the 
defect (within 100 µm), demonstrating that digestive treatments can be spatially controlled [108].  
Given the low cell density naturally surrounding defects and the further reduction in cell number 
immediately following digestive rinses, methods that actively recruit cells into the edge of the graft are an 
attractive option to draw viable cells to the wound edge. Chemotactic agents that have been explored for 
this purpose include platelet derived growth factor (PDGF) [14;110], insulin-like growth factor I (IGF-1) 
[14;18;110], basic fibroblast growth factor (bFGF) [14;110], vascular endothelial growth factor (VEGF) 
[110], and a variety of factors from the bone morphogenic protein (BMP) family [110]. Boyden chamber 
assay results indicate that PDGF, IGF-1, and bFGF effectively stimulate migration of bovine articular 
chondrocytes at 25, 50, and 100 ng/mL but are not effective at lower doses, such as 5 ng/mL [14]. A 
combination of matrix digestion and chemotactic stimulation was evaluated by McGregor et al. using 
bovine metacarpophalangeal joint cartilage, in which the zone of death resulting from the OATS™ 
harvesting tool was approximately 173 μm. Several growth factors alone and in combination with a 
collagenase rinse led to an improvement in the repopulation of the zone of death. Combined treatment 
with collagenase (0.6%, 10 mins) and IGF-1 (25 ng/mL) resulted in the greatest reduction in the depth of 
the death zone (~50% of the untreated control) at four weeks [14].  
More recently, material-based approaches have been investigated. For example, Wang et al. 
designed a “glue” by functionalizing chondroitin sulfate with methacrylate and aldehyde groups that form 
chemical bonds with both the native tissue and an acrylate-based scaffold [111]. This glue was tested in 
vitro via application to a cartilage explant and in vivo using a subcutaneous mouse model. The glue 
results in fixation of the poly(ethylene glycol) diacrylate (PEGDA) hydrogel construct to the cartilage, 
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exhibiting an integration strength that exceeds the bulk strength of the PEGDA hydrogel. While this 
system is a promising solution for integrating PEGDA-based hydrogels to the surrounding cartilage, it 
requires specific reactive chemical groups in the hydrogel in order to be an effective adhesive. Maher et 
al. developed a biodegradable, chondrocyte-laden nanofibrous hydrogel for the gap between the native 
and newly formed cartilage in order to improve the mechanical stability of the interface [112]. When the 
seeded scaffold system was tested in an in vitro cartilage gap model and supplemented with transforming 
growth factor β3 in the media, matrix elaboration was enhanced, with a resultant increase in maximum 
push-out strength. While this study highlights the importance of growth factors and cellularity in achieving 
cartilage-cartilage integration, the scaffold system discussed did not provide a mechanism to achieve 
local growth factor delivery or promote increased cell migration into the scaffold in vivo.  
1.2.5 Current Efforts in Cartilage-Bone Integration 
Tissue engineering approaches to achieve cartilage-bone integration have included single phase, 
multiphase, and gradient scaffold designs. Single phase scaffold designs have been evaluated in which 
cells are seeded onto bone scaffolds in order to generate calcified cartilage and cartilage-like tissue atop 
a bone-like material [113-117]. In addition, single phase hydrogel scaffolds which aim to regenerate the 
calcified cartilage layer and are designed to integrate with the underlying bone have been investigated 
[11;15]. Distinct from single-phase scaffolds, bi-layered scaffolds have been developed that combine 
cartilage and bone scaffolds using fibrin [118-121], suturing [122], polymer polymerization [123], layered 
hydrogel gelation [124], and electrospinning [125]. While these studies aimed to regenerate both cartilage 
and bone, interface regeneration was often not the focus, and therefore minimal analysis was performed 
to evaluate this end-point. 
Tri-phasic scaffolds that include a third distinct phase between the cartilage and bone have been 
designed to more closely mimic the native osteochondral architecture. For example, Kon et al. developed 
an acellular, tri-layered osteochondral scaffold that utilized a combination of calcium phosphate and 
extracellular matrix components to recapitulate the interface. The upper, intermediate, and lower layers 
consisted of 100% collagen I, 60% collagen I and 40% HA, and 30% collagen I and 70% HA, respectively 
[126]. The layers were joined via freeze drying and tested in an equine osteochondral defect. After in vivo 
culture, distinct unmineralized and mineralized regions were present. More recently, this scaffold was 
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tested in a pilot clinical trial of 30 patients in which safety and potential clinical benefit were demonstrated 
after a two year follow-up [127]. A novel scaffold composed of agarose hydrogel and composite 
PLGA/45S5 bioactive glass microspheres supported the region-specific co-culture of chondrocytes and 
osteoblasts. This design led to the production of three distinct yet continuous regions containing cartilage, 
calcified cartilage and bone-like matrices [128]. Marquass et al. introduced a tri-phasic scaffold consisting 
of a TCP layer to mimic bone and a collagen I hydrogel to mimic cartilage that were joined together by an 
intermediate activated plasma phase. When seeded with autologous mesenchymal stem cells (MSCs), 
the tri-phasic scaffold performed comparably to osteochondral autografts after one year in an ovine model 
[129]. In a study by Cheng et al., MSC-collagen microspheres were pre-differentiated into chondrocytes 
and osteoblasts using a novel collagen microencapsulation technology [130]. The microspheres were 
aggregated to form chondrogenic and osteogenic layers in an osteochondral scaffold with a middle layer 
of undifferentiated MSCs. Formation of a calcified cartilage interface occurred only in the group with all 
three layers, while no interface was observed when undifferentiated MSCs were cultured on bi-layered 
scaffolds with either chondrogenic or osteogenic layers. Heymer et al. fabricated a tri-layered scaffold 
with a hydrophobic interface to separate the cartilage and bone portions of the scaffold, comprised of 
collagen I fibers and polylactic acid, respectively [131]. When stem cells were seeded on the polylactic 
acid portion above the interface and cultured for three weeks in vitro, cartilage-like tissue was formed.  
Scaffold designs utilizing a compositional gradient have also been developed for osteochondral tissue 
repair [132-140]. While gradient scaffolds may offer a promising approach to achieve integration between 
cartilage- and bone-like phases, many of these scaffolds have yet to be tested in vitro or in vivo, and 
cellular studies that have been performed are preliminary, with a focus on achieving distinct cartilage and 
bone regions and little focus on the interface region.  
1.2.6 Summary 
Despite the promise of tissue engineering for osteochondral regeneration, achieving stable and 
integrative cartilage repair remains a significant clinical challenge. In addition, the native osteochondral 
interface, which is critical for cartilage maintenance over time, is not re-established using current tissue 
engineering approaches. As a result of these shortcomings, there is a significant clinical need for 
alternative repair solutions that encourage graft integration. In order to accomplish these goals, the 
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studies in this proposal consist of 1) complex scaffold design and optimization, as well as 2) development 
and implementation of a full thickness defect explant model. Scaffold phases for the cartilage-cartilage 
integration and cartilage-bone integration will be individually optimized. Subsequently, the two phases will 
be joined to form an integrative scaffold system to augment cartilage grafts and tested in an explant 
model.  
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CHAPTER 2:  EFFECT OF IGF-1 DOSE ON 
CHONDROCYTE MIGRATION  
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2.1 Introduction  
This thesis begins by focusing on the challenge of cartilage-cartilage integration. Hypocellularity at 
the graft-host interface contributes to the lack of integration between grafted and host cartilage [102;103]. 
The results of several published studies indicate that growth factors that induce cell homing improve 
integration [14;112] and repair [141]. Inspired by these findings, this study optimizes the release of 
insulin-like growth factor-1 from a microfiber scaffold that can be placed at the graft-host interface to 
promote cell migration from adjacent cartilage tissue. 
2.1.1 Background and Significance 
This study optimizes a microfiber scaffold, which releases insulin-like growth factor-1, that can be 
placed between a cartilage graft and the surrounding host tissue to promote cell migration to the healing 
cartilage-cartilage interface. Cartilage integration is hindered by the low cell density at the junction of the 
graft and native cartilage. In addition to the naturally low cellularity of cartilage [101], the trauma 
associated with surgical intervention can further reduce the cell density of the tissue at the wound edge 
via induction of chondrocyte apoptosis and necrosis [100], leaving a hypocellular region surrounding the 
defect [101]. To address this barrier to healing, it is envisioned that a thin, insulin-like growth factor-1-
releasing scaffold, which lines the cartilage defect and encases the cartilage graft, will home cells directly 
to the interface of the graft and host tissue, thus facilitating cell-mediated integration. 
To date, most cartilage-cartilage integration strategies have aimed to increase cellularity in the 
boundary region either by digestion rinses that break down the dense matrix at the border of 
autografts/allografts to facilitate cell migration [104-107] or chemotactic agents that draw viable cells into 
the gap between the graft and native tissue. Specifically, insulin-like growth factor-1 has been reported to 
increase chondrocyte migration in boyden chamber assays [14;18] and decrease the zone of cell death in 
cartilage explants when introduced via media supplementation at dose of 25 ng/mL [14].  
The necessity of recruiting cells to the defect site has been demonstrated using a miniature pig model 
in which fibrin with incorporated chemotactic and mitogenic factors was used to repair a partial thickness 
defect [141]. This one-step repair approach demonstrated the promise of growth factor delivery from a 
scaffold to achieve cartilage repair. More recently, material-based integration approaches have been 
investigated. Maher et al. developed a biodegradable, chondrocyte-laden, nanofibrous hydrogel for the 
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gap between the native and grafted cartilage in order to improve the mechanical stability of the interface 
[112]. When the seeded scaffold system was tested in an in vitro cartilage gap model and supplemented 
with transforming growth factor-β3 in the media, matrix elaboration was enhanced, with a resultant 
increase in maximum push-out strength. This study highlighted the importance of growth factors and 
cellularity to cartilage-cartilage integration; however, the reported scaffold system did not provide a 
mechanism to achieve local growth factor delivery or promote increased cell migration into the scaffold in 
vivo.  
Building on these findings, this aim will design and optimize a microfiber scaffold that can locally 
deliver insulin-like growth factor-1 to the healing cartilage-cartilage interface. Since the scaffold is 
designed to encircle a cartilage graft, it is important that the mesh does not contract in physiologic 
conditions, as this would result in the withdrawal of the scaffold away from the host cartilage. To ensure 
structural stability, a combination of polycaprolactone (PCL), which does not contract in physiological 
conditions [142], and poly(lactide-co-glycolide) (PLGA), which has been previously used to culture deep 
zone chondrocytes, will be used [143]. These polymers are well-studied, biodegradable materials that 
support cartilage formation in vitro [138;144] and in vivo [144-146]. For the homing agent, several growth 
factors have been shown to enhance chondrocyte migration; however, insulin-like growth factor-1 is 
chosen for this application because, in addition to enhancing migration of chondrocytes and stem cells 
[14;18], it promotes cartilaginous matrix deposition, [147;148] which is needed to connect the host and 
graft cartilage. Although there are promising findings reported in the literature for insulin-like growth 
factor-1 media supplementation in cartilage tissue engineering applications, the effects of releasing 
insulin-like growth factor-1 from microfibers on cell migration from cartilage has not yet been studied. 
2.1.2 Objectives 
The goal of this study is to fabricate microfibers that release insulin-like growth factor-1 and optimize 
the dose to maximize cell migration from cartilage explant tissue. It is anticipated that incorporation of 
insulin-like growth factor-1 incorporation will increase cell migration in a dose-dependent manner 
compared to an insulin-like growth factor-1-free control.  
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2.2 Materials and Methods 
2.2.1 Scaffold Fabrication and Characterization 
Unaligned microfiber scaffolds were fabricated by electrospinning [20;149]. For PLGA scaffold 
fabrication, a 54% (w/v) solution of PLGA (85:15, DL, High IV, Lakeshore Biomaterials) was mixed with 
N,N-dimethylformamide (DMF, Sigma-Aldrich) and ethyl alcohol. For PLGA:PCL blended microfiber 
fabrication, PLGA and PCL (Sigma-Aldrich, Mw ≈ 70,000-90,000) were dissolved at varying ratios in a 
mixture of 60/40 dichloromethane (DCM, Sigma-Aldrich) and DMF. For fibers containing insulin-like 
growth factor-1 (IGF-1, Invitrogen), finely ground BSA (5% w/w, Sigma Aldrich) was added directly to a 
solution of 32% polymer (5:1 PLGA:PCL) in 60/40 DCM/DMF and vortexed continuously. After one hour, 
IGF-1, suspended in distilled water at a concentration of 5 mg/mL, was added to the polymer melt, and 
the solution was vortexed for an additional hour. Each polymer solution was loaded into a 5 mL syringe 
with a stainless steel blunt tip needle (26.5 gauge for PLGA:PCL blends and 18 gauge for polymer-protein 
blends) that was 13 cm from the collecting target and electrospun at 8-10 kV using a custom 
electrospinning device. The polymer solution was deposited (1 mL/hour for PLGA and PLGA:PCL blend 
solutions, 0.8 mL/hour for polymer-protein solutions) onto a stationary collecting target using a syringe 
pump (Harvard Apparatus).  
As-fabricated microfiber scaffolds were imaged with SEM (2 kV, Hitachi 4700, Hitachi Ltd.) to 
evaluate fiber morphology. Scaffolds were sputter-coated (Cressington 108auto) with gold-palladium to 
reduce charging effects. Microfiber diameter was quantified via image analysis of SEM micrographs using 
ImageJ (National Institutes of Health, n=2).  
2.2.2 Scaffold Contraction Analysis 
To determine the contraction properties of blended polymer microfiber scaffolds, 10 mm scaffold 
disks were excised from meshes using a biopsy punch (Sklar) and sterilized via ultraviolet light exposure 
for 15 minutes on each side. Sterilized scaffold disks were submersed in DMEM at 37ºC and 5% CO2 and 
collected at 0, 2, 8, 24, and 72 hours. At each timepoint, the scaffold was imaged with a stereoscope 
(Olympus SZ61) and the diameter was measured using ImageJ (National Institutes of Health, n=3). Fiber 
morphology was visualized using SEM (2kV,Hitachi S-4700, n=2). 
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2.2.3 IGF-1 Release Characterization 
Scaffolds (thickness = 90-120µm) were cut into disks with a ten millimeter diameter using a biopsy 
punch (Sklar), sterilized via exposure to ultraviolet light for fifteen minutes on each side, and immersed in 
one milliliter of media (DMEM with 1% insulin, transferrin, selenous acid (ITS), 50 μg/mL proline, 0.1 μM 
dexamethasone, 0.9 mM sodium pyruvate, 50 μg/mL ascorbic acid) for three weeks at 37ºC and 5% CO2. 
Media was collected and replaced every three days. 
Insulin-like growth factor-1 release (n=4/group) was measured using an enzyme-linked 
immunosorbent assay (ELISA, R&D Systems) according to the manufacturer’s protocol. Briefly, samples 
were added directly to assay diluent in a prepared plate and incubated for two hours at 4°C prior to 
solution removal. Each well was washed four times before incubation for one hour with IGF-1 conjugate 
at 4°C. The conjugate was removed, the plate was washed four times, and the substrate solution was 
added to each well and allowed to react in the dark. The stop solution was added after 30 minutes and 
the absorbance was measured using a microplate reader (Tecan) at 450 nm and 570 nm, and the 
difference was used to calculate IGF-1 concentration.  
2.2.4 Cartilage Harvest and Culture 
Fresh immature bovine knee joints (Green Village Packing Co.) were soaked in soapy water followed 
by 70% ethanol for 20 minutes. The joint was opened in a sterile environment, and full thickness cartilage 
explants were extracted from the femoral groove and condyles using a sterile 6 mm biopsy punch (Sklar). 
The top and bottom third of the cartilage tissue was removed using a scalpel blade, and the remaining 
middle zone cartilage was placed atop a microfiber scaffold for culture. To prevent motion of the cartilage, 
a Teflon® ring was placed on top of the fiber scaffold and around the cartilage ring (Fig. 2.4). Cartilage 
explants were cultured in 3 mL of media (DMEM with 1% insulin, transferrin, selenous acid (ITS), 
50 μg/mL proline, 0.1 μM dexamethasone, 0.9 mM sodium pyruvate, 1% penicillin-streptomycin, 0.1% 
gentamicin sulfate, 0.1% antifungal (250 µg/mL amphotericin B), and 50 μg/mL ascorbic) acid in a twelve-
well plate for two weeks at 37ºC and 5% CO2. 
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2.2.5 Cell Imaging and Quantification 
Cell migration onto scaffolds was visualized using Calcein AM staining (n=6/group, Invitrogen) 
following the manufacturer’s suggested protocol. After washing in PBS, samples were imaged under 
confocal microscopy (Olympus Fluoview IX70) at excitation and emission wavelengths of 488 nm and 515 
nm, respectively. Images were stitched together in PowerPoint (Microsoft), and the area of fluorescence 
was quantified for each scaffold using ImageJ (National Institutes of Health).  
2.2.6 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples per group. One-way ANOVA was used to determine the effect of culture time on scaffold 
contraction, the effect of IGF-1 dose on fiber diameter, and the effect of IGF-1 dose on scaffold cell 
number. The Tukey-Kramer post-hoc test was used for all pair-wise comparisons, and significance was 
attained at p<0.05. Statistical analyses were performed with JMP IN (4.0.4, SAS Institute, Inc.).  
2.3 Results 
2.3.1 Polymer Blend Optimization  
The contraction properties of the scaffold were characterized by measuring scaffold dimensions with 
ImageJ after in vitro culture in media (Fig. 2.1). Before immersion, all scaffolds had a similar fiber 
diameter; however, after eight hours of in vitro culture, the scaffolds composed of PLGA:PCL at a ratio of 
7:1, 9:1 and 100% PLGA were significantly smaller than the 5:1, 3:1, and 1:1 compositions. The 5:1, 3:1, 
and 1:1 compositions did not contract significantly during 72 hours of culture. Fiber morphology was 
visualized using SEM, and fiber curling was observed in contracted fiber groups after 72 hours (Fig. 2.1).  
2.3.2 IGF-1 Scaffold Characterization 
Scaffolds containing IGF-1 were visualized using SEM after fabrication, and ImageJ was used to 
analyze fiber diameter (Fig. 2.2). Fiber morphology was similar between the three meshes with varied IGF 
doses, with smooth, randomly aligned fibers observed for each group. All three scaffold groups exhibited 
fiber diameters of approximately one micron. IGF-1 release from the fibers was measured using an ELISA 
(Fig. 2.3). Both scaffold groups had similar release profiles, with a burst release followed by slower, 
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sustained release thereafter. The burst release, which occurred within the first 24 hours, accounted for 
78.5 ± 0.026% and 83.6 ± 0.002% of the IGF-1 which was released from the low and high dose scaffolds, 
respectively, over a three-week period. Twice as much IGF-1 was released from the high dose fibers 
compared to the low dose fibers after 22 days. Based on the amount released after 22 days, 
incorporation efficiency of active IGF-1 into the fibers is at least 8.6% ± 1.6% and 7.6% ± 1.4% for the low 
and high doses, respectively.  
2.3.3 Cell Migration 
Cell migration onto the scaffolds from cartilage explants after two weeks in culture was visualized 
using fluorescence microscopy (Fig. 2.5). Cells were observed on every scaffold in more than one 
location. Cell clusters were observed on scaffolds for all groups, most prominently in the control and high 
dose groups. For the control and low dose groups, the cells on the scaffold were randomly located in 
areas under the cartilage; however, the migrated cell population on the high dose scaffold mirrored the 
shape and size of the cartilage explant which had been cultured atop the scaffold, with dense areas of 
cells observed on every sample in this group. In order to compare the cell migration between groups, 
fluorescence was quantified using ImageJ for each scaffold, and the average area of fluorescence for 
each group was calculated (Fig. 2.5). No difference was found between the control and low dose group, 
but significantly higher fluorescence was measured for the high dose group with respect to both other 
groups.  
2.4 Discussion 
The goal of this thesis aim is to design a scaffold that can be placed between the host and graft 
cartilage to promote integration. Since cartilage-cartilage healing is hindered by low cellularity, the homing 
of cells to the wound edge through a scaffold that surrounds the cartilage graft may facilitate local, cell-
mediated tissue generation that connects the graft to the surrounding host cartilage. This study 
specifically focuses on the fabrication and optimization of microfibers that release insulin-like growth 
factor-1, which is a known homing factor for chondrocytes and stem cells. In this study, microfibers with 
varying concentrations of insulin-like growth factor-1 are fabricated via electrospinning, and cell migration 
from cartilage explants cultured atop the scaffolds is evaluated using confocal image analysis. The 
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migration results demonstrate that, while cells migrate onto all scaffolds, insulin-like growth factor-1 
incorporated at a dose of 100 ng/mg results in more cells on the scaffold after two weeks of culture than a 
lower dose (50 ng/mg) or scaffold without growth factor.  
Microfibers with incorporated insulin-like growth factor-1 were reproducibly fabricated using the 
electrospinning process. The polymer base of the scaffold was first optimized to eliminate contraction 
behavior in physiologic conditions. Polycaprolactone, incorporated at 17% w/w (5:1 PLGA:PCL) confers 
structural stability. This formulation resulted in uniform fiber morphology that was stable over time in 
culture medium at physiologic conditions. Furthermore, the addition of polycaprolactone did not alter the 
fiber morphology or significantly change the fiber diameter compared to the poly(lactide-co-glycolide)-
based scaffolds that were previously used for chondrocyte culture [150]. Addition of the growth factor also 
did not change the appearance or alignment of the fibers.  
The scaffolds with high and low doses of incorporated insulin-like growth factor-1 released growth 
factor into the media when incubated in physiologic conditions. Both scaffolds exhibited a burst release in 
the first 24 hours followed by sustained release for at least three weeks. The burst release profile is 
consistent with other published reports of biological factor release from electrospun fibrous scaffolds 
[22;151;152]. Consistent with the theoretical incorporation, the high dose scaffolds released twice as 
much insulin-like growth factor-1 compared to the low dose scaffolds over time, demonstrating that the 
incorporation method is scalable within this range of concentrations.  
The growth factor-free and insulin-like growth factor-1 containing scaffolds supported cell migration 
and attachment when cultured under cartilage explants. While migrated cells were observed on all 
scaffold types, the high dose scaffolds had significantly staining for cells than the control and low dose 
groups after two weeks of culture. Furthermore, the area of the scaffold covered in cells in the high dose 
group resembled the shape of the cartilage explant (6 mm circle), which was not true of the other two 
scaffold groups. These findings may indicate that the high dose scaffolds induced more uniform migration 
from the surface of the cartilage explant than the other groups. Conversely, it is possible that the cells 
migrated from a focal area and then moved across the scaffold.  
It is important to note that the insulin-like growth factor-1 delivered via the scaffold in this study is at a 
significantly lower dose than many published studies that use media supplementation. Based on the 
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measured growth factor that was released into a culture media volume of one milliliter (Fig. 2.3), the high 
dose scaffold resulted in an insulin-like growth factor-1 concentration of less than 2 ng/mL after the first 
media change. While there are inconsistencies between studies in the literature, the lowest dose at which 
insulin-like growth factor-1 has been reported to enhance migration is 10 ng/mL in a Boyden chamber 
assay performed with immature bovine chondrocytes [18]. The response measured at a lower dose in this 
study may suggest that the local availability of the insulin-like growth factor-1, released directly at the cut 
edge of the cartilage, increases efficacy of the growth factor for stimulating migration. However, in order 
to directly compare these doses, a media supplementation study would need to be conducted in parallel 
with a scaffold release study.  
A limitation of this study is the inability to distinguish between cell proliferation and cell migration. 
While migration studies can be conducted at shorter timescales (<24 hours) to reduce the confounding 
effect of cell proliferation, this study required a longer culture period because of the time required for the 
cells to move out of the tissue and onto the scaffolds. In a pilot experiment, earlier timepoints were 
investigated (4 and 7 days, data not shown); however, there were too few cells on the scaffolds to 
accurately quantify. In the next chapter, cell proliferation on the insulin-like growth factor-1 scaffolds will 
be tracked independently of a migration source, and these studies will help to elucidate the potential role 
of proliferation in the increased cell number reported here. Ultimately, the goal of this aim is to maximize 
cell number on the scaffold to optimize it for acellular in vivo implementation. Therefore, the scaffold with 
the most cells—the high dose insulin-like growth factor-1 scaffold—is ideal for the current application.  
2.5 Conclusions 
In summary, insulin-like growth factor-1 incorporation in polymer fiber scaffolds at a dose of 100 
ng/mg increases cell number on scaffolds that are cultured adjacent to viable cartilage tissue over a two 
week period. Based on these findings, it is apparent that insulin-like growth factor-1 delivery from an 
electrospun scaffold can be used to home and support cells from cartilage tissue.  
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Figure 2.1 Polymer blend optimization. Scaffolds with PLGA:PCL ratio of 5:1 and lower are stable in 
physiologic conditions, with no significant change in dimensions after 72 hours (n=3, *p<0.05 for 
difference from original dimension). Scanning electron micrographs show changes in fiber morphology 
after soaking for 7:1, 9:1, and 100% PLGA compositions.  
 
  















































Figure 2.2 Scaffold fabrication and groups. Scaffolds were generated by electrospinning 
PLGA:PCL polymer with varying amounts of insulin-like growth factor-1 (IGF-1) incorporated. 














Figure 2.3 Insulin like growth factor-1 (IGF-1) release from microfiber scaffolds. IGF-1 was released 
from both low and high dose scaffolds over 22 days. High dose scaffolds released twice as much IGF-1 



















































Figure 2.4 Experimental setup. Custom-designed Teflon® rings secured the microfiber scaffolds and 
ensured that cartilage explants remained on top of the scaffolds throughout the culture period.  
Custom Clamp















Figure 2.5 Migration from cartilage
explants onto scaffolds. Calcein AM
stained cells that were attached to the
scaffolds after two weeks of culture. After
removing cartilage explants, the scaffolds
were imaged from the top view (top).
Fluorescence was quantified using
ImageJ (bottom left) and more
fluorescence was measured for the high
dose scaffolds (*p<0.05 for difference
between groups).


































CHAPTER 3: CHONDROCYTE RESPONSE ON 
IGF-1 MICROFIBER SCAFFOLDS  
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3.1 Introduction 
In chapter 2, the dose of incorporated insulin-like growth factor-1 was optimized to promote cell 
migration from cartilage tissue into acellular, fiber-based scaffolds. It was determined that incorporating 
insulin-like growth factor-1 incorporation at a dose of 100 ng/mg increased cell number on scaffolds. In 
addition to promoting cell migration from cartilage tissue, the scaffold must also support cell viability and 
matrix production to bridge the gap between the two cartilage surfaces over time. This study will 
determine the response of chondrocytes on the polymer-fiber scaffolds because this cell population will 
likely be responsible for new cartilage formation in the cup walls after in vivo implantation.  
3.1.1 Background and Significance 
Healthy cartilage consists of dense extracellular matrix, rich in proteoglycans and collagen II [25;26], 
that is actively maintained by resident chondrocytes. Together, the charged proteoglycans and the 
collagen network support compressive loads endured by the joint and provide shear strength [24;31-35]. 
These significant structure-function relationships underscore the importance of rebuilding the cartilage 
matrix to restore functional properties; however, once damaged, cartilage possesses a limited intrinsic 
capacity for self-repair. Although surgical treatments are available, the resulting repair tissue is often 
fibrocartilaginous and does not persist over time. Moreover, for cases in which cartilage repair is achieved 
macroscopically, a gap in the matrix is observed microscopically at the interface between the cartilage 
graft and surrounding host cartilage [3]. This void in matrix may lead to micromotion between the graft 
and host tissue, contributing to graft failure and limiting long-term clinical outcomes [99]. 
To address this clinical limitation, the ideal integration scaffold will support matrix production by native 
chondrocytes to bridge the gap between healthy and healing cartilage. While the response of 
chondrocytes on electrospun scaffold systems has been investigated by many groups [153-157], the 
response of chondrocytes on fibers that release growth factors is relatively under characterized.  
3.1.2 Objectives 
The goal of this study is to investigate chondrocyte response on the optimized insulin-like growth 
factor-1 microfibers that will form the walls of the integration cup to determine if the cup walls support 
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chondrocyte attachment, viability and matrix production over time. It is anticipated that the scaffold will 
support cell attachment as well as matrix elaboration.  
3.2 Materials and Methods 
3.2.1 Scaffold Fabrication 
Unaligned microfiber scaffolds (thickness = 90-120µm, Ø=10mm)  were fabricated using the 
electrospinning process [20;149]. For the fabrication of PLGA:PCL blended microfibers, PLGA and PCL 
(Sigma-Aldrich, Mw ≈ 70,000-90,000) were dissolved in a 5:1 ratio in a mixture of 60/40 dichloromethane 
(DCM, Sigma-Aldrich) and dimethylformamide (DMF). For fibers containing IGF-1 (Invitrogen), finely 
ground bovine serum albumin (BSA , 5% w/w, Sigma Aldrich) was added directly the polymer melt and 
vortexed continuously. After one hour, IGF-1, suspended in distilled water at a concentration of 5 mg/mL, 
was added to the polymer melt, and the solution was vortexed for an additional hour. Each polymer 
solution was loaded into a 5 mL syringe with a stainless steel blunt tip needle (26.5 gauge for PLGA:PCL 
blends and18 gauge for polymer-protein blends) that was 13 cm from the collecting target and 
electrospun at 8-10 kV using a custom electrospinning device. The polymer solution was deposited (1 
mL/hour for polymer solutions, 0.8 mL/hour for polymer-protein solutions) onto a stationary collecting 
target using a syringe pump (Harvard Apparatus).  
3.2.2 Cells and Cell Culture 
Primary articular chondrocytes were isolated from neonatal calf knees obtained from a local abattoir 
(Green Village Packing Co.) according to published protocols [79]. Briefly, cartilage tissue was extracted 
from the femoral groove and condyles, minced, and incubated for 16 hours with 0.1% w/v collagenase 
(Worthington) in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS, Atlanta Biologicals), 2% antibiotics (10,000 U/mL penicillin, 10 mg/mL streptomycin), and 
0.1% antifungal (250 µg/mL amphotericin B). The cell suspension was filtered to separate the cells from 
extracellular matrix debris before plating (30 μm, Spectrum). The isolated chondrocytes were maintained 
in high-density culture in fully-supplemented DMEM with 10% FBS, 1% non-essential amino acids, 1% 
antibiotics, and 0.1% antifungal for three days before seeding. All media supplements are purchased from 
Cellgro-Mediatech unless otherwise specified. 
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To seed the scaffolds, 10 µL of concentrated cell suspension was pipetted onto each scaffold to 
achieve a seeding density of 100,000 cells/cm
2
 and incubated for 25 minutes at 37°C and 5% CO2 before 
submersion in media. Cell-laden scaffolds were cultured at 37°C and 5% CO2 in 1.5 mL of media which 
was refreshed three times weekly. Cell culture media consisted of DMEM supplemented with 1% ITS+ 
Premix (BD Biosciences), 1% penicillin-streptomycin, 0.1% gentamicin sulfate, 0.1% antifungal 
(250 µg/mL amphotericin B), and 40 µg/mL L-proline (Sigma). 
3.2.3 Cell Imaging and Number 
Prior to seeding the scaffolds, the cell membranes were stained using the Vybrant™ Cell-Labeling 
Solutions kit (Molecular Probes) following the manufacturer’s protocol. The cells were trypsinized, rinsed 
with F/S medium, and counted. Cells were then spun down and resuspended at a density of 1x10
6 
cells/mL. Dye (5 µL, Vybrant DiO solution) was added, and mixtures were incubated for 20 minutes in the 
dark under sterile conditions. Cells were collected via centrifugation, the dye was aspirated, and cells 
were resuspended in fresh F/S medium. This step was repeated three times for a total of four washes. 
Cells were then recounted and seeded onto scaffolds. For imaging, medium was aspirated from wells and 
rinsed with sterile phosphate buffered saline (PBS). The samples were imaged under confocal 
microscopy (Olympus Fluoview, n=2) at 488 nm. 
Cell proliferation (n=5) was determined using the Quanti-iT™ PicoGreen
®
 dsDNA assay kit (Molecular 
Probes, Eugene, OR) following sample digestion. The sample was rinsed with PBS and exposed to a 
freeze-thaw cycle in 500  μL of 0.1% Triton-X solution (Sigma) in order to lyse the cells. After desiccation 
for 12 hours in a CentriVap Concentrator (Labconco Co.), the samples were digested for 18 hours at 65°C 
with papain (8.3 activity units/mL) in 0.1 M sodium acetate (Sigma), 10mM cysteine-HCl (Sigma), and 50
mM ethylenediaminetetraacetate (Sigma). For DNA content, a 25  μL aliquot of the sample was mixed 
with 175 μL of the PicoGreen
®
 working solution, and fluorescence was measured with a microplate reader 
(Tecan, Research Triangle Park, NC) at excitation and emission wavelengths of 485 and 535 nm, 
respectively. The conversion factor of 7.7 pg DNA/cell was used to determine cell number [158;159].  
3.2.4 Matrix Deposition 
Total collagen content (n=5) was quantified using a modified hydroxyproline assay [160] with bovine 
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collagen I solution (Biocolor, Carrickfergus, UK) as the standard. A 40 μL aliquot of sample digest was 
mixed with 10 μL 10 N sodium hydroxide and heated to 250°C for 25 minutes in order to hydrolyze the 
collagen. The hydrolyzate was then oxidized at room temperature for 25 minutes with 450 μL of buffered 
chloramine-T reagent prior to the addition of Ehrlich’s reagent (15% p-dimethylaminobenzaldehyde in 2:1 
isopropanol/percholoric acid). Absorbance was measured at 555 nm with a microplate reader (Tecan). 
Additionally, collagen distribution (n=2) was evaluated via histology. The samples were first fixed in 
neutral buffered formalin with 1% cetylpyridinium chloride (Sigma) for one day and stored in 0.01 M 
cacodylic acid at 4°C. Prior to processing, samples were soaked overnight in 5% polyvinyl alcohol (PVA, 
Sigma-Aldrich), embedded in a frozen block of PVA, and sectioned at -21 °C using a cryostat (Model 
OFT, Bright Instrument Company Microtome). Sections were soaked in distilled water for one hour to 
remove residual PVA, stained with picrosirius red staining for one hour, and exposed to 0.1 N hydrochloric 
acid for two minutes (n=2). For collagen I and II immunostaining, sections were incubated with primary 
antibody overnight. Cell nuclei were stained with 4',6-diamidino-2-phenylindole (Sigma). A FITC-
conjugated secondary antibody (1:200 dilution, Abcam) was used and samples were imaged under 
confocal microscopy (Olympus Fluoview IX70) at excitation and emission wavelengths of 488 nm and 
568 nm, respectively. Cover-slipped sections were imaged using a brightfield microscope (Zeiss, Axiovert 
25). 
Sample glycosaminogylcan content (GAG, n=5) was determined with a modified 1,9-
dimethylmethylene blue (DMB) binding assay [161-163], with chondrotin-6-sulfate (Sigma) as the 
standard. The absorbance difference between 540 nm and 595 nm was used to improve the sensitivity in 
signal detection. In addition, histology was used to visualize GAG distribution. Sections were exposed to 
3% acetic acid for three minutes, stained with alcian blue for 45 minutes, and rinsed twice with acid-
alcohol (pH=1) for one minute (n=2) [159]. Cover-slipped sections were imaged using a brightfield 
microscope (Zeiss, Axiovert 25). 
3.2.5 Mineralization Potential 
Alkaline phosphatase (ALP) activity (n=5) was measured using a colorimetric assay based on the 
hydrolysis of p-nitrophenyl phosphate (pNP-PO4) to p-nitrophenol (pNP) [164]. The samples were lysed in 
0.1% Triton™ X solution, exposed to a freeze-thaw cycle, and crushed with a mortar. A 25 μL aliquot was 
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added to pNP-PO4 solution (Sigma) and incubated for 10 minutes at 37°C. Absorbance was measured at 
405 nm using a microplate reader (Tecan). 
3.2.6 Statistical Analysis 
Results are presented as mean ± standard deviation, with n equal to the number of samples per 
group. One-way ANOVA was used to determine the effects of IGF-1 dose on cell migration. The Tukey-
Kramer post-hoc test was used for all pair-wise comparisons, and significance was attained at p<0.05. 
Statistical analyses were performed with JMP IN (4.0.4, SAS Institute, Inc.). 
3.3 Results 
3.3.1 Cell Distribution, Viability, Number, and Alkaline Phosphatase Activity 
Full thickness chondrocytes were cultured on polymer scaffolds with and without IGF-1 for three 
weeks (Fig. 3.1). Cell distribution on the scaffolds was assessed via live-cell tracking (Fig. 3.2). 
Chondrocytes were evenly distributed on the scaffolds at each timepoint. Quantitatively, cell number was 
similar on both scaffold types on day 1, with a significant increase in cell number measured for the control 
group between day 1 and day 14. Mineralization potential, assessed by measuring alkaline phosphatase 
activity, was highest for the control group on day 1, with significantly lower ALP activity detected on the 
IGF-1 scaffold. ALP activity decreased over time between day 1 and day 14 for both scaffold groups. 
3.3.2 Matrix Production 
Matrix deposition was quantified at each timepoint in terms of GAG and collagen. (Fig. 3.3). 
Significantly more GAG was measured on both scaffold types on day 14 compared to day 1. No 
differences were measured in terms of collagen deposition at any timepoint. Matrix distribution was 
visualized histologically, and staining revealed that both GAG and collagen were localized to the seeded 
surface of the scaffold.  
3.4 Discussion 
The goal of this chapter is to determine the response of chondrocytes on the fiber-based scaffolds in 
vitro. Chondrocytes are expected to interact with the scaffolds in vivo because they were shown to 
migrate into the scaffolds from cartilage tissue in chapter 1. To determine the response of chondrocytes 
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on the scaffolds over time, cells were isolated from full thickness articular cartilage and seeded onto the 
scaffolds. Cell number, matrix deposition, and mineralization potential were measured over three weeks 
of culture. The chondrocytes attached, remained viable, and produced matrix on both control and IGF-1 
scaffolds. The results of this study demonstrate that the microfiber scaffolds support the attachment, 
proliferation and biosynthesis of chondrocytes.  
In terms of cell number and matrix production, both scaffolds supported similar cellular activity in this 
study. While insulin-like growth factor-1 is known to enhance cartilage matrix deposition [147;165], these 
effects are reported for studies in which insulin-like growth factor-1 is introduced via continuous media 
supplementation at higher levels than the concentrations that are released from these scaffolds 
[147;166;167]. Furthermore, for the studies presented here, the fiber-based scaffolds are soaked in 
serum media overnight prior to seeding to enhance cell attachment by surface protein coating. This pre-
soak step occurs during the “burst release” phase of the insulin-like growth factor-1 release from the 
scaffolds, and therefore decreases the total growth factor to which cells are exposed. In an in vivo 
environment, insulin-like growth factor-1 is naturally present [167]. Therefore, the insulin-like growth 
factor-1 released from the scaffold will not act in isolation but will instead locally augment the native 
concentration. It is possible that, while the insulin-like growth factor-1 did not increase matrix deposition in 
this study over the control scaffold, it may have an effect when combined with the insulin-like growth 
factor-1 that is naturally present in an in vivo environment. In addition, Mauck et al. demonstrated synergy 
between insulin-like growth factor-1 stimulation and dynamic loading [166]. Applied to our system, this 
may suggest that the insulin-like growth factor-1 released from the fibers may enhance matrix production 
when combined with the loaded environment that is found in vivo. In order to further understand the 
potential additive effect of scaffold insulin-like growth factor-1, native insulin-like growth factor-1, and 
loading, future studies could evaluate the response of cells on the insulin-like growth factor-1 scaffolds in 
media containing insulin-like growth factor-1 levels similar to that found in vivo with and without loading. 
In contrast to the similar trends for matrix deposition on scaffolds with and without insulin-like growth 
factor-1-free, the alkaline phosphatase activity was significantly modulated by scaffold type. On day 1, 
alkaline phosphatase activity of the chondrocytes was significantly reduced on the insulin-like growth 
factor-1 scaffolds. This finding is not surprising as others have reported the suppression of thyroid 
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hormone-induced alkaline phosphatase activity by insulin-like growth factor in rat epiphyseal 
chondrocytes [168]. While this study does not investigate the underlying mechanisms that drive the 
suppression of alkaline phosphatase activity, future studies that evaluate gene expression of hypertrophic 
markers may help to further elucidate the pathway by which insulin-like growth factor-1 affects 
mineralization behavior. The scaffold-mediated suppression of alkaline phosphatase activity, a marker of 
mineralization potential, may be advantageous for cartilage-cartilage healing because diseased cartilage 
tissue is particularly susceptible to pathological mineralization [169], and a scaffold which counteracts this 
natural tendency may reduce the susceptibility of the healing cartilage tissue to ectopic mineralization.  
3.5 Conclusions 
This study evaluates the response of chondrocytes on the microfiber scaffold that will comprise the 
walls of the integration cup system. The scaffolds were initially seeded with cells to mimic the ideal in vivo 
conditions, in which chondrocytes have migrated from the cartilage into the scaffold. The fiber-based 
scaffold that releases insulin-like growth factor-1 supported cell attachment and matrix elaboration over 
time, while reducing alkaline phosphatase activity. These findings suggest that the scaffold, optimized in 
chapter 1 to promote cell migration, will sustainably support chondrocyte attachment, growth, and 
biosynthesis over time.   
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Figure 3.1 Study design. Polymer scaffold with and without insulin-like growth factor-1 (IGF-1) are 
generated via electrospinning using a 5:1 mixture of poly(lactide-co-glycolide) (PLGA) and 
polycaprolactone (PCL). Each scaffold type was seeded with full thickness chondrocytes (FTCs) and 














Figure 3.2 Cell viability, number, and alkaline phosphatase activity. Live cell imaging shows that 
chondrocytes are viable throughout the culture period. Cell number was similar between groups for all 
timepoints. ALP activity was significantly suppressed in the IGF scaffold on day 1, with significant 
decrease over time between day 1 and day 7 for both groups (n=5, *p<0.05 for difference between 




































































Figure 3.3 Matrix deposition. Chondrocytes produced GAG over time, with significantly more GAG 
measured on day 14 compared to day 1 for both groups. Collagen content was not different over time or 
between groups (n=5, *p<0.05 for difference between groups on a given timepoint, #p<0.05 for difference 
from corresponding group at previous timepoint) GAG and collagen were observed on the seeded edge 
of the scaffold using alcian blue and picrosirius red staining, respectively (n=2). Scaffolds were negative 















































CHAPTER 4: THE EFFECT OF CERAMIC 
CRYSTALLINITY ON DEEP ZONE 
CHONDROCYTE RESPONSE AND CALCIFIED 
CARTILAGE FORMATION  
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4.1 Introduction 
In chapters 2 and 3, the walls of the cup system were optimized to promote cartilage-cartilage 
integration. A microfiber scaffold, which released insulin-like growth factor-1, enhanced cell migration from 
cartilage tissue into the scaffold supported chondrocyte viability and matrix deposition. The focus of this 
chapter shifts to optimize a scaffold to promote cartilage-bone integration in the base of the cup system.  
The ideal base will serve to integrate the cartilage to the underlying bone by promoting the formation 
of calcified cartilage tissue. Previous work demonstrated that hydrogel-ceramic scaffolds enhance the 
formation of calcified cartilage-like tissue by deep zone chondrocytes [11;15]; however, hydroxyapatite, a 
crystalline, relatively inert ceramic, was used and the effect of poorly crystalline bioactive ceramics on 
chondrocyte response have not yet been determined. In this chapter, the effect of ceramic crystallinity on 
chondrocyte response will be optimized for calcified cartilage formation to promote cartilage-bone 
integration in the base of the cup. 
4.1.1 Background and Significance 
Current cartilage repair products, such as chondrocyte implantation and minced cartilage 
transplantation, as well as many cartilage scaffolds in development, do not ensure calcified cartilage 
regeneration. As a result, the neo-cartilage-to-bone junction is vulnerable to poor integration. To address 
this limitation, osteochondral interface tissue engineering efforts began with cell-based approaches [113], 
followed by recent reports of a hydrogel-hydroxyapatite composite scaffold system for calcified cartilage 
formation [11;15]. Both alginate and agarose have been investigated as the hydrogel phase; however, the 
alginate system was limited by inherently low mechanical properties as well as slow gelation time, leading 
to ceramic particle aggregation [15]. Agarose exhibits a faster gelation time, allowing for homogenous 
distribution of mineral and cells within the constructs. Furthermore, the culturing of chondrocytes in 
agarose hydrogels resulted in higher mechanical properties than were measured for the alginate system 
[11], further indicating that agarose is a promising material for calcified cartilage engineering.  
While various hydrogels have been utilized for cartilage and calcified cartilage tissue engineering, 
relatively few studies have evaluated the effect of varying calcium phosphate parameters on chondrocyte 
response. To date, most studies have used crystalline hydroxyapatite, which is a relatively inert calcium 
phosphate; however, the mineral of the native osteochondral interface is poorly crystalline [59]. While the 
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effect of calcium phosphate crystallinity on chondrocyte response is unclear, reports indicate that ceramic 
crystallinity modulates cellular response, as it has been shown to control matrix elaboration in bone 
marrow cells [170;171]. In addition, studies show that bioactive calcium phosphate sources enhance 
mineralized tissue formation in bone tissue engineering applications [172]. Inspired by these findings, this 
study will investigate the effect of crystallinity on calcified cartilage formation using two bioactive calcium 
phosphate mineral sources. 
4.1.2 Objectives 
The objective of this study is to investigate the effect of calcium phosphate crystallinity on calcified 
cartilage formation by deep zone chondrocytes. Specifically, poorly crystalline calcium deficient apatite 
and crystalline beta tricalcium phosphate will be incorporated into agarose scaffolds with deep zone 
chondrocytes to evaluate formation of calcified cartilage. It is hypothesized that ceramic crystallinity will 
modulate chondrocyte response, with the less crystalline, more biomimetic calcium deficient apatite 
resulting in enhanced matrix production.  
4.2 Materials and Methods 
4.2.1 Ceramic Characterization  
Calcium deficient apatite (CDA) was purchased from Sigma-Aldrich and sintered (Thermolyne, 
Thermo Scientific) at 900° for three hours to produce β-tricalcium phosphate (TCP). Particles of both 
ceramics were imaged using scanning electron microscopy (SEM). In addition, calcium and phosphorus 
content (n=6), crystal structure (n=2), chemistry (n=2), and specific surface area (n=3) were determined. 
Particle size and morphology was assessed using SEM (5kV, 1000x, Hitachi S-4700) after sputter-coating 
with gold-palladium for ten seconds (Cressington 108 Auto). Ceramic calcium and phosphorus content 
(n=6) were determined using inductively coupled plasma analysis (ICP, Thermo Jarrell Ash, Trace Scan 
Advantage) [173]. Briefly, 10  mg of ceramic was dissolved in several drops of 17% HCl and brought to 
100 mL with double distilled water. The resulting solutions were pumped through argon plasma excited by 
a 2 kW/27.12 MHz radiofrequency generator. The concentration of each element was determined using 
its characteristic wavelength (Ca, 317.9 Å; P, 213.6Å) [173]. The crystal structures of the ceramics were 
evaluated with X-ray diffraction (XRD, X-ray Diffractometer, Inel). The samples were scanned over a 
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range of 0-120°, with a step size of 0.029°. Ceramic chemistry was examined using Fourier transform 
infrared spectroscopy (FTIR, FTS 3000MX Excalibur Series, Digilab), wherein dehydrated samples were 
mixed with potassium bromide and scanned in absorbance mode (400 scans, 4 cm
−1 
resolution). The 
specific surface area of each ceramic was calculated using the Brunauer-Emmett-Teller (BET) method 
(n=3, NOVA-win 2002 BET analyzer, Quantachrome Corporation) after overnight dehydration. 
4.2.2 Cells and Cell Culture 
Primary DZCs were isolated and pooled from the femoral articular cartilage of five immature calf 
knees (Green Village Packing Co.) following previously described protocols [79]. The bottom third of the 
cartilage was separated, and the calcified cartilage was removed by scraping. The cartilage was minced 
and digested with collagenase type 2 (310 U/mg, Worthington) for 16 hours in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals), 2% 
antibiotics (10,000 U/mL penicillin, 10 mg/mL streptomycin), and 0.2% antifungal (250 µg/mL 
amphotericin B). The deep zone chondrocyte suspension was filtered before plating (30 µm, Spectrum). 
The isolated chondrocytes were maintained in high-density culture in fully-supplemented DMEM with 10% 
FBS, 1% non-essential amino acids, 1% antibiotics, and 0.1% antifungal for three days prior to seeding in 
the hydrogel [15]. All media supplements were purchased from Cellgro-Mediatech, unless otherwise 
specified.  
4.2.3 Scaffold Fabrication and Culture 
Chondrocytes were encapsulated at a density of 10 million cells/mL in 2% low gelling agarose 
(Agarose Type VII, Sigma), and a biopsy punch (Sklar Instruments) was used to core cylindrical scaffolds 
(Ø = 5 mm, height = 2.4 mm) [11]. Acellular and cellular agarose scaffolds with 1.5% w/v ceramic, added 
at the time of fabrication, and corresponding controls without ceramic were fabricated (Fig. 4.2). All 
samples were cultured under humidified conditions at 37⁰C and 5% CO2 and maintained in medium 
composed of DMEM supplemented with 1% ITS+ Premix (BD Biosciences), 1% penicillin-streptomycin, 
0.1% gentamicin sulfate, 0.1% amphotericin B, and 40 µg/mL L-proline (Sigma). The media was changed 
every other day and freshly supplemented with 50 µg/mL ascorbic acid (Sigma). In order to induce 
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hypertrophy, DZCs were stimulated with 25 nM triiodothyronine (T3, Sigma) during the first three days of 
culture [174]. 
4.2.4 Cell Number and Distribution 
Cell number (n=5) was determined using the Quanti-iT™ PicoGreen
®
 dsDNA assay kit (Molecular 
Probes) following sample digestion. The sample was rinsed with PBS and exposed to a freeze-thaw cycle 
in 500  μL of 0.1% Triton™-X solution (Sigma) in order to lyse the cells. A pestle was used to manually 
pulverize the samples. After desiccation for 12 hours in a CentriVap Concentrator (Labconco Co.), the 
samples were digested for 18 hours at 65°C with papain (8.3 activity units/mL) in 0.1 M sodium acetate 
(Sigma), 10 mM cysteine HCl (Sigma), and 50 mM ethylenediaminetetraacetate (Sigma). For DNA 
content, a 25 μL aliquot of the sample was mixed with 175 μL of PicoGreen
®
 working solution, and 
fluorescence was measured with a microplate reader (Tecan) at excitation and emission wavelengths of 
485 and 535 nm, respectively. The conversion factor of 7.7 pg DNA/cell was used to determine cell 
number [158;159].  
Cell distribution (n=2) was evaluated via histology. The samples were first fixed in neutral buffered 
formalin with 1% cetylpyridinium chloride (Sigma) for 24 hours, followed by dehydration with an ethanol 
series. The dehydrated samples were embedded in paraffin (Paraplast X-tra Tissue Embedding Medium, 
Fisher Scientific), and 7 μm sections were obtained from the center of the scaffold. The paraffin was 
cleared with xylenes, and the samples were rehydrated and stained with hematoxylin for ten minutes and 
eosin Y for two minutes. Cover-slipped samples were imaged using a brightfield microscope (Zeiss, 
Axiovert 25). 
4.2.5 Matrix Deposition 
Total collagen content (n=5) was quantified using a modified hydroxyproline assay [160] with bovine 
collagen I solution (Sigma) as the standard. Briefly, a 40 μL aliquot of sample digest was mixed with 10 μL 
of 10 N sodium hydroxide and heated to 250°C for 25 minutes in an autoclave to hydrolyze the collagen. 
The hydrolyzate was oxidized at room temperature for 25 minutes with 450 μL of buffered chloramine-T 
reagent prior to incubation with 425 μL of Ehrlich’s reagent (15% p-dimethylaminobenzaldehyde in 2:1 
isopropanol/percholoric acid) at 65°C. Absorbance was measured at 555 nm with a microplate reader 
45 
(Tecan). All matrix values were normalized by sample wet weight to account for differences in sample 
size.  
Collagen distribution (n=2) was evaluated via histology. The samples were first fixed in neutral 
buffered formalin with 1% cetylpyridinium chloride (Sigma) for 24 hours, followed by dehydration with an 
ethanol series. The dehydrated samples were embedded in paraffin (Paraplast X-tra Tissue Embedding 
Medium, Fisher Scientific), and 7 μm sections were obtained from the center of the scaffold. The paraffin 
was cleared with xylenes, and the samples were rehydrated, stained with picrosirius red for one hour, and 
exposed to 0.1 N hydrochloric acid for two minutes (n=2). Cover-slipped samples were imaged using a 
brightfield microscope (Zeiss, Axiovert 25). In addition, collagen I, II, and X were assessed using 
immunohistochemistry (n=2) [11]. Specifically, monoclonal antibodies for collagen I (1:00 dilution) and 
collagen II (1:100 dilution) were purchased from Abcam, and antibodies for collagen X were purchased 
from the Developmental Studies Hybridoma Bank (University of Iowa). After deparaffinization, sections 
were treated with 1% hyaluronidase for 30 minutes at 37°C, 1% acetic acid for four hours, and incubated 
with primary antibody overnight. Cell nuclei were stained with 4',6-diamidino-2-phenylindole (Sigma). A 
FITC-conjugated secondary antibody (1:200 dilution, LSAB2 Abcam) was used, and samples were 
imaged under confocal microscopy (Olympus Fluoview IX70) at excitation and emission wavelengths of 
488 nm and 568 nm, respectively.  
Sample glycosaminoglycan content (GAG, n=5) was determined with a modified 1,9-
dimethylmethylene blue (DMB) binding assay [161-163] with chondrotin-6-sulfate (Sigma) as the 
standard. The absorbance difference between 540 nm and 595 nm was used to improve the sensitivity in 
signal detection. In addition, histology was used to visualize GAG distribution. Deparaffinized sections 
were exposed to 3% acetic acid for three minutes, stained with alcian blue for 45 minutes, and rinsed 
twice with acid-alcohol (pH = 1) for one minute (n=2) [159]. Cover-slipped samples were imaged using a 
brightfield microscope (Zeiss, Axiovert 25). 
4.2.6 Mineralization  
Alkaline phosphatase (ALP) activity (n=5) was measured using a colorimetric assay based on the 
hydrolysis of p-nitrophenyl phosphate (pNP-PO4) to p-nitrophenol (pNP) [164]. The samples were lysed 
in 0.1% Triton™ X solution, exposed to a freeze-thaw cycle, and crushed with a pestle. A 25  μL aliquot 
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was added to pNP-PO4 solution (Sigma) and incubated for 10 minutes at 37°C. Absorbance was 
measured at 405 nm using a microplate reader (Tecan). 
Calcium and phosphate distribution (n=2) were evaluated as an indicator of overall mineral 
distribution [175]. For calcium staining, deparafinized histology sections were stained with alizarin red for 
one hour, rinsed with tap water, followed by 0.01 N hydrochloric acid in 70% ethanol for two minutes. For 
phosphate staining, deparaffinized samples were stained with 5% silver nitrate and exposed to UV light 
(365 nm) for 25 minutes before a tap water-rinse. Cover-slipped samples were imaged using a brightfield 
microscope (Zeiss, Axiovert 25). 
4.2.7 Chondrocyte Hypertrophy 
The expression (n=5) of collagen X, Indian Hedgehog (Ihh), matrix metalloproteinase-13 (MMP-13), 
parathyroid hormone-related protein (PTHrP), and alkaline phosphatase (ALP) were measured at day 1 
and 14 using reverse transcription followed by real-time polymerase chain reaction (RT-PCR). Primer 
sequences are listed in Table 4.1. Total RNA was isolated using the TRIzol (Invitrogen) extraction 
method. The isolated RNA was reverse-transcribed into cDNA using the SuperScript III First-Strand 
Synthesis System (Invitrogen). PCR reactions (25 ul) were carried out using SYBR GreenER qPCR 
SuperMix (Invitrogen) on an iCycler instrument (Bio-Rad). Relative expression data were quantified using 
2
-(Ct sample−Ct GAPDH)
, where Ct is the cycle threshold normalized to the housekeeping gene, glyceraldehyde 
3-phosphate dehydrogenase (GAPDH). 
4.2.8 Media Ion Analysis 
Media calcium concentration (n=6) was quantified using the Arsenazo III dye (Pointe Scientific). The 
media was diluted with water in a 1:10 ratio and allowed to react with the dye for five minutes. 
Absorbance was measured at 620 nm using a microplate reader (Tecan). Media phosphate concentration 
(n=6) was quantified using the BioVision Phosphate Assay Kit. The media was diluted with water in a 1:10 
ratio and allowed to react with 30 µL of dye for 30 minutes. Absorbance was measured at 650 nm using a 
microplate reader (Tecan).  
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4.2.9 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples per group. A two-way analysis of variance (ANOVA) was performed to determine the effects of 
ceramic type and culturing time on cell response (proliferation, matrix deposition, ALP activity, solution ion 
concentration) as well as ceramic parameters (calcium and phosphorus weight content, Ca/P ratio and 
surface area). A one-way ANOVA was used to determine the effects of scaffold group on gene 
expression at each timepoint. The Tukey-Kramer post-hoc test was used for all pair-wise comparisons, 
and significance was attained at p<0.05. Statistical analyses were performed with JMP IN (4.0.4, SAS 
Institute, Inc.). 
4.3 Results 
4.3.1 Ceramic Characterization 
Ceramic particle shape, calcium and phosphate content, crystallite structure, chemistry, and specific 
surface area were characterized prior to scaffold fabrication and are summarized in Figure 4.1. Electron 
microscopy revealed irregular particle morphology for CDA and rhombic-shaped particles for TCP. Crystal 
planes characteristic of hydroxyapatite (002, 211, 300, and 202) (JCPDS 9-432) were identified in the 
CDA XRD spectra (Fig. 4.1). Characteristic TCP crystal planes (214, 300, 0210, 128, and 220) were 
identified in the TCP XRD spectra (JCPDS 9-0169). The broader peaks present in the CDA spectra 
indicate smaller crystallite size compared to the sharper peaks of the TCP spectra. Analysis by FTIR 
confirmed phosphate presence via bending peaks for both ceramics, although a carbonate peak 
[173;176;177] was observed only in the CDA spectra. In terms of molar calcium and phosphate content, 
TCP had higher calcium and phosphorus content than the CDA (p<0.05); however, the two ceramics had 
similar calcium/phosphate molar ratios. The specific surface area of CDA was significantly higher than the 
specific surface area of the TCP. 
4.3.2 Cell Distribution and Number 
Deep zone chondrocytes were cultured in agarose scaffolds with CDA, TCP, or without ceramic , with 
and without T3 stimulation for two weeks (Fig 4.2). Cell distribution was assessed via hematoxylin and 
eosin staining for each group over time (Fig. 4.3). Chondrocytes were uniformly distributed throughout 
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every scaffold at all timepoints, with higher cell density observed by day 14 compared to day 1 for all 
groups. Quantitatively, cell number was similar in all groups on day 1, with an increase in cell number on 
day 7 and day 14. Significantly more cells were measured for the CDA group than the ceramic-free and 
TCP groups on day 7 and day 14. Trends between groups and over time for the unstimulated and T3-
stimulated cell populations were similar.  
4.3.3 Matrix Deposition 
Matrix deposition was measured in terms of collagen and GAG for each group over time. Collagen 
deposition increased over time for the unstimulated control group and all stimulated groups between day 
1 and day 7 (Fig. 4.4). Between day 7 and day 14, collagen content increased for the unstimulated 
ceramic-containing groups and for the stimulated CDA group. For both unstimulated and stimulated 
groups, the CDA-containing scaffold resulted in the most collagen by day 14. This finding was 
qualitatively confirmed with picrosirius red staining. Immunohistochemistry was used to determine the 
collagen types present in the unstimulated groups on day 14 (Fig. 4.5). Positive collagen II staining was 
observed for all groups, with the most positive staining observed for the CDA group. Collagen I and X 
staining was observed only for the ceramic-free and the TCP groups on day 14. The most collagen I and 
X was visualized in the TCP-containing scaffolds that were stimulated with T3.  
Glycosaminoglycan content increased over time for all groups (Fig. 4.6). For the unstimulated 
constructs, the CDA-containing scaffold resulted in the highest GAG content by day 7 and day 14. In the 
presence of T3 stimulation, no difference in GAG was measured between groups on day 7; however, the 
CDA group had significantly higher GAG content on day 14 than the control or TCP groups. Alcian blue 
staining showed pericellular GAG depositions for all groups on day 7, with positive staining observed 
throughout the scaffold for the unstimulated and stimulated CDA groups on day 14. 
4.3.4 Mineralization Potential and Hypertrophy 
Mineralization potential was assessed by measuring the alkaline phosphatase (ALP) activity for each 
group over time, and mineral distribution was evaluated via histology (Fig. 4.7). For the unstimulated 
chondrocytes, ALP activity was highest in the CDA group on day 1, with significantly lower ALP activity for 
all groups by day 7, which persisted to day 14. In the presence of T3, the ceramic-free and TCP groups 
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exhibited enhanced ALP activity on day 7 and day 14; however, low ALP activity was measured at every 
timepoint for the CDA group. Histological staining with alizarin red and von Kossa revealed uniformly 
distributed mineral for both ceramic-containing groups at all timepoints, with no phosphate or calcium 
staining observed in the ceramic-free control group at any timepoint.  
The expression of hypertrophic markers were measured on day 1 and day 14 for each group (Fig. 
4.8). On day 1, collagen X and Ihh expression were downregulated for ceramic-containing groups 
compared to the ceramic-free control. The CDA group exhibited upregulated PTHrP expression 
compared to the ceramic-free group and downregulated ALP expression compared to both the ceramic-
free and TCP groups. On day 14, for the unstimulated groups, collagen X was downregulated in the CDA 
group compared to both the ceramic-free and TCP groups, and the MMP13 was upregulated for the TCP 
group with respect to the ceramic-free control group. In the presence of T3, Ihh was upregulated in the 
TCP group, and MMP13 was downregulated for both ceramic-containing groups on day 14.  
4.3.5 Media Ion Concentrations 
Calcium and phosphate concentration in the media were measured for each group at each timepoint 
(Fig. 4.9). For both stimulated and unstimulated groups, media calcium was significantly lower in the 
media of the CDA groups on day 1 than all other groups. Media phosphate concentration was significantly 
higher for the TCP group than all other groups on day 1. After day 1, there were no differences detected 
in either calcium or phosphate concentration between groups.  
4.4 Discussion 
The goal of this chapter is to determine the effect of ceramic crystallinity on deep zone chondrocyte 
response and to identify a bioactive calcium phosphate source that promotes calcified cartilage formation. 
In this study, two composite scaffolds were generated by adding either poorly crystalline calcium deficient 
apatite or crystalline tricalcium phosphate to agarose. The response of deep zone chondrocytes cultured 
within the scaffold were evaluated in terms of cell viability and number, matrix deposition, mineralization 
potential, and gene expression over two weeks of in vitro culture. The results collectively demonstrate 
that, while chondrocytes survive and produce matrix in all constructs, the presence of poorly crystalline 
calcium deficient apatite enhances cell growth and matrix deposition both with and without the addition of 
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thyroid hormone stimulation, while the presence of crystalline tricalcium phosphate does not. Based on 
these findings, it is clear that ceramic crystallinity is an important design parameter for tissue engineering, 
and calcium deficient apatite is a promising calcium phosphate for calcified cartilage tissue engineering.  
To limit confounding variables and differences derived from varying the ceramic manufacturer, the 
tricalcium phosphate was obtained by directly sintering the calcium deficient apatite. This experimental 
design ensured that the presence of trace minerals, such as zinc, which may affect cell response[178-
180], were not varied between the two calcium phosphates. While sintering the ceramic did produce 
crystalline tricalcium phosphate with a similar calcium phosphate ratio to the calcium deficient apatite, it 
also removed carbonate and decreased the specific surface area. Although this study does not 
specifically examine the effects of carbonate and particle shape, cellular response may be collectively 
influenced by a combination of crystallinity, carbonation, and ceramic surface area. 
The agarose-calcium deficient apatite and agarose-tricalcium phosphate composite scaffolds both 
supported chondrocyte viability, growth, and matrix elaboration over time. While no differences were 
measured in terms of cell number, glycosaminoglycan content, or collagen content between the ceramic-
free control and the tricalcium phosphate group, presence of calcium deficient apatite in the scaffold 
significantly enhanced cell number and matrix deposition. This finding expands on previously reported 
results demonstrating that calcium deficient carbonated apatite coatings enhanced matrix production by 
bovine chondrocytes seeded on cellulose scaffolds [181]. The agarose-calcium deficient apatite 
composite scaffold was transformed over the culture period by the cells into a mineralized matrix that was 
rich in collagen II and glycosaminoglycans. 
Importantly, the response of cells to calcium deficient apatite was not altered by thyroid hormone 
stimulation. Thyroid hormone promotes the hypertrophic phenotype in deep zone chondrocytes [11;174] 
and will likely be introduced into the scaffold after in vivo implantation in a full thickness defect via the 
blood [182]. However, it is unknown if all cells in the defect will be exposed to the hormone; therefore, the 
ideal calcified cartilage scaffold will enhance matrix elaboration in both the presence and absence of 
thyroid hormone. Khanarian et al. has demonstrated that thyroid hormone stimulation affects deep zone 
chondrocyte growth, matrix deposition, and mineralization. In the agarose-hydroxyapatite system, 
enhanced matrix deposition was observed only in the presence of thyroid hormone. Thus, the ability of 
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the agarose-calcium deficient apatite scaffold to stimulate matrix deposition in the absence of thyroid 
hormone represents an improvement over the response observed for agarose-hydroxyapatite scaffolds 
[11].  
In addition to matrix elaboration, ceramic crystallinity modulated mineralization potential and 
hypertrophy of the chondrocytes. In the absence of thyroid hormone, on day 1, the calcium deficient 
apatite resulted in elevated alkaline phosphatase activity compared to the control and β-tricalcium 
phosphate groups; however, low alkaline phosphatase activity was measured thereafter. In the presence 
of hypertrophic stimulation, both the control and TCP groups exhibited elevated alkaline phosphatase 
activity on day 7 and day 14. Suppression of this activity was measured for the calcium deficient apatite 
group, with low alkaline phosphatase activity persisting throughout the two weeks of culture. In addition to 
decreased alkaline phosphatase activity, calcium deficient apatite presence also downregulated 
hypertrophic markers on day 1 and day 14, suggesting that the pre-incorporation of a biomimetic mineral 
may reduce the need for cell-mediated mineralization in the long term. Since cartilage tissue is 
particularly susceptible to mineralization in disease states [169], the ability to regulate hypertrophy and 
mineralization may offer a viable method to prevent the overgrowth of mineralized tissue in the cartilage 
defect over time. 
While this study demonstrates that calcium deficient apatite and tricalcium phosphate elicit different 
deep zone chondrocyte responses, the effects of crystallinity cannot be decoupled from the effects of 
carbonate presence and surface area, which were also varied between the two calcium phosphates. The 
presence and dose of carbonate in calcium phosphates has been shown to modulate osteoblast 
response [183]. Specifically, hydroxyapatites with higher carbonate content resulted in lower alkaline 
phosphatase activity, consistent with the findings for the carbonated calcium deficient apatite in this study. 
In addition, while the effect of calcium phosphate surface area on chondrocytes is unknown, differences 
in mineral surface area has been shown to modulate bone formation [184-186]. It has been postulated 
that differences in cell response related to surface area changes may be driven, in part, by the differences 
in proteins absorbed onto the ceramic surface [184] or by differences in calcium phosphate dissolution, as 
both processes are coupled to surface area [187]. While protein absorption was not measured in this 
study, differences between the two ceramics in terms of calcium and phosphorus dissolution were 
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detected, with decreased calcium in the media from the CDA group and increased phosphate in the 
media from the TCP group. Future studies that specifically evaluate varying carbonate content and 
calcium phosphate surface area may help to elucidate the mechanisms that underlie the differences in 
matrix deposition and mineralization potential driven by the ceramic type that were observed in this study.  
4.5 Conclusions 
This study focuses on optimization of the calcium phosphate phase of a hydrogel-ceramic composite 
scaffold for calcified cartilage regeneration. Two bioactive ceramics, calcium deficient apatite and 
tricalcium phosphate, were incorporated into deep zone chondrocyte-laden agarose hydrogels that were 
cultured in the presence or absence of thyroid hormone stimulation. Although the cells remained viable 
and deposited matrix in all scaffold groups, the most matrix deposition was measured for the scaffolds 
which contained calcium deficient apatite. Moreover, the promotion of matrix elaboration by calcium 
deficient apatite was robust and persisted in the presence of thyroid hormone stimulation. These findings 




Gene Sense    Antisense Amplicon Size (bp)
ALP TGCGACTGACCCTTCACTCTC CACCAGCAGGAAGAAGCCTTT 84
Col X TGGATCCAAAGGCGATGTG GCCCAGTAGGTCCATTAAGGC 82
Ihh ATCTCGGTGATGAACCAGTG CCTTCGTAATGCAGCGACT 97
MMP13 ACATCCCAAAACGCCAGACAA GATGCAGCCGCCAGAAGAAT 109
PTHrP ACCTCGGAGGTGTCCCCTAA GCCCTCATCATCAGACCCAA 80
GAPDH GCTGGTGCTGAGTATGTGGT CAGAAGGTGCAGAGATGATGA 213
Table 4.1  Primer Sequences for Gene Expression.
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Figure 4.1 Ceramic characterization. Calcium deficient apatite (CDA) was sintered at 900°C for three 
hours to produce beta tricalcium phosphate (TCP). Scanning electron microscopy (SEM) images show 
irregular particle shape for the CDA and a rhombic particle shape for the TCP (10,000x, n=2). Crystalline 
peaks are detected for both ceramics using X-ray diffraction (XRD), with broader peak widths for the CDA 
(n=2). Using Fourier transform analysis (FTIR), phosphate bending peaks are observed for both 
ceramics; however, a carbonate peak is detected only for the CDA (n=2). TCP has higher calcium and 
phosphorus weight content than the TCP; however, both ceramics have similar calcium/phosphorus 
molar ratio (n=6, *p<0.05 for difference between ceramics). The specific surface area of the CDA is 




Ca (wt%, n=6) 31.58  0.36* 33.54  0.40*
P (wt%, n=6) 17.35  0.14* 18.56  0.18*
Ca/P Molar Ratio (n=6) 1.41  0.02 1.40  0.02






































































Figure 4.2 Study design. Deep zone chondrocytes are mixed with agarose to make cellular constructs 
with either no particles (control), calcium deficient apatite (CDA) particles, or tricalcium phosphate (TCP) 
particles to generate three study groups. Each scaffold group was cultured in vitro with or without thyroid 

















Figure 4.3 Cell number and distribution. Hematoxylin and eosin staining reveals uniform cell 
distribution throughout all scaffolds at day 14 (10x, n=2). The calcium deficient apatite (CDA) group 
measures the highest cell number at day 14 both with and without thyroid hormone (T3) stimulation (n=5, 


























































































Figure 4.4 Collagen deposition. Picrosirius red staining shows positive collagen staining throughout all 
scaffolds, with the darkest staining observed for the calcium deficient apatite (CDA) group on day 14 (10x, 
n=2). The CDA group measures the highest collagen deposition on day 14 in the presence and absence 
of thyroid hormone (T3) stimulation (n=5, *p<0.05 for difference between groups, #p<0.05 for difference 












































































Figure 4.5 Day 14 collagen immunohistochemistry. Weak collagen I staining is detected for all groups 
except the calcium deficient apatite (CDA) group, with the brightest staining observed for the stimulated 
TCP group. Collagen II staining is detected for all groups with the most positive staining for the CDA 
group. Collagen X staining is positive for all groups except the CDA group, with the strongest staining 











Figure 4.6 Glycosaminoglycan deposition. Alcian blue staining shows positive glycosaminoglycan 
staining throughout all scaffolds, with the darkest staining observed for the calcium deficient apatite 
(CDA) groups on day 14 (10x, n=2).The CDA group measures the highest proteoglycan deposition on day 
14 in the presence and absence of thyroid hormone (T3) stimulation (n=5, *p<0.05 for difference between 











































































Figure 4.7 Alkaline phosphatase activity and mineral distribution. The calcium deficient apatite 
(CDA) group measures the highest ALP activity on day 1, with low ALP activity thereafter. The ceramic-
free and TCP groups exhibit enhanced day 7 and day 14 ALP activity in the presence of thyroid hormone 
(T3), with the tricalcium phosphate (TCP) group measuring the highest ALP activity on day 14 (n=5, 
*p<0.05 for difference between groups, #p<0.05 for difference from corresponding group at previous 
timepoint). Von Kossa staining revealed similar staining on day 1 and day 14 for all groups, with black 
nodules present in the TCP and CDA groups. Alizarin red staining shows positive calcium staining 
throughout the CDA and TCP scaffolds at all timepoints, with negative staining for the ceramic-free 











































































































Figure 4.8 Gene expression. Calcium deficient
apatite (CDA) and tricalcium phosphate (TCP)
groups exhibited downregulated col X and Ihh on
day 1 compared to the control. The CDA group
also exhibited the lowest ALP expression and the
highest PTHrP. On day 14, the untreated CDA
group exhibited the lowest col X expression.
MMP13 was upregulated at day 14 for the
unstimulated TCP group. The stimulated TCP
group exhibited upregulated Ihh, and both
stimulated ceramic groups MMP13 expression
was downregulated with respect to the stimulated
control group (n=5, *p<0.05 for difference between
groups).



































































































Figure 4.9 Media ion concentrations. The calcium deficient apatite (CDA) group had lower media 
calcium concentration on day 1; however, no difference was noted between the CDA and control group 
after day 1. The tricalcium phosphate (TCP) group resulted in higher phosphate concentration in the 
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CHAPTER 5: THE EFFECT OF CERAMIC DOSE 
ON DEEP ZONE CHONDROCYTE RESPONSE 
AND CALCIFIED CARTILAGE FORMATION IN 
AGAROSE SCAFFOLDS  
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5.1 Introduction 
In chapter 4, the effect of ceramic crystallinity on calcified cartilage formation was investigated. It was 
determined that poorly crystalline calcium deficient apatite is promising for calcified cartilage regeneration 
because it promotes cell proliferation and matrix production, resulting in a calcified matrix that is rich in 
proteoglycans and collagen II. Reports have demonstrated, using an agarose-hydroxyapatite composite, 
that ceramic dose can influence cell response [11]; thus, in this chapter, the dose of calcium deficient 
apatite in agarose will be optimized to maximize matrix deposition and mechanical properties.  
5.1.1 Background and Significance 
This study evaluates the response of deep zone chondrocytes to varied doses of calcium deficient 
apatite in agarose scaffolds to promote calcified cartilage regeneration. While calcium deficient apatite 
enhances matrix deposition at a dose of 1.5% w/v, studies have shown that ceramic dose affects 
chondrocyte response and the resultant mechanical properties of the newly formed tissue [11]. Khanarian 
et al. evaluated the effect of the hydroxyapatite dose in agarose scaffolds on hypertrophy-stimulated deep 
zone chondrocytes. While 1.5% and 3% hydroxyapatite resulted in similar matrix deposition and cell 
number, the scaffold with 3% hydroxyapatite exhibited higher mechanical properties after two weeks of 
culture.  
In this study, the response of deep zone chondrocytes in the presence and absence of thyroid 
hormone will be evaluated in agarose constructs with four doses of calcium deficient apatite: 0.75%, 
1.5%, 3%, and 4.5%. In a full thickness defect, both hypertrophic and non-hypertrophic deep zone 
chondrocytes will be present near the cartilage-bone interface in the defect, as these are the cells located 
closest to this region. Studies have demonstrated that thyroid hormone (T3) stimulates the hypertrophic 
phenotype in deep zone chondrocytes [188], and the deep zone chondrocytes that reside near a full 
thickness defect will likely be exposed to thyroid hormone because it is present in the circulation [182].  
5.1.2 Objectives 
The objective of this study is to investigate the effect of calcium deficient apatite dose on 
chondrocyte response in order to determine the ceramic dose that is most conducive to regenerating 
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calcified cartilage. It is hypothesized that increasing ceramic content will increase hypertrophy and matrix 
deposition. 
5.2 Materials and Methods 
5.2.1 Cells and Cell Culture 
Primary deep zone chondrocytes (DZCs) were isolated and pooled from the femoral articular cartilage 
of five immature calf knees (Green Village Packing Co.) following previously described protocols [79]. The 
bottom third of the cartilage was separated, and the calcified cartilage was removed by scraping. The 
cartilage was minced and digested with collagenase type 2 (310 u/mg, Worthington) for 16 hours in 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Atlanta 
Biologicals, Atlanta, GA), 2% antibiotics (10,000 U/mL penicillin, 10 mg/mL streptomycin), and 0.2% 
antifungal (250 µg/mL amphotericin B). The DZC suspension was filtered before plating (30 µm, 
Spectrum). The isolated chondrocytes were maintained in high-density culture in fully-supplemented 
DMEM with 10% FBS, 1% non-essential amino acids, 1% penicillin-streptomycin, 0.1% gentamicin 
sulfate, and 0.1% antifungal for three days prior to seeding in the hydrogel [15]. All media supplements 
were purchased from Cellgro-Mediatech unless otherwise specified.  
5.2.2 Scaffold Fabrication, Characterization, and Culture 
Chondrocytes were encapsulated at a density of 10 million cells/mL in 2% low gelling agarose 
(Agarose Type VII, Sigma) and varying doses of CDA (Fig. 5.1). A biopsy punch (Sklar Instruments, West 
Chester, PA) was used to core cylindrical scaffolds (Ø = 5 mm, height = 2.4 mm) [11]. Acellular and 
cellular agarose scaffolds with varying concentrations of ceramic, added at the time of fabrication, and 
corresponding controls without ceramic were fabricated.  
All samples were cultured under humidified conditions at 37⁰C and 5% CO2 and maintained in ITS 
media composed of DMEM supplemented with 1% ITS+ Premix (BD Biosciences), 1% penicillin-
streptomycin, 0.1% gentamicin sulfate, 0.1% antifungal (250 µg/mL amphotericin B), and 40 µg/mL L-
proline (Sigma). The medium was changed every other day and freshly supplemented with 50 µg/mL 
ascorbic acid (Sigma). In order to induce hypertrophy, DZCs were stimulated with 25 nM triiodothyronine 
(T3, Sigma) during the first three days of culture [174]. 
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Gross morphology of acellular scaffolds was assessed with a stereoscope (Olympus SZ61). Scaffold 
wet weight (n=3) was measured (P114 Pinnacle Series Balance, Denver Instruments), and ash weight 
was determined by thermogravimetric analysis (TA Q-50, TA Instruments). Scaffold mechanical properties 
(n=3) were determined on a shear-strain controlled rheometer (TA instruments) following published 
protocols [189]. Briefly, each sample was placed between two flat porous platens and immersed in DMEM 
to prevent dehydration. First, the equilibrium compressive Young’s modulus (Eeq) was calculated at 15% 
compressive strain, which is within the physiological range for articular cartilage [190]. A dynamic shear 
test was then performed (0.01 Hz to 10 Hz) with a logarithmic frequency sweep at a shear strain 
amplitude of 0.01 radian. Both the magnitude of the complex shear modulus (|G*|) and phase shift angle 
(δ) between the applied strain and the resulting torque were determined at 1 Hz.  
5.2.3 Cell Viability and Number 
Cell viability and death (n=2) were visualized using live/dead staining (Invitrogen). The samples were 
rinsed with phosphate buffered saline (PBS, Sigma), stained following the manufacturer’s suggested 
protocol, and imaged under confocal microscopy (Olympus Fluoview IX70) at wavelengths of 488 nm and 
568 nm, respectively. Cell number (n=5) was determined using the Quanti-iT™ PicoGreen
®
 dsDNA assay 
kit (Molecular Probes, Eugene, OR) following sample digestion. The sample was rinsed with PBS and 
exposed to a freeze-thaw cycle in 500 μL of 0.1% Triton™-X solution (Sigma) in order to lyse the cells. 
After desiccation for 12 hours in a CentriVap Concentrator (Labconco Co.), the samples were digested for 
18 hours at 65°C with papain (8.3 activity units/mL) in 0.1 M sodium acetate (Sigma), 10 mM cysteine-
hydrochloric acid (Sigma), and 50 mM ethylenediaminetetraacetate (Sigma). For DNA content, a 25 μL 
aliquot of the sample was mixed with 175 μL of the PicoGreen
®
 working solution, and fluorescence was 
measured with a microplate reader (Tecan) at excitation and emission wavelengths of 485 and 535 nm, 
respectively. The conversion factor of 7.7 pg DNA/cell was used to determine cell number [158;159]. 
5.2.4 Mineralization 
Alkaline phosphatase (ALP) activity (n=5) was measured using a colorimetric assay based on the 
hydrolysis of p-nitrophenyl phosphate (pNP-PO4) to p-nitrophenol (pNP) [164]. The samples were lysed in 
0.1% Triton™ X solution, exposed to a freeze-thaw cycle, and crushed with a pestle. A 25 μL aliquot was 
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added to pNP-PO4 solution (Sigma) and incubated for 10 minutes at 37°C. Absorbance was measured at 
405 nm using a microplate reader (Tecan). In addition, phosphate distribution (n=2) was evaluated as an 
indicator of overall mineral distribution. For phosphate staining, depariffinized samples were stained with 
5% silver nitrate and exposed to UV light (365 nm) for 25 minutes before a tap water rinse. Cover-slipped 
sections were imaged using a brightfield microscope (Zeiss, Axiovert 25). 
5.2.5 Matrix Deposition 
Total collagen content (n=5) was quantified using a modified hydroxyproline assay [160] with bovine 
collagen I solution (Biocolor, Carrickfergus, UK) as the standard. Briefly, a 40 μL aliquot of sample digest 
was mixed with 10 μL of 10 N sodium hydroxide and heated to 250°C for 25 minutes in order to hydrolyze 
the collagen. The hydrolyzate was then oxidized at room temperature for 25 minutes with 450 μL buffered 
chloramine-T reagent prior to the addition of 425 µL Ehrlich’s reagent (15% p-
dimethylaminobenzaldehyde in 2:1 isopropanol/percholoric acid). Absorbance was measured at 555 nm 
with a microplate reader (Tecan). All matrix values were normalized by sample wet weight in order to 
account for any differences in sample size. Additionally, collagen distribution (n=2) was evaluated via 
histology. The samples were first fixed in neutral buffered formalin with 1% cetylpyridinium chloride 
(Sigma) for 24 hours followed by dehydration with an ethanol series. The dehydrated samples were 
embedded in paraffin (Paraplast X-tra Tissue Embedding Medium, Fisher Scientific), and 7 μm sections 
were obtained from the center of the scaffold. Paraffin was cleared with xylenes, the samples were 
rehydrated, stained with picrosirius red staining for one hour, and exposed to 0.1 N hydrochloric acid for 
two minutes (n=2). In addition, collagen I and II were assessed using immunohistochemistry (n=2) [11]. 
Specifically, monoclonal antibodies for collagen I (1:00 dilution) and collagen II (1:100 dilution) were 
purchased from Abcam (Cambridge, MA). After fixation, samples were treated with 1% hyaluronidase for 
30 minutes at 37°C and incubated with primary antibody overnight. Cell nuclei were stained with 4',6-
diamidino-2-phenylindole (Sigma). A FITC-conjugated secondary antibody (1:200 dilution, LSAB2 Abcam) 
was used, and samples were imaged under confocal microscopy (Olympus Fluoview IX70, Center Valley, 
PA) at excitation and emission wavelengths of 488 nm and 568nm, respectively.  
Sample glycosaminoglycan content (GAG, n=5) was determined with a modified 1,9-
dimethylmethylene blue (DMB) binding assay [161-163], with chondrotin-6-sulfate (Sigma) as the 
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standard. The absorbance difference between 540 nm and 595 nm was used to improve the sensitivity in 
signal detection. In addition, histology was used to visualize glycosaminoglycan distribution. 
Deparaffinized sections were exposed to 3% acetic acid for three minutes, stained with alcian blue for 45 
minutes, and rinsed twice with acid-alcohol (pH=1) for one minute (n=2) [159]. 
5.2.6 Statistical Analysis 
Results are presented as mean ± standard deviation, with n equal to the number of samples per 
group. A two-way analysis of variance (ANOVA) was performed to determine the effects of ceramic dose 
and culturing time on cell response (proliferation, matrix deposition, ALP activity, solution ion 
concentration, and mechanical properties). The Tukey-Kramer post-hoc test was used for all pair-wise 
comparisons, and significance was attained at p<0.05. Statistical analyses were performed with JMP IN 
(4.0.4, SAS Institute, Inc.). 
5.3 Results 
5.3.1 Scaffold Characterization 
Scaffolds with 0%, 0.75%, 1.5%, 3%, and 4.5% CDA were fabricated (Fig. 5.1) and characterized in 
terms of gross appearance, wet and ash weight, and mechanical properties (Table 5.1). The ceramic-free 
scaffold was translucent, whereas the ceramic-containing scaffolds were more opaque. While wet weights 
were similar between the control and the 0.75%, 1.5% and 3% CDA groups, the 4.5% CDA group was 
significantly heavier than the ceramic-free control. A dose-dependent increase in ash weight was 
detected for all ceramic-containing groups. Day 1 mechanical properties were measured for all groups in 
terms of compressive modulus, dynamic shear modulus, and phase shift angle. While there were no 
differences detected between groups for Young’s modulus or phase shift angle, the dynamic shear 
modulus was significantly higher than the control group for both the 3% and 4.5% CDA groups.  
5.3.2 Cell Viability and Number 
Cell number and viability were tracked over time for all groups (Fig. 5.2). Cell number was similar for 
all groups on day 1. For the unstimulated groups, cell number increased over time for all ceramic-
containing groups and was maintained for the ceramic-free control group. On day 21, the highest cell 
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number was measured for the 4.5% group; however, there was a decrease in cell number in this group 
between day 21 and day 42. On day 42, the 0.75%, 1.5%, and 3% groups exhibited the highest cell 
number. These findings were confirmed with live/dead staining that showed viable cells in all groups. In 
the presence of T3 stimulation, an increase in cell number for all ceramic containing groups was 
measured by day 7, with higher cell number for ceramic-containing groups than the control regardless of 
dose. On day 21, the 3% and 4.5% groups exhibited the highest cell number; however, a significant 
decrease in cell number was measured for these groups between day 21 and day 42. On day 42, the 
highest cell number was detected for the 0.75% and 1.5% groups. Corresponding viability staining 
revealed many dead cells in the 3 and 4.5% CDA groups that had been stimulated with T3, with viable 
cells detected in all other groups.  
5.3.3 Matrix Deposition 
Collagen and glycosaminoglycan (GAG) deposition were measured for all groups over time (Fig. 5.3, 
Fig. 5.4, and Fig. 5.5). Collagen deposition in the unstimulated groups increased over time between day 1 
and day 14 for the ceramic-free, 0.75% and 1.5% groups. On day 14 and day 21, significantly higher 
collagen content was measured for the unstimulated 0%, 0.75% and 1.5% CDA groups compared to the 
unstimulated 3% and 4.5% groups and for the stimulated 0.75% and 1.5% CDA compared to the 
stimulated 3% and 4.5% CDA groups. On day 42, the highest collagen content was measured for the 
0.75% group, with a dose-dependent decrease in collagen measured for the 1.5, 3, and 4.5% groups 
compared to the 0.75% group. For the groups stimulated with T3, collagen content was highest in the 
0.75% and 1.5% CDA scaffolds on day 42 and lowest for the 3% and 4.5% groups throughout the study. 
The histological analysis corroborated these findings, with strongly positive staining for the 0.75% and 
1.5% groups both with and without T3 and weak staining observed in the unstimulated 4.5% group and 
the stimulated 3 and 4.5% groups. Collagen content was further analyzed for all groups on day 42 via 
immunohistochemical staining (Fig.5.4). All scaffolds exhibited weak or negative collagen I and collagen 
X staining and positive collagen II staining.  
Glycosaminoglycan content was measured for each group over time (Fig. 5.5). In the absence of T3, 
the highest GAG content was measured for the 0.75%, 1.5%, and 3% groups on day 42, and a significant 
loss of GAG was detected for the 4.5% group between day 21 and day 42. In the presence of T3, the 
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0.75% and 1.5% groups exhibited the highest GAG content on day 42, with no GAG detected in the 3% 
and 4.5% groups at this timepoint. In both cases, the control maintained constant GAG from day 14 to 
day 42. Histological analysis confirmed these findings, revealing strong staining of uniformly distributed 
GAG for the 0.75%, 1.5%, and 3% unstimulated groups as well as the 0.75% and 1.5% stimulated 
groups.  
5.3.4 Mechanical Properties 
Mechanical properties were assessed on days 1, 21, and 42 for all groups (Fig. 5.6). Properties 
increased over time for all ceramic-containing groups, and the unstimulated 0.75%, 1.5% and 3% groups 
exhibited higher Young’s modulus and dynamic shear modulus by day 42 than the control. On day 42, the 
stimulated 0.75% and 1.5% exhibited higher mechanical properties than the control but lower properties 
than corresponding unstimulated groups. In the presence of T3, the 0%, 3%, and 4.5% group had the 
lowest mechanical properties; however, in the absence of T3, the 3% resulted in the strongest constructs.  
5.3.5 Mineralization 
Alkaline phosphatase (ALP) activity and von Kossa staining were used to assess mineralization 
potential and mineral distribution (Fig. 5.7). ALP activity was elevated on day 1 for the 3% and 4.5% 
groups, with low ALP activity after day 1 for all unstimulated groups. For T3-stimulated groups, a late 
peak in ALP activity on day 42 was observed for the 3% group. Positive von Kossa staining was observed 
for all mineral-containing groups at day 42. 
5.4 Discussion 
The goal of this study is to optimize the dose of ceramic in an agarose-calcium deficient apatite 
composite scaffold for calcified cartilage formation. To this end, the response of deep zone chondrocytes 
was evaluated over time in agarose scaffolds with 0%, 0.75%, 1.5%, 3%, and 4.5% calcium deficient 
apatite in the presence and absence of thyroid hormone. The results demonstrate that deep zone 
chondrocytes are sensitive to calcium deficient apatite dose within agarose gels, with the highest matrix 
deposition detected for 0.75%, 1.5%, and 3% unstimulated groups and 0.75% and 1.5% stimulated 
groups. While the 0.75% and 1.5% groups both promoted matrix elaboration in the presence and 
absence of thyroid hormone, the constructs with 1.5% calcium deficient apatite exhibited significantly 
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higher mechanical properties by day 42 compared to the 0.75% calcium deficient apatite. Based on these 
findings, a calcium deficient apatite dose of 1.5% is the optimal for calcified cartilage regeneration.  
In this study, lower doses of calcium deficient apatite promoted the development of a matrix rich in 
glycosaminoglycan and collagen II, while higher doses inhibited matrix elaboration. This finding echoes 
previously reported results by Khanarian et al. [11], showing that matrix deposition was elevated for deep 
zone chondrocytes in the presence of 1.5% and 3% hydroxyapatite and thyroid hormone but was 
inhibited when the dose of hydroxyapatite was raised to 6%. In our study, we measured inhibition of 
matrix deposition in the presence of thyroid hormone beginning at a lower dose of 3%. This difference is 
likely a result of the increased bioactivity of calcium deficient apatite compared to hydroxyapatite, as 
bioactive ceramics at high doses have been shown to result in less matrix than more inert ceramics in 
vivo [172]. This effect may be related to surface chemistry and ion dissolution. In addition, in agarose-
ceramic composites, high doses of calcium phosphate particles within the scaffold limit the space 
available for matrix elaboration relative to lower doses. The incorporation of a high dose of ceramic also 
influences the scaffold mechanics. Therefore, chondrocytes cultured within the high dose gels experience 
a stiffer environment, and the reduction in matrix deposition may be a result of these mechanical cues. 
Schuh et al. has shown that chondrocytes cultured in stiff agarose scaffolds produce less GAG than 
chondrocytes cultured in softer agarose scaffolds, indicating that mechanosensing may play a central role 
in modulating matrix elaboration in three-dimensional constructs [191]. 
The trends for matrix/scaffold weight were similar to matrix/cell, with glycosaminoglycan and collagen 
production elevated per cell for the low dose groups and suppressed for the high dose groups. This 
suggests that low doses of calcium deficient apatite not only promote chondrocyte proliferation, resulting 
in more cells that are capable of producing glycosaminoglycans and collagen, but may also increase 
biosynthesis at a cellular level. Elevation of matrix production/cell over the control scaffold was significant 
for glycosaminoglycans for unstimulated 0.75%, 1.5%, and 3% groups and stimulated 0.75% and 1.5% 
groups. However, in terms of collagen/cell, a significant elevation in matrix/cell was measured only for the 
unstimulated 1.5% group. This finding is in agreement with previously reported results that indicate there 
is a tendency for chondrocytes to preferentially produce glycosaminoglycans relative to collagen in 
hydrogel-based tissue engineered constructs [11;192].   
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Mechanical properties of the gel, measured at day 1, 21, and 42 follow similar patterns to the matrix 
deposition. The highest compressive and shear moduli were measured for the 1.5% and 3% unstimulated 
groups. Despite the high glycosaminoglycan and collagen content found for the 0.75% group, the 
resulting construct was not as strong as the 1.5% and 3% groups, indicating that the mineral may play a 
synergistic role in reinforcing the glycosaminoglycan-collagen matrix. Similar findings were reported for 
agarose-hydroxyapatite scaffolds in which higher doses of mineral were found to result in higher 
mechanical properties despite no measurable differences in matrix content between the scaffold groups 
[188]. 
This study demonstrated that, in addition to matrix production, chondrocyte mineralization potential 
was modulated by the dose of calcium deficient apatite. On day 1, alkaline phosphatase activity was 
upregulated for the 3% and 4.5% groups, with a significant decline in activity by day 7. In the stimulated 
groups, a second peak in ALP activity was measured for the 3% CDA group on day 42. Positive von 
Kossa staining was observed for all groups, with no marked differences between corresponding 
stimulated or unstimulated groups. While the histological analysis indicates similar mineral presence, the 
nature of the mineral cannot be distilled from the stains, and it is possible that the cells have remodeled 
the mineral over time in the scaffolds. The early alkaline phosphatase activity is consistent with the results 
from chapter 4 and previous reports of deep zone chondrocytes cultured in agarose-ceramic constructs 
[11]. Since the calcium deficient apatite causes early (day 1) calcium precipitation from the media 
(chapter 4), it is possible that the precipitation of high doses of calcium into the scaffold enhance the 
alkaline phosphatase activity in the high dose scaffolds. In a study by Subramony et al., high doses of 
ceramic within polymer scaffolds were also reported to result in increased early alkaline phosphatase 
activity of mesenchymal stem cells, corroborating findings that alkaline phosphatase activity is a function 
of ceramic dose [193]. The late peak in alkaline phosphatase activity on day 42 for the 3% group mirrors 
a late peak previously reported for chondrocytes cultured on polymer scaffolds with 10% incorporated 
hydroxyapatite, in which a similar late peak was not observed for a higher dose of hydroxyapatite or for a 
ceramic-free control [154].  
In summary, the results of this study demonstrate that deep zone chondrocyte response is modulated 
by calcium deficient apatite dose in agarose scaffolds in terms of growth, biosynthesis, and 
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mineralization. While low doses of bioactive mineral promote glycosaminoglycan and collagen II 
deposition, high doses of ceramic inhibit chondrocyte biosynthesis. Though both 0.75% and 1.5% 
ceramic enhanced matrix deposition in the presence and absence of thyroid hormone stimulation, the 
1.5% dose resulted in the highest mechanical properties and was the only dose to result in increased 
glycosaminoglycan and collagen deposition per cell by day 42.  
5.5 Conclusions 
Collectively, the results of this study and chapter 4 provide the optimal design specifications to 
promote calcified cartilage-like tissue formation by the hydrogel-based scaffold of the multi-phased cup 
integration system. An agarose-calcium deficient apatite system incorporating 1.5% ceramic supports 
chondrocyte viability and promotes matrix deposition, resulting in increased mechanical properties. 
Therefore, the hydrogel-ceramic scaffold in the base of the cup will consist of agarose with 1.5% calcium 
deficient apatite.  
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Figure 5.1 Study design. Deep zone chondrocytes and calcium deficient apatite (CDA) were added to 
agarose to fabricate scaffolds with five different doses of CDA particles. Each scaffold group was cultured 



























Scale Bar = 2 mm
Wet Weight (mg) 41.3  0.8 41.4  0.9 40.7  0.6 42.3  0.7 43.8  0.9*
Ash Weight (mg) N/A 0.4  0.1 0.6  0.2 1.2  0.2 2.0  0.2
Compressive 
Modulus (kPa)
5.1  1.6 5.8  1.4 4.7  0.9 8.4  1.7 7.8  1.5
Dynamic Shear
Modulus (kPa)
7.9  0.3 11.1  1.7 8.8  2.1 11.6  0.9* 13.4  1.1*
Phase Shift (deg) 1.3  0.7 2.7  0.7 1.9  1.3 1.8  0.7 2.7  0.8
*p<0.05 for difference from ceramic-free control
Table 5.1 Acellular scaffold characterization for agarose constructs with varied CDA content
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Figure 5.2 Cell number, viability, and distribution. In the absence of thyroid hormone (T3) stimulation, 
cell number was highest for the 0.75, 1.5 and 3% calcium deficient apatite (CDA) groups by day 42. In the 
presence of thyroid hormone (T3), cell number was highest for the 0.75 and 1.5% groups on day 42 (n=6, 
*p<0.05 for difference between groups, #p<0.05 for difference from corresponding group at previous 
timepoint). Uniformly distributed, viable cells were observed in all groups, except the stimulated 3% group 
and both 4.5% groups (n=2).   
  




































































Day 42, scale bar = 200 µm
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Figure 5.3 Collagen production. Collagen production, normalized by wet weight, was highest for the 
unstimulated 0.75% and stimulated 0.75 and 1.5% calcium deficient apatite (CDA) groups by day 42 
(n=6, *p<0.05 for difference between groups, #p<0.05 for difference from corresponding group at previous 
timepoint). Collagen content, normalized by cell number, was highest for the stimulated 1.5% CDA group, 
and lowest for the stimulated and unstimulated 3 and 4.5% CDA groups. Significant increases over the 
control are highlighted in green, and significant decreases are shown in red (n=6, *p<0.05). Picrosirius 
red staining confirms the quantitative findings and shows uniform collagen distribution throughout the 
agarose constructs (n=2). 
  
Day 42, scale bar = 200 µm
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Collagen/cell (ng/cell) on day 42
Groups 0% 0.75% 1.5% 3% 4.5%
-T3 0.93  0.3 0.88  0.2 0.76  0.0 0.47  0.0 0.58  0.2
+T3 0.50 0.1 0.63 0.1 0.70 0.1 0.20 0.1 0.22 0.1
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Figure 5.4 Collagen immunohistochemistry. Negative collagen I and X staining and positive collagen II 

































Day 42, scale bar = 400 µm
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Figure 5.5 Glycosaminoglycan production. Glycosaminoglycan (GAG) content, normalized by wet 
weight, was highest for the unstimulated 0.75, 1.5 and 3% calcium deficient apatite (CDA) groups and for 
the stimulated 0.75 and 1.5% CDA groups by day 42 (n=6, *p<0.05 for difference between groups, 
#p<0.05 for difference from corresponding group at previous timepoint). GAG content, normalized by cell 
number, followed similar trends, with significant increases over the control highlighted in green and 
significant decreases shown in red (n=6, p<0.05). Alcian blue staining confirms the quantitative findings 
and shows uniform collagen distribution throughout the agarose constructs (n=2). 
  
Day 42, scale bar = 200 µm


















































































GAG/cell (ng/cell) on day 42
Groups 0% 0.75% 1.5% 3% 4.5%
-T3 0.72 ± 0.1 1.46 ± 0.2 1.62 ± 0.2 1.30 ± 0.2 0.31 ± 0.3




Figure 5.6 Mechanical properties. Dynamic
shear modulus and Young’s modulus were
highest for the unstimulated 0.75 and 1.5%
calcium deficient apatite (CDA) groups on day
42 (n=3, *p<0.05 for difference between
groups, #p<0.05 for difference from
corresponding group at previous timepoint,



























































































































































Figure 5.7 Mineralization. ALP activity was highest for the 3 and 4.5% groups on day 1 with low ALP 
activity thereafter for all groups, except for the stimulated 3% group, which exhibited a peak in activity on 
day 42 (n=6, *p<0.05 for difference between groups, #p<0.05 for difference from corresponding group at 
previous timepoint). Von Kossa staining shows uniform mineral distribution through the ceramic-
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CHAPTER 6: EFFECT OF CERAMIC DOSE IN 
MICROFIBER SCAFFOLDS ON DEEP ZONE 
CHONDROCYTE RESPONSE AND CALCIFIED 
CARTILAGE FORMATION  
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6.1 Introduction 
In chapters 4 and 5, ceramic composition and dose were optimized in an agarose-ceramic composite 
scaffold for interface regeneration, and it was determined that calcium deficient apatite promoted 
glycosaminoglycan and collagen production in a dose-dependent manner. In this chapter the dose of 
calcium deficient apatite in polymeric microfiber scaffolds will be optimized to enhance calcified cartilage 
formation in the base of the cup-shaped scaffold. Preliminary findings from an in vivo study in rabbits [17] 
suggest that the combination of fiber-based scaffolds with hydrogels containing ceramic increases the 
organization of the newly formed interface compared to either scaffold alone, indicating that a hybrid 
scaffold composed of polymer, hydrogel, and ceramic phases may be ideal for calcified cartilage 
regeneration. While agarose is well-suited for chondrocyte culture and regeneration of cartilage tissue, a 
hydrogel-based scaffold system may not provide a sufficient physical barrier between the cartilage and 
bone regions due to its high water content. Furthermore, although an interface scaffold made of hydrogel 
will integrate well with hydrogel-based cartilage grafts, an agarose-based scaffold is difficult to handle 
given the dimensions of the interface (<300 µm thick). Therefore, the agarose-ceramic scaffold will be 
combined with a fibrous scaffold to form the base of the cup to facilitate integration with cartilage grafts 
while improving structural integrity and ease of handling.  
6.1.1 Background and Motivation 
This study optimizes a microfiber-ceramic scaffold to serve as a temporary barrier to osseous 
upgrowth during the healing of full thickness defects and to promote calcified cartilage formation by 
chondrocytes. Fiber-based scaffolds composed of polymers and ceramic particles have been studied for 
osteochondral tissue engineering applications [125;137;194], and chondrocytes have been shown to 
attach, proliferate, and produce matrix on these scaffold systems. However, few studies have investigated 
the use of a poorly crystalline ceramic phase that mimics the native interface. Furthermore, though the 
response of articular, full thickness chondrocytes has been characterized on a variety of scaffolds, the 
response of deep zone chondrocytes, which reside directly above the interface on polymer-ceramic 
scaffolds, has not been studied in detail.  
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6.1.2 Objectives 
 The first objective of this study is to fabricate and characterize a scaffold for interface 
regeneration using the stable 5:1 PLGA:PCL microfiber composition, optimized in chapter 1, and varying 
concentrations of calcium deficient apatite. The second objective is to evaluate the dose of calcium 
deficient apatite that is most conducive to regenerating calcified cartilage in microfiber scaffolds. 
Increasing the content of calcium deficient apatite is hypothesized to increase matrix deposition and 
mineralization potential, similar to the response of chondrocytes in composite hydrogel scaffolds. 
6.2 Materials and Methods 
6.2.1 Scaffold Fabrication and Characterization 
Unaligned microfiber scaffolds were fabricated using the electrospinning process [20;149] (Fig. 6.1). 
For control scaffolds, a 32% (w/v) polymer (5:1 PLGA (85:15, Lakeshore Biomaterials):PCL (Sigma-
Aldrich, Mw ≈ 70,000-90,000) solution in 60/40 DCM/DMF was vortexed continuously for one hour. To 
fabricate PLGA:PCL-calcium deficient apatite (CDA, Sigma-Aldrich) scaffolds, CDA nanoparticles were 
directly added to the PLGA:PCL polymer solution at varying concentrations. Each solution was loaded 
into a 5 mL syringe with a stainless steel blunt tip needle (26.5 gauge for PLGA:PCL blends, 23 gauge for 
polymer-ceramic blends) that was 13 cm from the collecting target, and electrospun at 8-10 kV using a 
custom electrospinning device. The polymer solution was deposited (1 mL/hour) onto a stationary 
collecting target using a syringe pump (Harvard Apparatus).  
As-fabricated microfiber scaffolds were imaged with SEM (2 kV, Hitachi 4700, Hitachi Ltd.) to 
evaluate fiber morphology and Energy Dispersive X-ray Analysis (EDXA, 15 kV Princeton Gamma Tech) 
was utilized to determine scaffold elemental composition. Scaffolds were sputter-coated (Cressington 
108auto) with gold-palladium to reduce charging effects. Microfiber diameter (n=3) was quantified via 
image analysis of SEM micrographs. The scaffolds were imaged in both secondary and backscatter 
modes and EDXA spectra were collected at randomly selected scaffold regions. Signal was collected at 
100 seconds with a dead time of ~30% and 3000-4000 counts per second (CPS). The weight fraction of 
CDA incorporated in the electrospun scaffolds (n=3) was validated using thermo-gravimetric analysis 
(TGA-Q500, TA Instruments). The sample was loaded into a calibrated platinum pan, heated to 100°C in 
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nitrogen, and ramped at 20°C/minute to 700°C in oxygen. The ash weight was determined at the end of 
the temperature ramp. The degradation temperature of PLGA and PCL is approximately 400°C; therefore, 
the residual weight corresponded to the weight percent of mineral in the fibers.  
Chemistry and crystallinity (n=2) of the as-fabricated polymer and polymer-ceramic microfiber 
scaffolds were analyzed using Fourier Transform Infrared Spectroscopy (FTIR, PerkinElmer Frontier) and 
X-ray diffraction (XRD, X’Pert
3
 Powder, PANalytical), respectively. The FTIR spectra were collected in 
attenuated total reflectance (ATR) mode at a resolution of 4 cm
-1
. X-ray diffraction spectra were collected 
using a zero background plate over a range of 20-40° with a step size of 0.01 and a scan time of 120 
seconds/step.  
Polymer degradation was examined in vitro after 7, 14, 28, 42, 56, 70, and 84 days of culture in ITS-
supplemented medium. At each timepoint, total weight loss (n=6) was determined for each sample. After 
incubation, the samples were rinsed with distilled water, dried in a vacuum (CentriVap, Labconco), and 
the dry weight was measured (SE2 balance, Sartorius). 
6.2.2 Cells and Cell Culture 
Primary deep zone chondrocytes were isolated and pooled from the femoral articular cartilage of five 
immature calf knees (Green Village Packing Co.) following published protocols [79]. The bottom third of 
the cartilage was separated and the calcified cartilage was removed by scraping. The cartilage was then 
minced and digested with collagenase type 2 (310 u/mg, Worthington) for 16 hours in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, 
GA), 2% antibiotics (10,000U/mL penicillin, 10mg/mL streptomycin), and 0.2% antifungal (250 µg/mL 
amphotericin B). The deep zone chondrocyte suspension was filtered before plating (30 µm, Spectrum, 
Rancho Dominguez, CA). The isolated chondrocytes were maintained in high-density culture in fully-
supplemented DMEM with 10% FBS, 1% non-essential amino acids, 1% penicillin-streptomycin, 0.1% 
gentamicin sulfate, and 0.1% antifungal for three days prior to seeding in the hydrogel [15]. All media 
supplements were purchased from Cellgro-Mediatech unless otherwise specified.  
To seed the cells onto the scaffolds, 10 µL of concentrated cell suspension was pipetted onto each 
scaffold to achieve a seeding density of 100,000 cells/cm
2 
and incubated for 25 minutes at 37°C and 5% 
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CO2 before submersion in media. Cell-laden scaffolds were cultured at 37°C and 5% CO2 in 1.5 mL of 
media which was refreshed three times weekly. 
6.2.3 Cell Viability and Number 
Cell viability and death (n=2) were visualized using live/dead staining (Invitrogen). The samples were 
rinsed with phosphate buffered saline (PBS, Sigma), stained following the manufacturer’s suggested 
protocol, and imaged under confocal microscopy (Olympus Fluoview IX70) at wavelengths of 488 nm and 
568 nm, respectively. Cell proliferation (n=5) was determined using the Quanti-iT™ PicoGreen
®
 dsDNA 
assay kit (Molecular Probes, Eugene, OR) following sample digestion. The sample was rinsed with PBS 
and exposed to a freeze-thaw cycle in 500 μL of 0.1% Triton-X solution (Sigma) in order to lyse the cells. 
After desiccation for 12 hours in a CentriVap Concentrator (Labconco Co.), the samples were digested for 
18 hours at 65°C with papain (8.3 activity units/mL) in 0.1 M sodium acetate (Sigma), 10 mM cysteine-
HCl (Sigma), and 50mM ethylenediaminetetraacetate (Sigma). For DNA content, a 25 μL aliquot of the 
sample was mixed with 175 μL of the PicoGreen
®
 working solution and fluorescence was measured with 
a microplate reader (Tecan, Research Triangle Park, NC), at excitation and emission wavelengths of 485 
and 535 nm, respectively. The conversion factor of 7.7 pg DNA/cell was used to determine cell number 
[158;159]. 
6.2.4 Matrix Deposition 
Total collagen content (n=5) was quantified using a modified hydroxyproline assay [160] with bovine 
collagen I solution (Sigma) as the standard. Briefly, a 100 μL aliquot of sample digest was dehydrated in a 
vacuum oven (Isotemp Vacuum Oven Model 280A, Fisher Scientific) overnight and mixed with 25 μL 2 N 
sodium hydroxide and heated to 250°C for 25 minutes in order to hydrolyze the collagen. The hydrolyzate 
was then oxidized at room temperature for 25 minutes with 450 μL of buffered chloramine-T reagent prior 
to the addition of Ehrlich’s reagent (15% p-dimethylaminobenzaldehyde in 2:1 isopropanol/percholoric 
acid). Absorbance was measured at 555  nm with a microplate reader (Tecan). Additionally, collagen 
distribution (n=2) was evaluated via histology. The samples were first fixed in neutral buffered formalin 
with 1% cetylpyridinium chloride (Sigma) for one day and stored in 0.01 M cacodylic acid at 4°C. Prior to 
processing, samples were soaked overnight in 5% polyvinyl alcohol (PVA, Sigma-Aldrich), embedded in a 
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frozen block of PVA, and sectioned at -21 °C using a cryostat (Model OFT, Bright Instrument Company 
Microtome). Sections were soaked in distilled water for one hour to remove residual PVA, stained with 
picrosirius red staining for one hour, and exposed to 0.1 N hydrochloric acid for two minutes (n=2). For 
collagen I and II immunostaining, sections were incubated with primary antibody overnight. Cell nuclei 
were stained with 4',6-diamidino-2-phenylindole (Sigma). A FITC-conjugated secondary antibody (1:200 
dilution, Abcam) was used and samples were imaged under confocal microscopy (Olympus Fluoview 
IX70) at excitation and emission wavelengths of 488 nm and 568 nm, respectively. Cover-slipped sections 
were imaged using a brightfield microscope (Zeiss, Axiovert 25). 
Sample glycosaminogylcan content (GAG, n=5) was determined with a modified 1,9-
dimethylmethylene blue (DMB) binding assay [161-163], with chondrotin-6-sulfate (Sigma) as the 
standard. The absorbance difference between 540 nm and 595 nm was used to improve the sensitivity in 
signal detection. In addition, histology was used to visualize GAG distribution. Sections were exposed to 
3% acetic acid for three minutes, stained with alcian blue for 45 minutes, and rinsed twice with acid-
alcohol (pH=1) for one minute (n=2) [159]. Cover-slipped sections were imaged using a brightfield 
microscope (Zeiss, Axiovert 25). 
6.2.5 Mineralization 
Alkaline phosphatase (ALP) activity (n=5) was measured using a colorimetric assay based on the 
hydrolysis of p-nitrophenyl phosphate (pNP-PO4) to p-nitrophenol (pNP) [164]. The samples were lysed in 
0.1% Triton™ X solution, exposed to a freeze-thaw cycle, and crushed with a mortar. A 25 μL aliquot was 
added to pNP-PO4 solution (Sigma) and incubated for ten minutes at 37°C. Absorbance was measured at 
405 nm using a microplate reader (Tecan). In addition, phosphate distribution (n=2) was evaluated as an 
indicator of overall mineral distribution. For phosphate staining, samples were stained with 5% silver 
nitrate and exposed to UV light (365 nm) for 25 minutes before a tap-water rinse. Cover-slipped sections 
were imaged using a brightfield microscope (Zeiss, Axiovert 25). Media calcium concentration (n=5) was 
quantified using the Arsenazo III dye (Pointe Scientific), The media was diluted with water in a 1:10 ratio 
and allowed to react with the dye for five minutes. Absorbance was measured at 620 nm using a 
microplate reader (Tecan). Media phosphate concentration (n=5) was quantified using the BioVision 
Phosphate Assay Kit. The media was diluted with water in a 1:10 ratio and allowed to react with 30 µL of 
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dye for 30 minutes. Absorbance was measured at 650 nm using a microplate reader (Tecan).  
6.2.6 Statistical Analysis 
Results are presented in the form of mean ± standard deviation, with n equal to the number of 
samples per group. A two-way analysis of variance (ANOVA) was performed to determine the effects of 
ceramic dose and culturing time on cell response (proliferation, matrix deposition, ALP activity, and 
solution ion concentration). The Tukey-Kramer post-hoc test was used for all pair-wise comparisons and 
significance was attained at p<0.05. Statistical analyses were performed with JMP IN (4.0.4, SAS 
Institute, Inc.). 
6.3 Results 
6.3.1 Scaffold Characterization 
The structural and chemical properties of the scaffold were characterized post-fabrication (Fig. 6.2 
and Fig. 6.3). The microfibers were randomly aligned when examined via SEM regardless of CDA dose 
(Fig. 6.2). The presence of nodules along the fibers was noted for all ceramic-containing meshes. Fiber 
diameter was also measured for each composition, with no significant differences found between groups. 
The elemental composition of the fibers was analyzed using energy-dispersive x-ray analysis (EDXA, Fig. 
6.2). While carbon and oxygen were found in all groups, only the ceramic-containing groups exhibited 
peaks for phosphorus and calcium. Thermogravimetric analysis was used to verify mineral dose in the 
composite fibers. Residual weight of the 0% CDA microfibers was 0.36 ± 0.38% and 9.71 ± 0.46%, 
14.55 ± 0.06% and 19.92 ± 0.44% for the 10%, 15% and 20% CDA microfibers, respectively.  
The chemical composition of the fibers was also investigated via FTIR, which further confirmed the 
presence of ceramic within the fibers (Fig. 6.3). Typical infrared bands for the PCL and PLGA stretching 
modes were observed in the ceramic-free (0% HA) and ceramic-containing (10%, 15%, 20% CDA) 
groups. These bands include the ester carbonyl stretch from the PLGA (C=O) at 1746 cm
-1
 and from the 
PCL at 1726 cm
-1
, the PLGA methyl group C–H stretch at 1452 cm
-1
, the PLGA C–O–C ether group at 
1183 cm
-1
 and 1080 cm
-1
, and the PLGA C–O stretch at 1129 cm
-1 
[195]. The ceramic composite 
microfibers showed characteristic peaks corresponding to the third vibrational PO4
3-
 band from 566-628 
cm
-1
, as observed in the spectra reported in chapter 4 for the calcium deficient apatite. X-ray diffraction 
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was used to analyze the crystallinity of the scaffolds. One peak, at 2Θ =23.83 was present in the ceramic-
free, blended polymer scaffold which is characteristic of PCL [196]. In addition to the characteristic PCL 
peak, crystal planes 002, 211, 300, and 202, characteristic of the CDA (as reported in chapter 4), were 
identified in the XRD spectra of all ceramic containing scaffolds. Composition-dependent degradation was 
assessed by measuring dry weight over the course of a three month in vitro culture period (Fig. 6.4). The 
ceramic-free fibers exhibited the greatest degradation, with 87.76 ± 0.89% remaining after 84 days. 
Greater mass was retained with increasing ceramic content as 20% CDA fibers retained 91.08 ± 0.74% of 
their initial mass after 84 days. 
6.3.2  Cell Viability and Number 
The attachment, viability, and distribution of deep zone chondrocytes on the microfiber meshes were 
visualized using confocal microscopy (Fig. 6.5). The chondrocytes attached uniformly to the fiber surface 
on day 1 and assumed similar morphologies on all compositions. The cells maintained a rounded 
morphology throughout culture. Dead cells were rarely observed on any scaffold group. 
Cell number was similar on all scaffold compositions on days 1, 7, 14, and 21 (Fig. 6.5). A significant 
increase in the number of cells was measured on all compositions between day 1 and day 7 with no 
significant increase over time noted thereafter for any scaffold type. A significantly greater number of cells 
were measured on the 20% CDA group on day 42 as compared to the ceramic-free control group.  
6.3.3 Matrix Deposition 
Matrix deposition in terms of collagen and GAG were measured for all compositions over the duration 
of the study (Fig. 6.6 and Fig. 6.7). Significantly greater collagen was measured in the 10% CDA group as 
compared to the ceramic-free control and the 15% CDA group on day 14. By day 21, similar collagen 
deposition was measured for all groups, with more collagen measured for each group as compared to the 
corresponding value from day 1. On day 42, more collagen was measured in the ceramic-free control as 
compared to the corresponding value from day 21. Additionally, the 20% CDA group exhibited higher 
collagen content than the 10% CDA group on day 42. Collagen distribution was visualized by picrosirius 
red staining, which showed positive staining for all groups. While collagen was localized to the edge of 
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the ceramic-free control scaffold, it was distributed throughout the depth of the ceramic-containing 
scaffolds.  
In terms of GAG content, significantly more GAG was detected in the 10% CDA scaffolds on day 7 
compared to day 1. By day 14, GAG content was similar between all scaffold compositions, with more 
GAG measured at day 14 for all groups compared to corresponding day 1 values. On day 42, higher GAG 
content was measured in the 15% CDA and 20% CDA scaffolds as compared to corresponding day 21 
values. Significantly more GAG was measured in the 15% CDA group as compared to the ceramic-free 
control and 10% CDA group on day 42; however, the most GAG was measured for the 20% CDA group 
on day 42. Media GAG content was also measured for all compositions over the duration of the study, 
and GAG was detected in the media of all scaffold groups during the culture period. The distribution of 
GAG in the scaffolds was visualized by alcian blue staining. On day 42, the GAG was concentrated at the 
edge of the scaffold for all groups, with the greatest penetration observed for the 20% CDA scaffold.  
6.3.4 Mineralization 
Alkaline phosphatase activity was quantified to measure chondrocyte mineralization potential over 
time (Fig. 6.8). The highest ALP activity was found for the 10% group on day 1, with a significant 
decrease in ALP activity measured for all compositions between day 1 and day 7. No significant 
differences between groups were measured between groups after for any timepoint after day 1. Mineral 
distribution visualized via von Kossa staining showed similar dose-dependent mineral distribution on the 
composite microfibers and no mineral in the 0% HA group (Fig. 6.8). 
Media calcium and phosphate concentration was also measured over the duration of the study to 
better understand mineralization mechanics on the microfibers (Fig. 6.8). Significantly more calcium was 
measured in the media of the ceramic-free control scaffolds on day 1 compared to the control media and 
the media from the ceramic-containing scaffold groups. After day 1, no difference was detected between 
groups in terms of calcium concentration. Measurement of media phosphate showed significantly lower 
media phosphate in the all scaffold groups on day 1 as compared to the control media.  
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6.4 Discussion 
The overarching goal of thesis aim 2 is to engineer an integrative scaffold that can be placed between 
the healing cartilage and host subchondral bone to promote calcified cartilage formation and support 
osteointegration of the cartilage graft with the native bone tissue. The regeneration of the calcified 
cartilage will improve fixation of the grafts to the bone and protect the cartilage from osseous invasion. 
This study specifically addresses the characterization and in vitro optimization of a microfiber-calcium 
deficient apatite composite to form the base of the cup-shaped integration scaffold. In this study, 
microfiber scaffolds with varying concentrations of calcium deficient apatite are fabricated using 
electrospinning, and deep zone chondrocyte response is investigated in terms of cell viability, cell 
number, mineralization potential, and matrix production over time. The cell response measured on the 
scaffolds collectively demonstrate that, while all scaffold groups support chondrocyte attachment and 
proliferation, increasing ceramic dose results in increased matrix deposition. Based on these findings, it is 
apparent that 20% CDA is the optimal dose of ceramic for the base of the integration scaffold.  
Composite meshes that approximate the native osteochondral interface in thickness (~150 µm [39]) 
are reproducibly generated using electrospinning and can be handled with ease. By adjusting 
electrospinning parameters, scaffolds containing up to 20% calcium deficient apatite can be electrospun 
with similar fiber diameters. While the fiber diameter is controlled, it is noted that fiber nodularity appears 
to increase with mineral content, similar to other reported findings [154]. Therefore, although this study 
did not specifically investigate cellular response with respect to varying surface nodularity, chondrocyte 
response may be influenced collectively by the change in mineral content and scaffold texture.  
In this study, ceramic incorporation increased glycosaminoglycan production at both 15% and 20% 
doses compared to the ceramic-free control and 10% groups and increased collagen production at the 
20% dose. This finding is similar to results reported by Chuang et al. [150], in which deep zone 
chondrocytes cultured on poly(lactide-co-glycolide) microfiber scaffolds with 15% incorporated 
hydroxyapatite particles resulted in significantly more glycosaminoglycan and collagen deposition by day 
21 compared to ceramic-free controls. In a study by Moffat et al. [154], matrix deposition of full thickness 
chondrocytes on aligned polymer nanofibers was not dependent on the dose of hydroxyapatite. 
Specifically, no differences were found in glycosaminoglycan or collagen deposition on scaffolds 
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containing 10% or 15% hydroxyapatite particles. The difference observed in our study, in which 15% 
calcium deficient apatite resulted in more glycosaminoglycan deposition than 10%, may be due to the 
increased bioactivity of the calcium deficient apatite with respect to hydroxyapatite, as increased 
bioactivity has been shown to promote matrix deposition in other scaffolding systems [172]. Alternatively, 
the enhanced glycosaminoglycan production may be attributed to the zonal cell population used here, as 
chondrocytes isolated from different zones have varying biosynthetic activity [37].  
In addition to promoting matrix production, the scaffold should ideally retain the deposited matrix to 
enable the formation of a dense, calcified matrix. In this study, measured collagen and 
glycosaminoglycan increased over time for all groups, and day 42 histological analysis revealed dense 
regions of matrix on the scaffold edge initially seeded with cells as well as penetration of the matrix into 
the scaffold for ceramic-containing groups. By day 42, collagen and glycosaminoglycans completely 
penetrated the 20% CDA scaffold. While glycosaminoglycans were detected in the media at each 
timepoint for all scaffold groups, the amount detected in the media was small in comparison to the 
glycosaminoglycans measured on the scaffolds (<10% for the 20% group on days 21 and 42), indicating 
that the majority of produced glycosaminoglycans were retained in the scaffold. This finding shows an 
improvement from the poly(lactide-co-glycolide)-hydroxyapatite scaffold used in studies by Moffat et al. 
[154] in which GAG and collagen were found to decrease over time, but is similar to findings by Chuang 
et al. [143]. In this study and the study by Chuang et al., larger fibers and deep zone chondrocytes were 
used, as compared to the smaller fibers and full thickness chondrocytes used by Moffat et al. These 
differences may account for the increased matrix deposition and retention.  
It is envisioned that this scaffold will serve three important functions in vivo. First, during early tissue 
formation, it is anticipated that the scaffold will serve as a temporary barrier against vascular invasion and 
ectopic mineralization, degrading over time as cell-mediated tissue formation occurs. Second, it will 
promote elaboration and support retention of matrix at the cartilage-bone interface, leading to the 
formation of a calcified cartilage layer. Finally, the ceramic within the fiber mesh is expected to promote 
integration with underlying bone. To this end, unpublished data from our laboratory demonstrates the 
osteointegrative potential of polymer-ceramic fiber meshes in vivo using a bone core model.  
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6.5 Conclusions 
Collectively, the results of this study provide the optimal design specifications for the microfiber-
ceramic composite that will compose the base of the cup integration system. A microfiber-based system 
incorporating 20% calcium deficient apatite results in enhanced cell growth and matrix elaboration by 
deep zone chondrocytes. Therefore, the base of the cup will consist of composite polymer-ceramic 
microfibers containing 20% calcium deficient apatite. 
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Figure 6.1 Study design. Scaffolds were generated by electrospinning PLGA:PCL polymer with varying 



















Figure 6.2 Incorporation of calcium deficient apatite in microfiber scaffolds. Scanning electron 
microscopy (SEM) was used to evaluate fiber morphology (n=3, white arrows indicate CDA). Fiber 
diameter, shown below each image, was measured using ImageJ. Energy dispersive x-ray analysis (n=3, 
bottom left) confirms calcium and phosphorus incorporation in scaffolds with ceramic. Thermogravimetric 
analysis verifies that ceramic is incorporated at the target dose (n=3). 
  











































Figure 6.3 Characterization of composite scaffolds composed of microfibers and calcium deficient 
apatite (CDA). Fourier transform infrared analysis shows similar spectra for all scaffolds, with additional 
phosphate bending peaks present in all ceramic-containing scaffolds. Crystalline peaks that correspond 
to polycaprolactone (*) were observed in all spectra, and peaks corresponding to calcium deficient apatite 











































Figure 6.4 Scaffold degradation over time. Polymer scaffolds with and without calcium deficient apatite 
degrade over time in culture media. At day 84, the remaining weight is 87.8% ± 0.89, 89.6% ± 1.40, 
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Figure 6.5 Cell viability and number.
Chondrocytes are viable on all scaffolds
throughout the 42 day culture period. Cell number
increases for all groups by day 7, but by day 42
there are significantly more cells on the 20%
calcium deficient apatite (CDA) scaffolds than the
control scaffolds (n=5, *p<0.05 for difference
between groups on a given timepoint, #p<0.05 for
difference from corresponding group at previous
timepoint).




























Figure 6.6 Collagen deposition. Picrosirius red staining (top) shows collagen deposition in all scaffold 
groups on day 42 (n=2, scale bar = 100 um). Collagen II (middle panel) and collagen I (bottom panel) 
show positive collagen II staining for all groups and negative staining for collagen I (n=2, scale bar = 100 
um). Significant collagen deposition is measured for all groups by day 21, with the highest collagen 
content detected for the 20% group on day 42. (n=5, *p<0.05 for difference between groups on a given 
timepoint, #p<0.05 for difference from corresponding group at previous timepoint, ^p<0.05 for difference 
from corresponding group at day 1). 
























































Figure 6.7 Glycosaminoglycan (GAG) content. Glycosaminoglycan content on the scaffolds increased 
for all groups by day 14, with the highest GAG content measured for the 20% calcium deficient apatite 
(CDA) group on day 42 (n=5, *p<0.05 for difference between groups on a given timepoint, #p<0.05 for 
difference from corresponding group at previous timepoint, ^p<0.05 for difference from corresponding 
group at day 1). GAG was measured in the media for all groups at day 7; however by day 42, GAG is only 
detected in the media of the 20% CDA group (n=6, *p<0.05 for difference from control media). Alcian blue 
staining on day 42 (bottom) confirmed the quantitative findings (n=2, scale bar = 100 µm).  
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Figure 6.8 Mineralization. Black nodules are visible in von Kossa-stained sections for mineral-containing 
groups on day 42 (top left, n=2). Alkaline phosphatase (ALP) activity is highest for the 10% group on day 
1 with a significant decrease measured for all groups between day 1 and day 7. Media calcium is 
significantly higher for the control group on day 1, with no difference between groups thereafter. Media 
phosphate is lower than the control media for the control and all ceramic groups on day 1, with no 
difference between scaffold groups thereafter (n=5, *p<0.05 for difference between groups on a given 
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CHAPTER 7: IN VITRO EVALUATION OF 
INTERFACE FORMATION IN AN 
OSTEOCHONDRAL EXPLANT MODEL  
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7.1 Introduction 
In the previous chapters, the phases of the scaffold that will form the cup walls (chapters 2 and 3) and 
the cup base (chapters 4, 5, and 6) were optimized independently to maximize cell migration and calcified 
cartilage formation by deep zone chondrocytes. This chapter evaluates the translational potential of the 
assembled cup integration system. The scaffold phases will be joined and tested in a full thickness defect 
model to investigate the effect of the scaffold system on cartilage repair. 
7.1.1 Background and Significance 
This study evaluates the translational potential of the cup integration system for use with current 
cartilage repair strategies. As the previous in vitro studies evaluated cell response on each scaffold 
phase, the ability of the multi-phased scaffold system to improve integration during cartilage repair must 
be assessed at the tissue level. The cup is designed to be versatile and compatible with a variety of 
available techniques, such as tissue transplantation, tissue engineered grafts, and cell implantation. 
Although rabbit models are frequently used to study cartilage repair, it is particularly challenging to study 
the implementation of a complex scaffold system using this model because the cartilage depth is limited 
to approximately 400 µm [2]. Due to the shallow depth of the rabbit cartilage, defects made surgically 
often penetrate into the marrow space [188]. Since the base of the cup scaffold is designed to be placed 
directly at the cartilage-bone interface, it is important that the defect depth is precisely controlled. 
Therefore, in this study, a full thickness defect model will be characterized and used to test the cup for 
use with clinically-relevant repair techniques in vitro.  
Organ culture models, derived from either large animal [112;197-201] or human [202;203] tissue, can 
assess integration and the effect of a scaffold on the maintenance of the surrounding native tissue with 
greater control and lower cost than in vivo studies. Specifically, the use of bovine tissue in this study 
affords a cartilage layer which is sufficiently thick to study scaffold design and evaluate the performance 
of the cup with various repair strategies. Importantly, the ability to generate defects with precisely defined 
depth in organ culture models has been previously demonstrated [200]. 
104 
7.1.2 Objectives 
There are two objectives of this study. The first objective is to test if the cup scaffold is compatible 
with clinically relevant cartilage repair strategies. The second objective of this study is to evaluate the 
ability of the cup system to improve integration between a cartilage graft and the surrounding host tissue. 
It is hypothesized that (1) the cup can be implemented with autograft procedures, cell implantation, and 
hydrogel grafts, (2) the cup will promote integration with surrounding cartilage and bone, and (3) the 
combined agarose-fiber-ceramic base will result in more matrix formation at the cartilage-bone interface 
than the fiber-ceramic base without agarose.  
7.2 Materials and Methods 
7.2.1 Explant Harvest and Culture 
Fresh, immature metacarpophalangeal bovine joints (Green Village Packing Co.) were skinned, de-
gloved, and soaked in soapy water followed by 70% ethanol for 20 minutes. The joint was opened in a 
sterile environment, and the articular cartilage rinsed with sterile phosphate buffered saline (PBS). 
Osteochondral explants were extracted using a 1/2" Milwaukee Pistol Grip Electric Drill (Model 0300-20) 
with a 7/16” diamond tipped cylindrical drill bit (Model number 102080 with a 3/8 inch stem mount, 
Starlite) while the joint surface was continuously irrigated with sterile PBS. Three or four plugs were 
harvested from each joint and stored in culture medium. The bone of each plug was trimmed (h = 5 mm) 
using a high profile histology blade (Shandon Blade, ThermoFisher). Defects were created using a biopsy 
punch (Sklar, 5 mm), and loose debris was removed using a high velocity water jet (Waterpik) (Fig. 7.1). 
Full thickness cartilage explants (Ø = 8 mm) were excised from the flat surface of bovine 
metacarpophalangeal joints with a biopsy punch (Sklar), and the bottom was gently scraped to remove 
osseous tissue. Explants were cultured in 8 mL Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% 
insulin, transferrin, selenous acid (ITS), 50 μg/mL proline, 0.1 μM dexamethasone, 0.9 mM sodium 
pyruvate, and 50 μg/mL ascorbic acid in a six-well plate.  
7.2.2 Cells and Cell Culture 
Primary articular chondrocytes were isolated from neonatal calf wrists obtained from a local abattoir 
(Green Village Packing Co.) according to published protocols [79]. Briefly, cartilage tissue was extracted 
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from the surface of the metacarpophalangeal joint, minced, and incubated for 16 hours with 0.1% (w/v) 
collagenase (Worthington) in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS, Atlanta Biologicals), 2% antibiotics (10,000 U/mL penicillin, 10 mg/mL streptomycin), 
and 0.1% antifungal (250 µg/mL amphotericin B). The cell suspension was filtered to separate the cells 
from extracellular matrix debris before plating (30 μm, Spectrum). The isolated chondrocytes were 
maintained in high-density culture in fully-supplemented DMEM with 10% FBS, 1% non-essential amino 
acids, 1% antibiotics, and 0.1% antifungal for three days before seeding. All media supplements are 
purchased from Cellgro-Mediatech unless otherwise specified. 
7.2.3 Scaffold Fabrication 
Unaligned microfiber scaffolds were fabricated by electrospinning [20;149]. For ceramic-free polymer 
fiber fabrication, a 32% (w/v) polymer (5:1 PLGA (85:15, Lakeshore Biomaterials):PCL (Sigma-Aldrich, 
Mw  ≈ 70,000-90,000)) solution in 60/40 DCM/DMF was vortexed continuously for one hour. For fibers 
containing insulin-like growth factor-1 (IGF-1, Invitrogen), finely ground BSA (5% w/w, Sigma Aldrich) was 
added directly to a solution of 32% polymer (5:1 PLGA:PCL) in 60/40 DCM/DMF and vortexed 
continuously. After one hour, IGF-1, suspended in distilled water at a concentration of 5 mg/mL, was 
added to the polymer melt, and the solution was vortexed for an additional hour. To fabricate PLGA:PCL-
calcium deficient apatite (CDA, Sigma-Aldrich) scaffolds, 20% w/w CDA nanoparticles were directly 
added to the PLGA:PCL polymer solution and vortexed for an additional hour. Each solution was loaded 
into a 5 mL syringe with a stainless steel blunt tip needle (26.5 gauge for PLGA:PCL blends, 23 gauge for 
polymer-ceramic blends, 18 gauge for IGF-1-polymer blends) that was 13 cm from the collecting target 
and electrospun at 8-10 kV using a custom electrospinning device. The polymer solution was deposited 
(1 mL/hour) onto a stationary collecting target using a syringe pump (Harvard Apparatus).  
To fabricate polymer cups, ceramic-free mesh (with or without IGF-1) was cut into squares (1.6 cm x 
1.6 cm, 90-120µm thick), wetted with 39 µL sol-gel solution (12:1 tetamethylorthosilicate (Sigma):water), 
compressed in a custom mold, and allowed to dry for five hours in ambient conditions (Fig. 7.3). Next, the 
bottom portion of the cup was removed with a biopsy punch (Sklar, 4 mm), and 20% CDA-polymer 
composite scaffolds (Ø = 5 mm) were wetted with 10 µL sol-gel solution, compressed onto the walls of the 
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cup in the custom-designed mold to form the base, and allowed to dry for five hours. The cup walls were 
trimmed (h = 3 mm) and sterilized with ultraviolet exposure for 15 minutes.  
7.2.4 Defect Repair and Culture 
Defects were immediately repaired following generation (Fig. 7.4). For autograft control repair, the 
excised plug was press-fit back into the defect site. For autograft+cup repair, the autograft was removed, 
placed into a scaffold cup (with or without IGF-1), and the autograft+cup was press-fit back into the defect 
site. For hydrogel control repair, full thickness chondrocytes, which were isolated from immature bovine 
wrist joints, were mixed at a density of 10 million cells/mL in 2% low gelling agarose (Agarose Type VII, 
Sigma) and pipetted into the defect site (~100 µL). The hydrogel was allowed to set in the defect for 20 
minutes before the repaired explant was submersed in media. For hydrogel+cup repair, a scaffold cup 
was press-fit into the defect, and the chondrocyte-agarose was added directly into the cup in the defect 
until the hydrogel was flush with the top of the defect (~100 µL). The hydrogel was allowed to set in the 
defect for 20 minutes before the repaired explant was submersed in media. For the 
hydrogel+cup+agarose-ceramic base repair, acellular agarose with 1.5% CDA was pipetted into the 
bottom of the cup prior to the addition of the chondrocyte-agarose gel. For chondrocyte implantation 
repair, Bio-Gide® (Ø = 5 mm, Geistlich) was saturated with 25 µL chondrocyte solution (12 million full 
thickness chondrocytes/mL in sterile saline) and sutured over the defect with four or five stiches (6-0 
Vicyrl, Ethicon). A needle was inserted under one edge of the flap, and the patch-defect border was 
sealed with 1-2 drops Evicel® Fibrin Sealant (Ethicon), which was allowed to set for 90 seconds. 
Chondrocytes suspended in sterile saline (100 µL, 12 million cells/mL) were injected into the defect under 
the patch using a syringe attached to the needle. The needle was removed, an additional suture stich 
closed the hole, and 1-2 drops Evicel® Fibrin Sealant (Ethicon) were administered to the top of the flap to 
completely seal the patch-defect border. After 90 seconds, the repaired defect was submersed in media. 
For the chondrocyte implantation+cup repair, a scaffold cup was inserted into the defect prior to suturing 
the patch, and the chondrocyte implantation procedure described above was employed. 
All repaired defects were cultured in a six-well plate in 9 mL DMEM with 1% insulin, transferrin, 
selenous acid (ITS), 50 μg/mL proline, 0.1 μM dexamethasone, 0.9 mM sodium pyruvate, and 50 μg/mL 
ascorbic acid refreshed three times weekly.  
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7.2.5 Histology Analysis 
Explants were rinsed in PBS and fixed in neutral buffered formalin with 1% cetylpyridinium chloride 
(Sigma) for three days. Following fixation, the samples were decalcified with 10% 
ethylenediaminetetraacetic acid (EDTA, Sigma) in tris-buffer at a pH of 7.3 for five weeks, followed by 
dehydration with an ethanol series. The dehydrated samples were embedded in paraffin (Paraplast X-tra 
Tissue Embedding Medium, Fisher Scientific), and 7 μm sections were obtained (Reichert-Jung RM 2030 
Microtome, Leica) from the center of the scaffold. To visualize collagen (n=3), samples were 
deparaffinized and stained in 0.1% direct red for one hour before rinsing in 0.01 N hydrochloric acid and 
cover-slipping. Glycosaminoglycans and cell nuclei were visualized (n=2) via staining with safranin-O for 
20 minutes, Weigert’s Hematoxylin for 7 minutes, and Fast Green for 12 minutes. Cover-slipped (Cytoseal 
XYL) samples were imaged with a brightfield microscope (Olympus DP72). 
7.2.6 Integration Strength 
Full thickness cartilage explants were cultured in DMEM with 1% ITS, 50 μg/mL proline, 0.1 μM 
dexamethasone, 0.9 mM sodium pyruvate, and 50 μg/mL ascorbic acid in a six-well plate for three days 
to confirm sterility. Explants were bisected, using a histology blade and custom blade guide. The blade 
guide ensured that the cut was made in the center of the explant perpendicular to the surface. After the 
cut was made, the explants were immediately rejoined with suture (6-0 Vicryl, Ethicon) with or without a 
scaffold placed between the two halves (n=3/group). Re-joined cartilage explants were cultured for four 
weeks with media refreshed three times weekly.  
Prior to testing, the suture was cut and removed from the cartilage explant, and the sample was 
loaded into a custom-designed shearing device (Fig. 7.9). The sample was positioned onto a platform that 
supported half of the cartilage explant, and a clamp was used to hold the explant in place. A platen in 
contact with the unsupported half was lowered at a rate of 0.5 mm/minute (DynaMight 8840, Instron) to 
shear the two halves apart. Force was recorded and converted to stress by dividing the surface area of 
the cartilage explant cross-section, which was measured for each explant following testing (n=3/group). 
The peak stress was averaged across three samples per group (Fig. 7.9). 
108 
7.2.7 Statistical Analysis 
Results are presented as mean ± standard deviation, with n equal to the number of samples per 
group. One-way ANOVA was used to determine the effects of scaffold presence on cartilage-cartilage 
integration strength. The Tukey-Kramer post-hoc test was used for all pair-wise comparisons, and 
significance was attained at p<0.05. Statistical analyses were performed with JMP IN (4.0.4, SAS 
Institute, Inc.). 
7.3 Results 
7.3.1 Full Thickness Defect Model Characterization 
On average, four osteochondral plugs were harvested per joint, and full thickness defects were 
reproducibly generated in each. Cells within both tissue regions (bone and cartilage) remained viable 
throughout the culture period, although a zone of death was observed at the cut edges of the cartilage for 
all samples by day 1 (Fig. 7.2). The zone of death produced by the drill appeared to penetrate further into 
the tissue compared to the zone created by the biopsy punch. Consistent with the live/dead cell imaging, 
the cell number measured in both the cartilage and bone regions remained unchanged over 14 days of 
culture. As expected, ALP activity was higher in the bone region than in the cartilage region, but no 
change was observed over time for either tissue type. Similarly, no changes were measured for the matrix 
content over time for either region.  
7.3.2 Gross Morphology of Repaired Full Thickness Defects 
After in vitro culture, top and side view images of all samples were recorded, and the gross 
morphology of the samples was assessed (Fig. 7.5). The cartilage and bone showed no macroscopic 
signs of deterioration, and the cartilage remained shiny and white on all samples. For the hydrogel 
groups, the hydrogel-based graft in the tissue remained translucent for all groups, although the groups 
repaired with a cup appeared more opaque than the cup-free control. For the autograft groups, the graft 
was proud to the defect in some samples, but there was no trend observed between groups for position of 
the graft. The samples repaired with allogenic cells remained intact, with the membrane covering the 
defect.  
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7.3.3 Histological Analysis 
Histological analysis was performed to evaluate collagen and GAG content at the graft-cartilage 
interface and at the graft-bone interface. For the groups repaired with an autograft (Fig. 7.6), evaluation of 
the cartilage-cartilage interface using safranin-o and picrosirius red revealed no evidence of cartilage-
cartilage connection; however, residual scaffold was visible in both groups repaired with a cup, and it 
appeared to be bonded to both the graft and host cartilage. No integration was observed at the graft-bone 
interface. 
For the groups repaired with a hydrogel graft (Fig. 7.7), evaluation of the cartilage-cartilage interface 
using safranin-o and picrosirius red showed evidence of cartilage-cartilage connection, with the hydrogel 
congruent to the cartilage edge in portions of all repairs. Residual scaffold was visible in the groups 
repaired with a polymer cup, and cells were noted within the fibrous matrix in both groups. At the 
hydrogel-bone interface, the hydrogel was interdigitated with the bone in the control group and in portions 
of the groups repaired with the integration cup. Residual scaffold was present at this interface as well, 
and cell nuclei were identified within the scaffold matrix. 
 For the groups repaired with chondrocyte implantation (Fig. 7.8), graft-cartilage connection was 
observed in sections stained with safranin-o and picrosirius red. The graft tissue observed at the 
cartilage-cartilage edge in the control group stained weakly for GAG and collagen. Stronger positive 
staining for both GAG and collagen was observed in the group repaired with the integration cup at the 
graft-host cartilage interface. The graft-bone interface was similar for both control and scaffold groups, 
with new tissue observed above the bone region that stained weakly for GAG and collagen. 
7.3.4 Integration Strength 
The integration strength at the cartilage-cartilage interface was determined for cartilage repaired with 
and without a scaffold containing IGF after four weeks of culture (Fig.7.9). All samples exhibited 
integration that enabled handling of the cartilage after the suture was removed to load and test the 
interface strength. Significantly stronger integration was measured for the cartilage repaired with a 
scaffold compared to the cartilage repaired without a scaffold, with an average measured maximum 
stress of 39.9 ± 6.4 kPa and 15.3 ± 4.4 kPa for the scaffold and control, respectively. 
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7.4 Discussion 
This study evaluates a degradable integration scaffold doped with insulin-like growth factor-1 and 
calcium phosphate nanoparticles for use with three clinically relevant cartilage repair techniques. Full 
thickness chondral defects in bovine osteochondral explants were repaired with an autograft, tissue-
engineered graft, or chondrocyte implantation in the presence and absence of the integration scaffold and 
cultured for four weeks in vitro. The ability of the scaffold to improve the strength of cartilage integration 
was measured by mechanical testing after four weeks of in vitro culture. The results of this study 
demonstrate that the integration cup can be implemented with all three repair techniques with minimal 
change to the standard repair process. Furthermore, the scaffold can enhance the integration strength 
between two full thickness cartilage explants over four weeks of in vitro culture.  
The defect model used in this study disrupts the cartilage, with limited damage to the surrounding 
tissue. Each sample was repaired immediately following defect creation and cultured statically for four 
weeks. All grafts remained seated in the defect throughout the culture period, with no macroscopic 
degradation or growth noted on any of the explants after four weeks. Histologically, changes in the matrix 
of the native tissue were minimal; several samples exhibited reduced glycosaminoglycan staining in 
regions of cartilage and increased collagen staining near the outer border of the host cartilage tissue.  
In the autograft repair samples, minimal integration was noted. In the control repair, the edge of both 
the graft and host tissue remained smooth and appeared unchanged. While the histological processing 
may have caused the samples to separate, no evidence of new tissue formation was observed at the 
interface. In the cup-repaired groups, the tissue looked similar to the control; however, residual scaffold 
material was observed in the gap between the graft and host cartilage. While the majority of scaffold was 
destroyed during processing, the remaining scaffold was bonded to the edge, indicating that the scaffold 
may have integrated with the cartilage. There was no evidence of integration at the cartilage-bone 
interface in the autograft samples, suggesting that blood and marrow that are usually present in the bone 
may be needed to provide a source of stem cells and growth factors in vivo [204] for cartilage-bone 
integration; however, in this study the bone was cleaned of marrow and blood.  
In the groups repaired with a hydrogel graft, evidence of integration at the cartilage-cartilage junction 
was observed in all three groups. In the control repair, the hydrogel graft was congruent with the host 
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cartilage, and positive collagen staining was observed at the interface. In the groups repaired with a cup, 
residual fiber was observed at the interface, with nuclei present in the scaffold, indicating that cells had 
migrated into the cup walls during culture. Other investigators have shown that hydrogel constructs more 
readily integrate with host cartilage than autograft cartilage tissue [201], which was supported by our 
histological findings in this study. In addition, the hydrogel graft remained connected to the bone, with 
positive staining for glycosaminoglycans and cells evident at the interface. In the group with the hydrogel-
ceramic composite in the base of the repair, cell nuclei were observed at the interface, suggesting that 
cells may have migrated into the thin acellular hydrogel-fiber-ceramic layer.  
In the groups repaired using chondrocyte implantation, new tissue formation was observed at the 
host-cartilage interface. In the presence of the integration scaffold, the tissue stained more positively for 
glycosaminoglycan content and collagen than the control repair. New tissue was also detected at the 
cartilage-bone interface in both groups; however, it did not stain strongly for glycosaminoglycans or 
collagen. The repair tissue was fibrous and did not resemble the structural organization of native 
cartilage, consistent with previous reports [200;203].  
In addition to histology, the integration of two pieces of full thickness cartilage was measured using a 
shear test when repaired with and without an IGF scaffold. This experimental design represents the 
autograft-repair technique, in which a healthy cartilage graft is placed next to the healthy host cartilage 
that shoulders a defect. The model employed here was used to ensure congruency between the two 
cartilage pieces, which is not always achieved in push-out tests that measure the integration of an inner 
disk and an annular ring. After four weeks of culture, the cartilage pieces integrated with each other in the 
control case; however, higher integration strength was achieved when a scaffold doped with insulin-like 
growth factor-1 was placed between the cartilage during repair. While the histological comparison of the 
cartilage-cartilage interface showed little difference in the autograft repair with and without the cup 
scaffold, this quantitative measurement suggests that the scaffold does promote integrative repair. Due to 
the unique testing procedure employed here and the use of full thickness tissue, it is difficult to compare 
our mechanical evaluation to other published studies; however, the integration strengths measured were 
the same order of magnitude to previously reported values (56.7 kPa and 28 kPa, respectively, after four 
weeks of in vitro culture with serum) determined using push-out tests to measure the integration of full 
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thickness bovine cartilage with a tissue engineered construct [201] and an autograft [205]. Unlike 
histology, the mechanical testing required only minor manipulation of the sample prior to analysis. This is 
important because it is likely that the polymer scaffold was destroyed during histological processing, 
limiting the observable differences between the control and scaffold-repaired group in the stained 
sections. In the histology images, remnants of the scaffold were detected on the edge of both the graft 
and host cartilage; this observation, combined with the higher integration strength that was measured in 
the scaffold group, suggests that the scaffold may improve integration by bonding to both graft and host 
cartilage. Importantly, the bonding measured here does not restore native strength, which has been 
measured to be 8.8 MPa using a push-out test [198].  
The explants used in this study were cultured in serum-free, chemically defined media that was 
previously optimized for osteochondral explant culture [206]. The use of this media facilitates study of the 
scaffold in isolation from confounding cellular effects caused by serum. However, because fetal bovine 
serum has been shown to enhance cartilage-cartilage integration [207], the use of serum-free media 
limits the comparisons that may be made to other studies that used media enriched with serum 
[197;198;200;201].  
Although this study provides valuable information regarding the interaction of the scaffold on native 
osteochondral tissue and integration of cartilage grafts, it is limited by several inherent shortcomings of 
the model. Primarily, because the explant tissue was isolated from the marrow, synovium, and 
mechanical loading that exist in the native joint, the in vitro explant model eliminates many of the factors 
that may provide additional healing or immunologic response in vivo. For example, after an intra-articular 
defect is formed, migrating cells from the synovial tissues may enhance scaffold-guided repair [208]. 
Furthermore, since mechanical loading and growth factors have a synergistic effect on cartilage formation 
[166], the growth-factor releasing scaffold may result in more cartilage formation in a loaded environment. 
The lack of marrow in the bone compartment reduces exposure to cells, such as mesenchymal stem 
cells, which may populate the base of the cup and contribute to enhanced calcified cartilage formation. 
Finally, in vivo, the healing cartilage would be perfused with a multitude of growth factors and immune 
cells that are present in the blood. Implanting the full thickness defect model in vivo in a subcutaneous 
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pouch, will more closely mimic this aspect of the complex native healing environment, and will be 
discussed in chapter 8.   
7.5 Conclusions 
Collectively, the results of this study indicate the cup integration scaffold can be utilized with a variety 
of cartilage repair techniques, including autografting, tissue engineering, and cell-based repair 
approaches. This study demonstrates that placement of the scaffold in a cartilage defect causes cells 
from the surrounding tissues to migrate into the scaffold, resulting in new tissue formation around the 
scaffold over time. Moreover, the scaffold increases the integration strength in a cartilage explant repair 
model.   
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Figure 7.1 Osteochondral tissue harvest and full thickness defect generation. Osteochondral tissue 
plugs were harvested using a diamond-tipped drill bit. The bone was trimmed using a histology blade and 
remaining debris was removed with a high velocity jet of phosphate buffered saline. A biopsy punch was 










Figure 7.2 Characterization of the full thickness defect model. Full thickness defect models were 
generated from bovine cartilage. Cell number and alkaline phosphatase (ALP) activity was maintained in 
culture over time for the bone and cartilage tissue, with higher ALP activity in the bone compared to the 
cartilage (n=5, * p<0.05 for difference between cartilage and bone at the same timepoint). Cells were 
viable in the bone and cartilage tissues overtime; however, a zone of death was observed on the cut 
edges of the cartilage. Collagen and GAG content was similar on day 1 and day 14 (picrosirus red and 
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Figure 7.3 Cup fabrication. To fabricate the cup scaffolds, fiber mesh is cut into squares, wetted with sol 
gel solution, and placed onto the bottom of a custom mold with protruding pegs. The top of the mold, with 
slots for the pegs, is lowered onto the base and a weight is applied. After drying, cup scaffolds are 
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Figure 7.4 Study design. Full thickness defects were repaired using three clinically relevant repair 
methods with varied scaffolds and cultured in vitro for four weeks.  
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Figure 7.5 Images of repaired explants after in vitro culture.
Repaired explants were fixed after four weeks of culture. The
cartilage remained white and shiny, and no differences were















Figure 7.6 Autograft-based repair. For each group, the top row shows safranin-O staining, and the 













































Figure 7.7 Hydrogel-based repair. For each group, the top row shows safranin-O staining, and the 
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Figure 7.8 Cell implantation-based repair. For each group, the top row shows safranin-O staining, and 
the bottom row shows picrosirius red staining for each group (n=2, 20x, bar = 100 µm).   
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Figure 7.9 Integration strength. A custom device (left) was used to test the integration strength of the 
repaired cartilage (middle). Full thickness cartilage explants (d = 8 mm) were repaired using suture with 
either no scaffold (n=3, left) or an IGF-1 microfiber scaffold (100 ng/mg), and the integration strength 





CHAPTER 8: IN VIVO EVALUATION OF 
INTERFACE FORMATION IN AN 
OSTEOCHONDRAL EXPLANT MODEL  
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8.1  Introduction 
In chapter 7, the translational potential of the fully assembled cup integration system was assessed in 
vitro. The scaffold phases were joined and tested in a full thickness defect model to investigate the effect 
of the scaffold system on integration of cartilage grafts with the surrounding host tissue. The scaffold was 
compatible with three clinically relevant repair strategies and improved the integration between full 
thickness cartilage explants. In this chapter, histological analysis of the scaffold in the full thickness 
explant model will be extended to in vivo subcutaneous culture. 
8.1.1 Background and Significance 
Building on the in vitro testing of each scaffold phase and the evaluation of the assembled cup in a 
full thickness defect model in vitro, this study evaluates the translational potential of the cup integration 
system for use with cartilage repair strategies in vivo. Subcutaneous culture of osteochondral organ 
models, which provides a nutrient-rich environment, has been previously used to assess cartilage-
cartilage integration with explant tissue models [106;198;203;209;210].  
8.1.2 Objectives 
The objective of this study is to evaluate the clinical translational potential of the total integration 
scaffold in vivo. It is hypothesized that the cup will improve integration with surrounding cartilage and 
bone and that the combined agarose-fiber-ceramic base will result in calcified cartilage formation that is 
more organized than the fiber-ceramic base without agarose.  
8.2 Materials and Methods 
8.2.1 Explant Harvest and Culture 
Fresh, immature metacarpophalangeal bovine joints (Green Village Packing Co.) were skinned, de-
gloved, and soaked in soapy water followed by 70% ethanol for 20 minutes. The joint was opened in a 
sterile environment, and the articular cartilage rinsed with sterile phosphate buffered saline (PBS). Full 
thickness cartilage explants (Ø = 8 mm) were excised from the flat surface of bovine 
metacarpophalangeal joints with a biopsy punch (Sklar), and the bottom was gently scraped to remove 
osseous tissue. Osteochondral explants were extracted using a 1/2" Milwaukee Pistol Grip Electric Drill 
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(model 0300-20) with a 7/16” diamond tipped cylindrical drill bit (Model number 102080 with a 3/8” stem 
mount, Starlite) while the joint surface was continuously irrigated with sterile PBS solution. Three or four 
plugs were harvested from each joint and stored in culture medium. The bone of each plug was trimmed 
(h = 5 mm) using a high profile histology blade (Shandon Blade, ThermoFisher). Defects were created 
using a biopsy punch (Sklar, 5 mm), and loose debris was removed using a high velocity water jet 
(Waterpik). Explants were cultured in 8 mL Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% insulin, 
transferrin, selenous acid (ITS), 50 μg/mL proline, 0.1 μM dexamethasone, 0.9 mM sodium pyruvate, and 
50 μg/mL ascorbic acid in a six-well plate.  
8.2.2 Cells and Cell Culture 
Primary articular chondrocytes were isolated from neonatal calf wrists obtained from a local abattoir 
(Green Village Packing Co.) according to published protocols [79]. Briefly, cartilage tissue was extracted 
from the surface of the metacarpophalangeal joint, minced, and incubated for 16 hours with 0.1 w/v% 
collagenase (Worthington) in DMEM, supplemented with 10% fetal bovine serum (FBS, Atlanta 
Biologicals), 2% antibiotics (10,000 U/mL penicillin, 10 mg/mL streptomycin), and 0.2% antifungal 
(250 µg/mL amphotericin B). The cell suspension was filtered to separate the cells from extracellular 
matrix debris before plating (30 μm, Spectrum). The isolated chondrocytes were maintained in high-
density culture in fully-supplemented DMEM with 10% FBS, 1% non-essential amino acids, 1% 
antibiotics, and 0.1% antifungal for three days before seeding. All media supplements are purchased from 
Cellgro-Mediatech unless otherwise specified. 
8.2.3 Scaffold Fabrication 
Unaligned microfiber scaffolds were fabricated by electrospinning [20;149]. For ceramic-free polymer 
fiber fabrication, a 32% (w/v) polymer (5:1 PLGA (85:15, Lakeshore Biomaterials):PCL (Sigma-Aldrich, 
Mw ≈ 70,000-90,000) solution in 60/40 DCM/DMF was vortexed continuously for one hour. For fibers 
containing insulin-like growth factor-1 (IGF-1, Invitrogen), finely ground bovine serum albumin (5% w/w, 
Sigma Aldrich) was added directly to a solution of 32% polymer (5:1 PLGA:PCL) in 60/40 DCM/DMF and 
vortexed continuously. After one hour, IGF-1, suspended in distilled water at a concentration of 5 mg/mL, 
was added to the polymer melt, and the solution was vortexed for an additional hour. To fabricate 
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PLGA:PCL-calcium deficient apatite (CDA, Sigma-Aldrich) scaffolds, 20% (w/w) CDA nanoparticles were 
directly added to the PLGA:PCL polymer solution and vortexed for an additional hour. Each solution was 
loaded into a 5 mL syringe with a stainless steel blunt tip needle (26.5 gauge for PLGA:PCL blends, 23 
gauge for polymer-ceramic blends, 18 gauge for IGF-1-polymer blends), placed 13 cm from the collecting 
target, and electrospun at 8-10 kV using a custom electrospinning device. The polymer solution was 
deposited (1 mL/hour) onto a stationary collecting target using a syringe pump (Harvard Apparatus).  
To fabricate polymer cups, ceramic-free mesh (with or without IGF-1) was cut into squares (1.6 cm x 
1.6 cm, 90-120µm thick), wetted with 39 µL sol-gel solution (12:1 tetamethylorthosilicate (Sigma):water), 
compressed in a custom mold, and allowed to dry for five hours in ambient conditions. Next, the bottom 
portion of the cup was removed with a 4 mm biopsy punch (Sklar), and 20% CDA-polymer composite 
scaffolds (Ø = 5 mm, t = 90-120µm) were wetted with 10 µL sol-gel solution, compressed onto the walls of 
the cup in the custom-designed mold to form the base, and allowed to dry for five hours. The cup walls 
were then trimmed (h = 3 mm) and sterilized with ultraviolet exposure for 15 minutes.  
8.2.4 Sample Preparation 
Defects were generated in osteochondral plugs with a biopsy punch (Sklar, 5 mm) and immediately 
repaired. For autograft control repair, the removed plug was press-fit back into the defect site. For 
autograft+cup repair, the autograft was removed, placed into a scaffold cup (with or without IGF-1), and 
the autograft+cup was press-fit back into the defect site. For chondrocyte implantation control repair, Bio-
Gide® (Ø = 5 mm, Geistlich) was saturated with 25 µL chondrocyte solution (12 million full thickness 
chondrocytes/mL in sterile saline) and sutured over the defect with four or five stiches (6-0 Vicyrl, 
Ethicon). A needle was inserted under one edge of the flap, and the patch-defect border was sealed 
using 1-2 drops Evicel® Fibrin Sealant (Ethicon), which was allowed to set for 90 seconds. Chondrocytes 
suspended in sterile saline (100 µL, 12 million cells/mL) were injected into the defect under the patch 
using a syringe attached to the needle. The needle was removed, an additional suture stitch was used to 
close the hole, and 1-2 drops Evicel® Fibrin Sealant (Ethicon) was administered to the top of the flap to 
completely seal the patch-defect border. After 90 seconds, the repaired defect was submersed in media. 
For the chondrocyte implantation+IGF cup repair, a scaffold cup was inserted into the defect prior to 
suturing the patch, and the chondrocyte implantation procedure described above was employed. For 
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hydrogel control repair, full thickness chondrocytes, isolated from immature bovine wrist joints, were 
mixed at a density of 10 million cells/mL in 2% low gelling agarose (Agarose Type VII, Sigma) and 
pipetted into the defect site (~100 µL). The hydrogel was allowed to set in the defect for 20 minutes 
before the repaired explant was submersed in medium. For hydrogel+IGF cup repair, a scaffold cup was 
press-fit into the defect, and the chondrocyte-agarose solution was added directly into the cup in the 
defect until the hydrogel was flush with the surface (~100 µL). The hydrogel was allowed to set in the 
defect for 20 minutes before the repaired explant was submersed in medium. For the hydrogel+IGF-
cup+hydrogel-ceramic base repair, acellular agarose with 1.5% CDA was pipetted into the bottom of the 
cup prior to the addition of the chondrocyte-agarose gel.  
8.2.5 Subcutaneous Implantation and Culture  
All surgical procedures were performed in accordance with a protocol approved by the Institutional 
Animal Care and Use Committee (IACUC) at the Columbia University Medical Center. Athymic rats (NIH-
rnu, 175-200 g) were used for this study. Animals were anesthetized in an inhalation chamber with 1–5% 
isoflurane in high flow oxygen and maintained under a surgical plane of anesthesia using isoflurane (1–
2%) administered through an oxygen mask. The surgical area was shaved, draped, and prepared using 
an alternating isopropanol/betadine scrubbing technique. Sustained release buprenorphine (1.2 mg/kg 
SQ), carprofen (5 mg/kg SQ q24 for 72 hours), and marcaine (2 mg/kg at the incision site) were 
administered to alleviate pain due to the operation. For prophylaxis against infection, an injection of baytril 
(5 mg/kg SQ) was administered immediately prior to surgery. Using aseptic technique, four individual 
subcutaneous pouches were surgically created in the dorsum of each rat by incisions approximately 1.5 
cm in length made with a scalpel (#15 blade, Feather). One repaired full thickness defect model (Fig. 8.1 
and Fig. 8.2) was placed in each pouch, and the incision was closed with wound clips (9 mm stainless 
steel autoclip, BD Diagnostic Systems). After four weeks, animals were sacrificed by carbon dioxide 
inhalation, and the scaffolds were excised and prepared for analysis. 
8.2.6 Histological Analysis 
Explants were rinsed in PBS and fixed in neutral buffered formalin with 1% cetylpyridinium chloride 
(Sigma) for three days. Following fixation, half the samples were decalcified with 10% 
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ethylenediaminetetraacetic acid (EDTA, Sigma) in tris-buffer at a pH of 7.3 for five weeks, followed by 
dehydration with an ethanol series. The dehydrated samples were embedded in paraffin (Paraplast X-tra 
Tissue Embedding Medium, Fisher Scientific), and 7 μm sections were obtained (Reichert-Jung RM 2030 
Microtome, Leica) from the center of the scaffold. Calcified samples were fixed in 80% ethanol for three 
days and embedded in poly-methylmethacrylate (PMMA, Sigma). The samples were sectioned (7 μm) 
with a Leica sliding microtome (SM2500S, Leica Microsystems Inc.) using a tungsten carbide blade 
(Delaware Diamond Knives Inc.). 
Sections were stained for cell nuclei, collagen, GAG, and mineral content (n=3. To visualize cell 
nuclei, samples were deparaffinized and stained with Weigert’s Hematoxylin for five minutes followed by 
eosin for two minutes. To visualize collagen content, deparaffinized samples were stained in 0.1% direct 
red for one hour before rinsing in 0.01 N hydrochloric acid and cover-slipping. Collagen alignment was 
evaluated by imaging picrosirius red-staining samples with polarized light. To distinguish collagen II, 
immunohistochemical staining was performed. Antigen retrieval was achieved via incubation with 
testicular hyaluronidase at 37ºC, and samples were subsequently incubated with collagen II antibody 
(Abcam, 1:100 dilution) overnight at room temperature. To visualize the bound antibodies, the sections 
were incubated with 3,3'-diaminobenzidine (DAB peroxidase kit, Vector Laboratories) and counterstained 
with Fast Green for three minutes.  
Glycosaminoglycans were visualized via staining with safranin-O for twenty minutes, Weigert’s 
Hematoxylin for seven minutes and Fast Green for 12 minutes. To visualize mineral content, calcified 
sections were stained with von Kossa (5% silver nitrate) and exposed to ultraviolet light (365 nm) for 15 
minutes. Following radiation, the plastic was removed by soaking in a 1:1 xylenes:chloroform mixture for 
45 minutes and the sample was stained with hematoxylin for seven minutes followed by safranin-o for 20 
minutes. Cover-slipped (Cytoseal XYL) samples were imaged with a brightfield microscope (Olympus 
DP72). The images were stitched together in Photoshop (Adobe) using the auto-align and auto-blend 
tools. After stitching, the area surrounding the stained section was digitally cleaned.  
8.2.7 Statistical Analysis 
Results are presented as mean ± standard deviation, with n equal to the number of samples per 
group. One-way ANOVA was used to determine the effects of scaffold presence on the strength of 
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cartilage integration. The Tukey-Kramer post-hoc test was used for all pair-wise comparisons, and 
significance was attained at p<0.05. Statistical analyses were performed with JMP IN (4.0.4, SAS 
Institute, Inc.). 
8.3 Results 
8.3.1 Animal Surgery 
Four implants were placed into the back of each rat (Fig. 8.1 and Fig. 8.2). All animals survived the 
surgery and gained weight over time (data not shown). No infections were noted, and no rats required 
additional antibiotics or analgesics. Immediately following surgery, nine rats reopened their incisions by 
removing the wound clips. The incisions were cleaned and closed within 12 hours using a buried stitch 
(Vicryl 4-0, Ethicon) under the supervision of a veterinarian.  
8.3.2 Gross Morphology of Implants 
Each repaired full thickness defect was removed from the subcutaneous pouch after four weeks and 
imaged prior to fixation (Fig. 8.3). All grafts remained well-seated in the defect, and no gross deterioration 
was noted for the cartilage or bone regions. Furthermore, no nodular growth on either tissue type was 
observed; all samples were similar in appearance to before implantation. All explants were surrounded by 
a thin sheath of fibrous and vascularized tissue, which bound the sample to the skin of the rat. While 
removal of the sheath was possible in some cases, the tissue surrounding the cartilage region was not 
removed to avoid manipulation that could interfere with the repair tissue.  
8.3.3 Autograft Control 
The autograft repair without a scaffold served as a control for the autograft groups that were 
augmented with the control (IGF-1-free) and optimized (with IGF-1) cups. The cartilage tissue maintained 
a glossy white appearance after implantation (Fig. 8.3). Histological analysis of the autograft control repair 
demonstrated that the graft maintained a matrix rich in GAGs and collagen, resembling healthy cartilage 
tissue (Fig. 8.4 and Fig. 8.5). The repair and native cartilage tissue were connected at the base of the 
graft, but the surface and middle regions of the graft were not congruent with the host tissue. Collagen 
alignment at the graft-host interface was observed in polarized images. Cells were not observed in the 
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cartilage-cartilage gap, and, despite the host and graft tissue remaining close together, there was little 
evidence of new cartilaginous tissue. Staining with von Kossa (Fig. 8.13) revealed mineralization in the 
cartilage compartment at the host-graft cartilage junction, although the presence of mineral in the 
cartilage tissue was not uniform across samples. 
8.3.4 Autograft with Control Cup  
The cartilage tissue maintained a glossy white appearance after implantation of the autograft group 
that was augmented with a cup without IGF-1 (Fig. 8.3). Histological analysis of the autograft repair with 
the IGF-1-free cup demonstrated that the graft maintained a matrix rich in GAGs and collagen, with 
noticeable depletion of the GAGs at the surface of the host tissue and loss of collagen evident in the 
center of the host and grafted cartilage (Fig. 8.6). The cartilage-cartilage interface was connected at the 
bottom of the defect, with separation between the graft and host tissue observed in the surface region. 
Evidence of newly formed, cellular cartilage tissue at the host-graft interface that stains positively for both 
GAG and collagen was observed. In addition, collagen alignment was increased at the interface, with the 
interface region appearing bright yellow when viewed using polarized light. The region just above the 
cartilage-bone interface stained strongly for collagen, which was aligned. Just below this region, where 
the base of the scaffold was placed, there was a region void of GAGs and collagen. Staining with von 
Kossa (Fig. 8.13) revealed mineralization in the cartilage compartment at the graft-bone junction, 
although the presence of mineral in the cartilage tissue was not uniform across samples. 
8.3.5 Autograft with IGF Cup 
Similar to the other autograft groups, the cartilage tissue maintained a glossy white appearance 
after implantation (Fig. 8.3). Histological analysis of the autograft repair demonstrated that the graft 
maintained a matrix rich in GAGs and collagen that resembles healthy cartilage tissue, although loss of 
GAGs was noted in the surface of the host tissue on one side of the cross section (Fig. 8.7). At the 
cartilage-cartilage interface, close contact was observed at the base of the grafts, with a gap observed in 
the region between the host and graft tissue in the middle and surface zone where the scaffold was 
placed. There was evidence of the scaffold in the gap, with cells budding from the graft tissue in the 
direction of the gap. At the graft-host junction, aligned collagen was observed using polarized light. The 
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cartilage-bone interface was uniform, with a thin region void of GAG and collagen where the base of the 
cup was placed, and a region directly above this which stained darkly for aligned collagen and GAG. 
Similar to the control cup, staining with von Kossa (Fig. 8.13) revealed mineralization in the cartilage 
compartment at the host-graft cartilage junction, although the presence of mineral in the cartilage tissue 
varied between samples. 
8.3.6 Chondrocyte Implantation Control 
For the chondrocyte implantation control group, the host cartilage maintained a glossy white 
appearance, and the defect was filled with translucent tissue (Fig. 8.3). Histological analysis revealed that 
the defect was filled with a collagen-rich, GAG-poor fibrous tissue (Fig. 8.8). The host tissue consisted of 
a matrix rich in GAG and collagen, although noticeable GAG depletion was observed in the surface 
region of the host cartilage. Inconsistent formation of new cartilage tissue at the cartilage-cartilage 
interface was also observed. While several cartilage-cartilage interfaces in the samples from this group 
were populated by a GAG-rich tissue deposit, others were void of cartilaginous tissue. Rounded cells 
were not observed in the middle of the defect, although chondrocyte-like cells were found in the newly 
formed tissue at the cartilage-cartilage interface. Positive GAG staining was also observed in the bone 
compartment throughout the depth of the explant. Evidence of ectopic mineralization was not detected 
(Fig. 8.13). 
8.3.7 Chondrocyte Implantation with IGF Cup 
For the cell-based repair with the IGF cup, the host cartilage maintained a glossy white appearance, 
and the defect was filled with a translucent tissue (Fig. 8.3). Histological analysis revealed a fibrous, 
collagen-rich, GAG-deficient tissue filling the defect (Fig. 8.9). The host cartilage tissue exhibited GAG 
loss from the surface region, although the collagen matrix was maintained. New cartilaginous tissue was 
observed at the cartilage-cartilage interfaces, although this tissue was observed only near the deep and 
middle cartilage zones. The tissue at the interface was cellular and stained positively for both GAG and 
collagen. Similar to the control chondrocyte implantation group, positive GAG staining was observed in 
the bone compartment throughout the depth of the explant. Positive mineral staining at the defect-bone 
interface was observed in the location where the mineralized cup base was placed (Fig. 8.13). 
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8.3.8 Hydrogel Graft Control 
The hydrogel graft served as a control for the hydrogel groups that were augmented with the IGF cup 
and the IGF cup with the agarose-calcium deficient apatite base. For this group, the host cartilage 
maintained a glossy white appearance, and the defect was filled with translucent tissue (Fig. 8.3). 
Histological analysis demonstrated that the host tissue maintained a matrix rich in GAG and collagen (Fig. 
8.10). Collagen and GAG were also observed in the hydrogel graft, with similar staining throughout, 
except for more positive GAG staining near the cartilage-bone interface. Inconsistent integration was 
noted at the cartilage-cartilage interface between samples, witch fibrous tissue observed between the 
hydrogel and native tissue. The cartilage-bone interface was interdigitated, and collagen and GAGs were 
observed directly above the bone tissue. There was no evidence of ectopic mineralization (Fig. 8.13).  
8.3.9 Hydrogel Graft with IGF Cup 
The host cartilage maintained a glossy white appearance, and the defect was filled with translucent 
tissue for the hydrogel group that was augmented with an optimized cup scaffold (Fig. 8.3). The cup had 
not degraded after four weeks and was visible in the cross-section of the defect prior to histological 
processing. Histological analysis demonstrated that the graft consisted of a matrix with GAGs and 
collagen, although there was noticeable depletion of the GAGs at the surface of the host tissue (Fig. 
8.11). New cellular tissue that stained positively for GAGs and collagen was observed at the cartilage-
cartilage interface throughout the depth of the cartilage tissue. The collagen in the new tissue was 
aligned. The cells in the new tissue that were closer to the surface of the tissue were small and similar in 
size to the cells in the adjacent tissue; however, cells near the deep zone were larger, matching the cells 
in the adjacent deep zone tissue. The newly formed tissue appeared to be on the host side of the fiber 
scaffold, although the fibrous scaffold was not clearly visible in the processed sections. The cartilaginous 
tissue regeneration observed in the hydrogel was confined to the cartilage defect. Positive mineral 
staining at the defect-bone interface was observed in the location where the mineralized cup base was 
placed (Fig. 8.13).  
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8.3.10 Hydrogel Graft with IGF Cup and Agarose-CDA Composite Base 
For the hydrogel group with the IGF cup and the agarose-CDA base, the host cartilage maintained a 
glossy white appearance, and the defect was filled with translucent tissue (Fig. 8.3). Similar to the 
hydrogel group with the IGF cup, the fiber scaffold had not degraded after four weeks and was visible in 
the cross-section of the defect prior to histological processing. Histological analysis revealed that the host 
tissue maintained a matrix rich in GAGs and collagen (Fig. 8.12), and the grafts consisted of a GAG- and 
collagen-rich matrix with uniformly distributed chondrocytes. A region void of matrix was observed in the 
center of the scaffold in one sample, likely the result of an air bubble that was introduced during in situ 
scaffold formation. Similar to the hydrogel repair with the IGF cup, new tissue was observed at the 
cartilage-cartilage interface in all depths of the cartilage tissue. The cells in the new tissue at the interface 
were consistent with the cell size in the adjacent host tissue. The bottom of the graft had a GAG-rich area 
in the region where the agarose-CDA base had been placed. The collagen that was deposited in the 
hydrogel at the cartilage-bone interface was aligned and was visible under polarized light. Positive 
mineral staining at the defect-bone interface was observed in the location where the mineralized cup base 
was placed (Fig. 8.13). 
8.4 Discussion 
The overarching goal of this research is to improve cartilage repair outcomes by engineering a 
scaffold system that improves integration of cartilage grafts with the host tissue. Specifically, this study 
evaluates the efficacy of a degradable polymer cup scaffold to promote cartilage-cartilage integration and 
cartilage-bone integration with three clinically relevant repair techniques. Full thickness chondral defects 
in bovine osteochondral explants were repaired with an autograft, tissue-engineered graft, or allogenic 
cell implantation in the presence and absence of an integration scaffold and cultured for four weeks 
subcutaneously in an athymic rat. The integration cup was implemented with all three repair techniques 
with minimal change to the standard repair process. Furthermore, the cup demonstrated potential to 
enhance the formation of new cartilage tissue at the cartilage-cartilage interface in the hydrogel repair 
methods, and led to aligned collagen at the cartilage-bone interface when combined with an agarose-
CDA base and used with a hydrogel cartilage graft.  
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In this study, the grafts were repaired ex vivo and transferred to a subcutaneous pouch in an athymic 
rat within one day. Despite the lack of a membrane or flap in the autograft and hydrogel repair groups, the 
grafts remained well-seated in the defect during culture, suggesting that the press-fit technique for the 
autograft placement and the in situ gelation for the hydrogel grafts are viable methods to achieve a tight fit 
of the graft within the defect. In addition, the fibrous sheath that surrounded the explant in the 
subcutaneous pouch likely contributes to holding the graft in place.  
This defect model disrupts the cartilage, with limited damage to the surrounding tissue. After the 
subcutaneous culture period, however, depletion of the host glycosaminoglycans was observed in several 
samples, which has been previously reported for similar models [210]. The loss of glycosaminoglycans 
occurred primarily in the region of the cartilage closest to the surface, which may be a result of the 
interaction of the cartilage with the rat subcutaneous environment. Alternatively, it could also be caused 
by degradation of the matrix by the resident chondrocytes, as surface zone cells have been shown to 
degrade proteoglycans more rapidly than deep zone chondrocytes [37]. In our study, depletion of the 
glycosaminoglycan matrix was inconsistent across groups, with no clear link between repair type and host 
tissue maintenance. 
For the defects repaired with an autologous graft, more consistent cartilage-cartilage integration was 
observed in the lower regions of the graft for all three groups. This finding may be an artifact of the model, 
as the surface zone was closer to the fibrous capsule, which may have interfered with the healing process 
in these regions. In several of the cross-sectional images, the fibrous capsule (most likely originating from 
the rat) extended from the outside of the explant into the region between the graft and host tissue. In 
addition, some of the grafts were proud to the surface of the defect, preventing the host and graft 
cartilage from healing together. This effect may be reduced in an intra-articular model in which the 
surface of the defect experiences loading.  
Differences in integration may also be due to varying between the biosynthetic capacities of the cells 
that reside in the distinct zones of articular cartilage. It was previously demonstrated that cells isolated 
from the deep zone of articular cartilage are more active than cells from the surface zone, producing more 
glycosaminoglycans when cultured in agarose [38]. Additionally, the chondrocytes residing in the deeper 
regions of immature bovine cartilage are more synthetically active than those in the surface zone when 
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surrounded by their native matrix, with a ten-fold increase in synthetic activity for the cells in the radial 
zone compared to the surface zone [211]. Generally, clear differences between groups in terms of 
integration at the cartilage-cartilage interface were not observed histologically, and quantification of the 
integration across all three samples did not reveal differences between groups (data not shown). The 
integration in the cup groups may improve as the fibrous scaffold degrades. In the IGF cup samples, a 
gap between the host and graft cartilage was observed where the scaffold was placed. Cells from the 
surrounding cartilage tissue are budding off the surface, and it is possible that, given more time, these 
cells will bridge the gap, connecting the graft to the host tissue. To further understand how the cup affects 
autograft repair, later timepoints may provide insightful data. In addition, to further encourage integration 
and cell migration into the cup, a digestion agent which has been shown to facilitate integration [104-108], 
such as chondroitinase ABC, hyaluronidase, or collagenase, could be employed. Future studies should 
evaluate the compatibility of the integration cup with digestive washing protocols and assess the effects of 
combining the two integration approaches.  
For the defects repaired via allogenic cell implantation, the bulk repair tissue that filled the defects 
was fibrous in nature, staining positive for collagen and negative for glycosaminoglycans. While the repair 
tissue was congruent with the host tissue, the formation of new cartilage tissue was inconsistent at the 
graft-host interface with and without the addition of the integration scaffold. The repair tissue at the 
interface was cellular and rich in glycosaminoglycans and collagen. After implantation, positive staining 
for glycosaminoglycans was observed in the bone tissue for all of the cell implantation-repaired samples, 
indicating that the injected chondrocytes may have traveled beyond the defect site, lodging in the bone 
tissue. Differences between groups were not observed with regard to this ectopic glycosaminoglycan-rich 
tissue formation. Because it is unclear if the final location of the injected cells recapitulates the scenario of 
cell implantation in an intact joint, future studies should be performed to evaluate the utility of the 
integration scaffold with cell-based repair techniques using an intra-articular model. 
For the defects repaired with a hydrogel graft, a matrix consisting of glycosaminoglycans and 
collagen was deposited within the bulk of the graft for all samples. No clear differences in bulk matrix 
were observed between groups. More consistent cartilage-cartilage integration, however, was observed 
in the groups that were augmented with an integration scaffold. New tissue formation in these samples 
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appeared to align with the location of the fibrous scaffold and was rich in glycosaminoglycans and 
collagen. Integration in the cup-repaired hydrogel samples was observed in the deep, middle, and surface 
zones of the cartilage, and the cells in the repair tissue were similar in appearance to the cells in the 
adjacent host tissue. The integration observed for the hydrogel groups is not surprising because the 
hydrogel graft used in this study is an immature tissue engineered graft, and immature grafts integrate 
with host tissue better than more mature grafts [199;201]. The addition of the agarose-calcium deficient 
apatite base resulted in dense glycosaminoglycan deposition in the base of the graft and aligned 
collagen, visible under polarized light. Interestingly, alignment of the collagen was not observed at the 
base of any other hydrogel groups, suggesting that that addition of agarose-calcium deficient apatite 
leads to more organized tissue formation at the cartilage-bone interface. This finding parallels results from 
the rabbit study completed by Kharanrian et al. [17], in which the combination of a polymer mesh and 
agarose-ceramic scaffold resulted in calcified cartilage formation that was more organized than in cases 
in which the defect was repaired with either an agarose-ceramic scaffold or polymer-ceramic scaffold 
alone. The mechanism by which the hydrogel-ceramic base drives tissue organization, however, remains 
unknown. 
This study enables the comparison between in vitro culture and subcutaneous culture of the full 
thickness defect model. In chapter 7, the model was cultured in static conditions in media that was 
replaced three times weekly, whereas in this chapter, the explant tissue was transferred to a 
subcutaneous pouch within one day of defect creation. As expected, the additional nutrients and the 
dynamic environment of the subcutaneous pouch result in more robust tissue growth, observed 
histologically. While differences between in vitro and in vivo culture are influenced by the available 
nutrients, they may also have been, in part, due to the difference in scaffold degradation rates in vitro and 
in vivo, as polymers degrade faster in vivo [212;213]. Therefore, although the same timepoint was used 
for both studies (four weeks), they may have been at different stages in the healing process.  
In this study, the use of explant tissue provided a model to study the interaction of repair scaffolds 
with host and graft tissue. The data described here indicate that subcutaneous culture of the full thickness 
explant model can be used to study a variety of cartilage repair methods. Although this model provides a 
valuable platform to study scaffold-host interaction and integration, it has several limitations which should 
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be addressed in subsequent studies. Since the explant tissue was isolated from the marrow, synovium, 
and mechanical loading that are found in the joint, the spontaneous repair that is observed in intra-
articular cartilage defects [214] is not recapitulated in this model. For example, after an intra-articular 
defect is formed, migrating cells from the synovial tissues may enhance scaffold-guided repair 
Furthermore, since mechanical loading and growth factors have a synergistic effect on cartilage formation 
[166], the growth-factor releasing scaffold may result in more cartilage formation in a loaded environment. 
The lack of marrow in the bone compartment also reduces exposure to cells, such as mesenchymal stem 
cells, which may populate the base of the cup and contribute to calcified cartilage formation in vivo. In this 
study, a glycosaminoglycan-rich tissue was observed in the bone compartment of the cell implantation-
repaired groups, suggesting that chondrocytes injected into the defect penetrated into the bone 
compartment. In an intra-articular defect, this would be less likely, as the creation of a defect results in 
blood that travels upward into the defect. The upward motion of the blood may counteract the downward 
trajectory of the cells injected into the defect. Another limitation of this model is the immaturity of the 
neonatal tissue used, as immature cartilage has higher cell density than older cartilage and possesses a 
greater innate healing capacity [74]. To elucidate the importance of these key differences, a full thickness 
defect model derived from mature tissue or in an intra-articular model of a mature animal could be used.  
8.5 Conclusions 
The results of this study collectively demonstrate that the integration scaffold system can be used to 
augment autografts, tissue engineered grafts, and cell implantation procedures. Furthermore, the 
optimized integration cup promotes cartilaginous tissue deposition at the graft-host cartilage junction in 
hydrogel and cell-based repairs.   
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Figure 8.1 Study design. Eight groups were generated by repairing the full thickness defect using 
different techniques. The repaired samples were cultured subcutaneously in an athymic rat for four 
weeks. 
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Figure 8.2 Subcutaneous rat study surgical procedure. An incision is made by holding the skin taut 
while a second surgeon creates a lateral cut using a #15 blade. The skin is then released and 
Metzenbaum scissors are used to create a subcutaneous pouch along the side of the animal. The 
repaired explant sample is placed into the pouch, the incision is closed using wound clips, and the 




Figure 8.3 Samples after in vivo implantation. All samples maintained similar dimensions and 






















Figure 8.4 Histology overview of repair. All sample defects were filled with repair tissue after 
implantation (hematoxylin and eosin, scale bar = 1 mm).  
















































Figure 8.5 Autograft control repair. The top three images show a cross-section stained with safranin-O 
(left) picrosirius red (middle) and collagen II (right) staining (4x, bar = 1 mm). Regions of interest are 
imaged (10x, bar = 200 µm) from areas indicated in the low magnification image with and without a 
polarizer. The hematoxylin and eosin (H&E) images in the top panel represent regions similar to the areas 
identified in the safranin-o overview image.    











































Figure 8.6 Autograft with control cup repair. The top three images show a cross-section stained with 
safranin-O (left) picrosirius red (middle) and collagen II (right) staining (4x, bar = 1 mm). Regions of 
interest are imaged (10x, bar = 200 µm) from areas indicated in the low magnification image with and 
without a polarizer. The hematoxylin and eosin (H&E) images in the top panel represent regions similar to 
the areas identified in the safranin-o overview image. 









































Figure 8.7 Autograft with IGF cup repair. The top three images show a cross-section stained with 
safranin-O (left) picrosirius red (middle) and collagen II (right) staining (4x, bar = 1 mm). Regions of 
interest are imaged (10x, bar = 200 µm) from areas indicated in the low magnification image with and 
without a polarizer. The hematoxylin and eosin (H&E) images in the top panel represent regions similar to 
the areas identified in the safranin-o overview image. 









































Figure 8.8 Chondrocyte implantation control repair. The top three images show a cross-section 
stained with safranin-O (left) picrosirius red (middle) and collagen II (right) staining (4x, bar = 1 mm). 
Regions of interest are imaged (10x, bar = 200 µm) from areas indicated in the low magnification image 
with and without a polarizer. The hematoxylin and eosin (H&E) images in the top panel represent regions 
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Figure 8.9 Chondrocyte implantation with IGF cup repair. The top three images show a cross-section 
stained with safranin-O (left) picrosirius red (middle) and collagen II (right) staining (4x, bar = 1 mm). 
Regions of interest are imaged (10x, bar = 200 µm) from areas indicated in the low magnification image 
with and without a polarizer. The hematoxylin and eosin (H&E) images in the top panel represent regions 
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Figure 8.10 Hydrogel graft control repair. The top three images show a cross-section stained with 
safranin-O (left) picrosirius red (middle) and collagen II (right) staining (4x, bar = 1 mm). Regions of 
interest are imaged (10x, bar = 200 µm) from areas indicated in the low magnification image with and 
without a polarizer. The hematoxylin and eosin (H&E) images in the top panel represent regions similar to 
the areas identified in the safranin-o overview image. 










































Figure 8.11 Hydrogel graft with IGF cup repair. The top three images show a cross-section stained 
with safranin-O (left) picrosirius red (middle) and collagen II (right) staining (4x, bar = 1 mm). Regions of 
interest are imaged (10x, bar = 200 µm) from areas indicated in the low magnification image with and 
without a polarizer. The hematoxylin and eosin (H&E) images in the top panel represent regions similar to 
the areas identified in the safranin-o overview image. 











































Figure 8.12 Hydrogel graft with IGF cup and agarose-calcium deficient apatite base repair. The top 
three images show a cross-section stained with safranin-O (left) picrosirius red (middle) and collagen II 
(right) staining (4x, bar = 1 mm). Regions of interest are imaged (10x, bar = 200 µm) from areas indicated 
in the low magnification image with and without a polarizer. The hematoxylin and eosin (H&E) images in 












































   
Figure 8.13 Mineralization. The bone and the bottom of the cup scaffold stain positively for mineral (von 
Kossa and safranin-O, scale bar = 1 mm).  





















































The objective of this thesis was to design a multi-phased integration scaffold for cartilage repair to 
improve healing of joint injuries. A scaffold was rationally designed and tested to address shortcomings of 
tissue repair methods that currently limit long-term clinical outcomes. The ideal scaffold system should 
promote graft integration to the host tissue at both the cartilage-cartilage and the cartilage-bone 
interfaces. The scaffold should increase cellularity at the cartilage-cartilage interface to promote cell-
mediated biological fixation of the graft and enhance calcified cartilage formation at the graft-subchondral 
bone junction. Finally, the ideal scaffold should be compatible with current clinical repair strategies. It was 
hypothesized that a cup-shaped scaffold, with insulin-like growth factor-1 in the walls to home cells and 
bioactive ceramic in the base to promote calcified cartilage formation, would promote integration of 
cartilage grafts at both the cartilage-cartilage and cartilage-bone interfaces. 
To evaluate these hypotheses, studies were designed to address three specific aims. Aim 1 
focused on the design and optimization of the cup walls to address cartilage-cartilage integration. To this 
end, insulin-like growth factor-1, a chemical homing agent for chondrocytes and stem cells, was 
incorporated into electrospun fibrous scaffolds to attract cells from cartilage tissue into the scaffold. The 
dose of insulin-like growth factor-1 was optimized to promote the homing of cells into the scaffold (chapter 
2). It was demonstrated that the insulin-like growth factor-1, incorporated at 100 ng/mg, significantly 
increased cell number on scaffolds cultured adjacent to cartilage tissue compared to growth factor-free 
control scaffolds. Next, the response of chondrocytes on the scaffold was assessed and it was shown that 
the scaffold supports cell attachment, viability, and matrix elaboration (chapter 3).  
In Aim 2, cartilage-bone integration was addressed. Bioactive ceramics were evaluated with 
varying crystallinity to optimize the ceramic phase of the scaffold (Chapter 4). Calcium deficient apatite, a 
biomimetic, bioactive calcium phosphate, was identified as an optimal ceramic for osteochondral interface 
regeneration because it significantly enhanced collagen II and glycosaminoglycan deposition. Since 
preliminary in vivo data had suggested that a polymer fiber-hydrogel-ceramic composite may be ideal for 
calcified cartilage regeneration, the ceramic dose was optimized in both agarose (Chapter 5) and 
polymeric fiber scaffolds (Chapter 6).  
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After optimizing both the walls and base of the cup for cartilage-cartilage and cartilage-bone 
integration, Aim 3 evaluated the potential for clinical translation of the complete scaffold. Using bovine 
tissue, a full thickness defect model was developed, characterized, and used to test the scaffold system. 
The cup system was used to repair the defect in conjunction with autologous tissue grafts, chondrocyte 
implantation, and hydrogel-based tissue engineered cartilage grafts. The effect of the cup on healing and 
integration was evaluated in vitro (chapter 7) and in vivo (chapter 8) with a subcutaneous athymic rat 
model. The major findings of each chapter are briefly highlighted below.  
9.1.1 Scaffold Design and Optimization for Cartilage-Cartilage Integration 
 The first aim developed and optimized the walls of the cup for placement at the cartilage-cartilage 
junction to promote integration. The walls were designed to be thin, easy-to-handle, degradable, and able 
to release homing agents. To meet these criteria, a polymeric fiber-based scaffold was developed by 
electrospinning a blend of poly(lactide-co-glycolide) and polycaprolactone with incorporated insulin-like 
growth factor-1. In chapter 2, the number of cells on scaffolds that were cultured adjacent to cartilage 
tissue was measured as a function of the concentration of insulin-like growth factor-1 in the fibers 
(chapter 2). Growth factor incorporation at 100 ng/mg led to increased cell number on scaffolds after two 
weeks of in vitro culture. This finding demonstrated that the release of a homing agent from a fibrous 
scaffold increases cellularity, and this dose of insulin-like growth factor-1 was used in subsequent studies. 
Chapter 3 determined the response of chondrocytes to the growth factor-releasing scaffold. Isolated from 
bovine tissue and seeded on the scaffolds, the chondrocytes demonstrated cell attachment, viability, and 
matrix elaboration. Lower mineralization potential was measured for scaffolds containing growth factors 
compared to those without. Collectively, these results informed the design of the walls of the cup, the 
cartilage-cartilage integration phase of the scaffold system.  
9.1.2 Scaffold Design and Optimization for Cartilage-Bone Integration 
 The second aim developed the base of the cup, designed to be placed at the cartilage-bone 
interface and optimized to promote integration by the formation of calcified cartilage. Previous reports 
showed that ceramics within a polymer scaffold promote cell-mediated formation of calcified cartilage 
[11;15]. Thus, bioactive calcium phosphates were incorporated into agarose hydrogels, and the response 
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of deep zone chondrocytes was evaluated with varying ceramic crystallinity (chapter 4). Poorly crystalline 
calcium deficient apatite resulted in significantly more glycosaminoglycan and collagen production over 
time compared to scaffolds without ceramic or with incorporated tricalcium phosphate, a crystalline 
ceramic. Next, the dose of calcium deficient apatite was optimized in agarose hydrogel scaffolds and 
polymer fiber scaffolds. For both scaffold platforms, a dose of ceramic was identified that promoted cell 
growth and biosynthesis, resulting in a calcified cartilage-like tissue.  
9.1.3 Evaluating the Clinical Potential of the Integrative Scaffold System 
 The third aim evaluated the clinical potential of the total integrative scaffold system. As tissue 
grafts and cell-based therapies are used in the clinic to treat cartilage lesions, the cup was tested with 
both approaches. In addition, since tissue-engineered cartilage grafts have been approved in Europe and 
are in the pipeline for FDA approval, the cup was also tested with an agarose-based, tissue-engineered 
cartilage graft. To evaluate clinical implementation, bovine osteochondral tissue was harvested, and a full 
thickness defect was made in the cartilage tissue. This organ culture model, derived from a large animal 
with cartilage sufficiently thick for scaffold evaluation, avoids the high costs associated with large animal 
in vivo studies. In vitro testing of the cup in the defect model demonstrated that the scaffold system was 
compatible with clinical repair techniques and led to stronger cartilage-cartilage integration (chapter 7). 
Subsequently, the full thickness defect model, repaired with the integration scaffold, was implanted 
subcutaneously into athymic rats, and cells migrated into the cup, depositing new tissue at the graft-host 
interface. When combined with the agarose-calcium deficient apatite base and used with the hydrogel 
graft, the cup scaffold resulted in organized collagen formation at the cartilage-bone interface.  
9.2 Future Directions 
The findings of this thesis demonstrate the promise of using a multi-phased scaffold to address 
cartilage-graft integration. However, to realize the clinical translation of the scaffold system, several areas 
of further study are needed, as described below. 
9.2.1 Human Cartilage Organ Model Testing 
 The bovine full thickness defect model enabled the evaluation of the clinical implementation of the 
integration scaffold system in conjunction with techniques similar to those used in the clinic. Nevertheless, 
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the immature cartilage tissue is inherently different from the tissue that would interact with the scaffold in 
a human surgery. To address this, the full thickness defect model could be extended to human 
osteochondral tissue. While human tissue is less available, excess osteochondral tissue can be 
harvested for this purpose from human grafts after allografting procedures. 
9.2.2 Intra-Articular in Vivo Testing 
 Although the full thickness defect model enables evaluation of the scaffold with host cartilage and 
bone tissue, it is necessary to evaluate the scaffold in the intra-articular environment. Compared to the 
organ culture model, an intra-articular model, such as the rabbit, would enable assessment of the scaffold 
in an environment with mechanical loading and the chemical cues from synovial fluid. 
9.2.3 Stem Cell-Seeded Scaffold  
 While an acellular approach offers advantages in cost, packaging, and clinical implementation, 
pre-seeding the scaffold with stem cells may improve the integration capacity of the system. Future 
studies will investigate the effects of scaffolds pre-seeded with synovium derived stem cells, which are 
well-suited for cartilage repair. In addition, the recent development of induced pluripotent stem cells 
(iPSC) may enable cell-based approaches that do not require an additional surgical procedure [215]. 
Preliminary studies with bovine synovium-derived stem cells show that the scaffolds support stem cell 
attachment and viability (Fig. 9.1), live stem cell tracking shown in red); however culture conditions will 




Figure 9.1 Synovium 
Derived Stem Cells on 
Microfiber Scaffolds 
with and without IGF. 
Synovium derived stem 
cells are shown in red on 
microfiber scaffolds. The 
cells attached and 
uniformly on the scaffolds 
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